document.write('

'); document.write('

ClinicalTrials.gov: Myocardial infarction AND Ischemia

'); document.write('

Evaluating the Effectiveness of the LifeVest Defibrillator and Improving Methods for Determining the Use of Implantable Cardioverter Defibrillators (The VEST/PREDICTS Study) <b>Conditions</b>: Death, Sudden, Cardiac; Myocardial Infarction; Arrhythmias, Cardiac<br/><b>Intervention</b>: Device: LifeVest<br/><b>Sponsors</b>: National Heart, Lung, and Blood Institute (NHLBI); Medtronic; ZOLL Lifecor; General Electric<br/><b>Not yet recruiting</b> - verified February 2008
Effect of Adjunctive Intracoronary Streptokinase on Late Term Left Ventricular Infarct Size and Volumes in Patients With Acute Myocardial Infarction <b>Conditions</b>: Acute Coronary Syndromes; Acute Myocardial Infarction; Reperfusion Injury<br/><b>Interventions</b>: Drug: Streptokinase; Procedure: primary percutanaeous coronary intervention<br/><b>Sponsor</b>: Istanbul University<br/><b>Completed</b> - verified February 2008
Beta-Cell Function in Glucose Abnormalities and Acute Myocardial Infarction <b>Conditions</b>: Myocardial Infarction; Unstable Angina Pectoris; Diabetes Mellitus; Impaired Glucose Tolerance<br/><b>Intervention</b>: Drug: Vildagliptin<br/><b>Sponsor</b>: Karolinska Institutet<br/><b>Not yet recruiting</b> - verified January 2008
Long Term Follow-up of Autologous Bone Marrow Mononuclear Cells Therapy in STEMI <b>Condition</b>: Myocardial Infarction<br/><b>Interventions</b>: Procedure: saline infusion; Procedure: autologous bone marrow mononuclear cells infusion<br/><b>Sponsor</b>: Xijing Hospital<br/><b>Active, not recruiting</b> - verified February 2008
XIENCE™ V Everolimus Eluting Coronary Stent System India Post-Marketing Registry <b>Conditions</b>: Coronary Disease; Coronary Artery Disease; Coronary Restenosis<br/><b>Intervention</b>: Device: XIENCE™ V Everolimus Eluting Coronary Stent<br/><b>Sponsor</b>: Abbott Vascular<br/><b>Recruiting</b> - verified February 2008
Do You Need to Assess Myocardial Ischemia in Type 2 Diabetes <b>Condition</b>: Type 2 Diabetes<br/><b>Intervention</b>: Other: a bicycle exercise test<br/><b>Sponsor</b>: Hospices Civils de Lyon<br/><b>Terminated</b> - verified February 2008
STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction <b>Condition</b>: Myocardial Infarction<br/><b>Interventions</b>: Drug: Tenecteplase; Drug: Clopidogrel, Enoxaparin; Procedure: Catheterisation<br/><b>Sponsor</b>: Boehringer Ingelheim Pharmaceuticals<br/><b>Not yet recruiting</b> - verified February 2008
3 Nehb Precordial Leads Anterior, Dorsalis and Inferior Allow Accurate Diagnostics of Different Heart Conditions <b>Condition</b>: Acute Myocardial Infarction With ST Segment Elevation<br/><b>Intervention</b>: <br/><b>Sponsor</b>: Assaf-Harofeh Medical Center<br/><b>Recruiting</b> - verified June 2007
Cost-Effectiveness Study in the Reduction of Coronary Restenosis With Sirolimus-Eluting Stents <b>Condition</b>: Coronary Artery Disease<br/><b>Interventions</b>: Device: bare metal stent; Device: Cypher-Stent (Implantation of a sirolimus-eluting stent)<br/><b>Sponsors</b>: Charite University, Berlin, Germany; Techniker Krankenkasse<br/><b>Completed</b> - verified February 2008
Left Ventricular Function Assessment After Acute Myocardial Infarction: Comparison Between Bi-, Three-Dimensional and Cardiac Magnetic Resonance <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Other: compare measurements of left ventricular volumes and LVEF (by Cardiac Magnetic Resonance and Echocardiography)<br/><b>Sponsor</b>: Assistance Publique Hopitaux De Marseille<br/><b>Not yet recruiting</b> - verified February 2008
Safety and Efficacy Study of Stem Cell Transplantation to Treat Dilated Cardiomyopathy <b>Condition</b>: Dilated Cardiomyopathy<br/><b>Intervention</b>: Biological: CD34+ autologous stem cell transplantation<br/><b>Sponsors</b>: University Medical Centre Ljubljana; Blood Transfusion Center of Republic of Slovenia<br/><b>Recruiting</b> - verified February 2008
Trial to Assess the Ocular Safety of SCH 530348 in Patients With Atherosclerosis (Study P05183) <b>Conditions</b>: Atherosclerosis; Ischemia; Myocardial Infarction; Cerebrovascular Accident<br/><b>Interventions</b>: Drug: SCH 530348; Drug: Placebo<br/><b>Sponsors</b>: Schering-Plough; The TIMI Study Group; Duke University<br/><b>Not yet recruiting</b> - verified February 2008
Perioperative Depression and Postoperative Arrhythmia in Elective Coronary Bypass Graft Surgery <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University Health Network, Toronto<br/><b>Recruiting</b> - verified January 2008
Stem Cell Study for Subjects With CHF <b>Conditions</b>: Myocardial Ischemia; Congestive Heart Failure; Cardiovascular Disease<br/><b>Intervention</b>: Biological: Autologous Stem Cells<br/><b>Sponsor</b>: Losordo, Douglas, M.D.<br/><b>Not yet recruiting</b> - verified February 2008
Survival of Patients With Primary Prophylactic ICD Indication <b>Conditions</b>: Death From Any Cause; Sudden Cardiac Death; Non-Sudden Cardiac Death<br/><b>Interventions</b>: Other: Intensified diagnostic and treatment measures following 1st appropriate ICD therapy; Other: Standard follow-up<br/><b>Sponsor</b>: Biotronik GmbH & Co. KG<br/><b>Recruiting</b> - verified February 2008
The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: tirofiban<br/><b>Sponsor</b>: Samsung Medical Center<br/><b>Completed</b> - verified August 2007
Prophylactic Intra-Coronary Adenosine to Prevent Post Coronary Artery Stenting Myonecrosis <b>Conditions</b>: Coronary Artery Stenosis; Coronary Artery Disease<br/><b>Intervention</b>: Drug: Adenosine<br/><b>Sponsor</b>: University of Ottawa Heart Institute<br/><b>Recruiting</b> - verified January 2008
Italian Registry on Unprotected Left Main <b>Conditions</b>: Cardiovascular Disease; Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University of Turin, Italy<br/><b>Not yet recruiting</b> - verified January 2008
Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-Aortic Balloon Counterpulsation <b>Conditions</b>: Shock, Cardiogenic; Heart Failure; Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Pyruvate<br/><b>Sponsor</b>: Herzzentrum Goettingen<br/><b>Not yet recruiting</b> - verified January 2008
Bare Metal Bifurcation Stent Clinical Trial in Humans <b>Conditions</b>: Coronary Artery Disease; Myocardial Ischemia<br/><b>Intervention</b>: Device: Medtronic Bifurcation Stent System<br/><b>Sponsor</b>: Medtronic Vascular<br/><b>Not yet recruiting</b> - verified January 2008
Randomized Multi-Center Comparison of the Conor Sirolimus-Eluting Coronary Stent to the Taxus Liberte Paclitaxel-Eluting Coronary Stent in the Treatment of Coronary Artery Lesions <b>Condition</b>: Coronary Atherosclerosis<br/><b>Interventions</b>: Device: Drug-eluting stent (Conor Cobalt Chromium Sirolimus-eluting Coronary Stent System); Device: Drug-eluting stent (TAXUS Liberte Paclitaxel-eluting Coronary Stent System)<br/><b>Sponsor</b>: Conor Medsystems<br/><b>Not yet recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccination in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified February 2008
Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™ <b>Conditions</b>: Transient Ischemic Attack; Thromboembolic Stroke; Stroke Prevention<br/><b>Interventions</b>: Device: EndoTex™ NexStent™; Device: Filter Wire EZ™<br/><b>Sponsor</b>: Boston Scientific Corporation<br/><b>Completed</b> - verified January 2008
Examining Heart Attacks in Young Women (The Variation In Recovery: Role of Gender on Outcomes in Young AMI Patients [VIRGO] Study) <b>Condition</b>: Myocardial Infarction<br/><b>Intervention</b>: <br/><b>Sponsor</b>: National Heart, Lung, and Blood Institute (NHLBI)<br/><b>Active, not recruiting</b> - verified January 2008
Study of 99mTc-Glucarate to Detect Acute Coronary Syndrome in Chest Pain Patients. <b>Condition</b>: Acute Coronary Syndrome<br/><b>Intervention</b>: Drug: 99mTc-glucarate solution<br/><b>Sponsors</b>: Molecular Targeting Technologies, Inc.; National Heart, Lung, and Blood Institute (NHLBI); Yale University<br/><b>Not yet recruiting</b> - verified February 2008
A Safety/Efficacy Study of Intra-Coronary Tenecteplase During Balloon Angioplasty to Treat Heart Attacks <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Tenecteplase<br/><b>Sponsors</b>: Brigham and Women's Hospital; Genentech<br/><b>Not yet recruiting</b> - verified January 2008
Drug Eluting Stents for In-Stent Restenosis 2 <b>Condition</b>: Coronary Disease<br/><b>Interventions</b>: Device: Sirolimus eluting stent (Cypher); Device: Paclitaxel-eluting stent (Taxus)<br/><b>Sponsors</b>: Deutsches Herzzentrum Muenchen; Technische Universität München<br/><b>Recruiting</b> - verified January 2008
Efficacy Study of Rapamycin- and Zotarolimus-Eluting Stents to Reduce Coronary Restenosis <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: rapamycin+probucol-eluting stent (ISAR stent); Device: polymer based Zotarolimus-eluting stent (Endeavor Resolute)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Not yet recruiting</b> - verified January 2008
3 Limus Agent Eluting Stents With Different Polymer Coating <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: biodegradable polymer Rapamycin-eluting stent (ISAR stent); Device: permanent polymer rapamycin-eluting stent (Cypher); Device: permanent polymer everolimus-eluting stent (Xience, Promus)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Efficacy Study of Drug-Eluting and Bare Metal Stents in Bypass Graft Lesions <b>Condition</b>: Coronary Artery Bypass<br/><b>Interventions</b>: Device: Cypher drug-eluting stent; Device: Taxus drug-eluting stent; Device: ISAR drug-eluting stent; Device: bare metal stents<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008

'); document.write('

'); document.write('

'); document.write('

ClinicalTrials.gov: Myocardial infarction AND Ischemia

'); document.write('

Evaluating the Effectiveness of the LifeVest Defibrillator and Improving Methods for Determining the Use of Implantable Cardioverter Defibrillators (The VEST/PREDICTS Study) <b>Conditions</b>: Death, Sudden, Cardiac; Myocardial Infarction; Arrhythmias, Cardiac<br/><b>Intervention</b>: Device: LifeVest<br/><b>Sponsors</b>: National Heart, Lung, and Blood Institute (NHLBI); Medtronic; ZOLL Lifecor; General Electric<br/><b>Not yet recruiting</b> - verified February 2008
Effect of Adjunctive Intracoronary Streptokinase on Late Term Left Ventricular Infarct Size and Volumes in Patients With Acute Myocardial Infarction <b>Conditions</b>: Acute Coronary Syndromes; Acute Myocardial Infarction; Reperfusion Injury<br/><b>Interventions</b>: Drug: Streptokinase; Procedure: primary percutanaeous coronary intervention<br/><b>Sponsor</b>: Istanbul University<br/><b>Completed</b> - verified February 2008
Beta-Cell Function in Glucose Abnormalities and Acute Myocardial Infarction <b>Conditions</b>: Myocardial Infarction; Unstable Angina Pectoris; Diabetes Mellitus; Impaired Glucose Tolerance<br/><b>Intervention</b>: Drug: Vildagliptin<br/><b>Sponsor</b>: Karolinska Institutet<br/><b>Not yet recruiting</b> - verified January 2008
Long Term Follow-up of Autologous Bone Marrow Mononuclear Cells Therapy in STEMI <b>Condition</b>: Myocardial Infarction<br/><b>Interventions</b>: Procedure: saline infusion; Procedure: autologous bone marrow mononuclear cells infusion<br/><b>Sponsor</b>: Xijing Hospital<br/><b>Active, not recruiting</b> - verified February 2008
Do You Need to Assess Myocardial Ischemia in Type 2 Diabetes <b>Condition</b>: Type 2 Diabetes<br/><b>Intervention</b>: Other: a bicycle exercise test<br/><b>Sponsor</b>: Hospices Civils de Lyon<br/><b>Terminated</b> - verified February 2008
3 Nehb Precordial Leads Anterior, Dorsalis and Inferior Allow Accurate Diagnostics of Different Heart Conditions <b>Condition</b>: Acute Myocardial Infarction With ST Segment Elevation<br/><b>Intervention</b>: <br/><b>Sponsor</b>: Assaf-Harofeh Medical Center<br/><b>Recruiting</b> - verified June 2007
STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction <b>Condition</b>: Myocardial Infarction<br/><b>Interventions</b>: Drug: Tenecteplase; Drug: Clopidogrel, Enoxaparin; Procedure: Catheterisation<br/><b>Sponsor</b>: Boehringer Ingelheim Pharmaceuticals<br/><b>Not yet recruiting</b> - verified February 2008
Cost-Effectiveness Study in the Reduction of Coronary Restenosis With Sirolimus-Eluting Stents <b>Condition</b>: Coronary Artery Disease<br/><b>Interventions</b>: Device: bare metal stent; Device: Cypher-Stent (Implantation of a sirolimus-eluting stent)<br/><b>Sponsors</b>: Charite University, Berlin, Germany; Techniker Krankenkasse<br/><b>Completed</b> - verified February 2008
Left Ventricular Function Assessment After Acute Myocardial Infarction: Comparison Between Bi-, Three-Dimensional and Cardiac Magnetic Resonance <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Other: compare measurements of left ventricular volumes and LVEF (by Cardiac Magnetic Resonance and Echocardiography)<br/><b>Sponsor</b>: Assistance Publique Hopitaux De Marseille<br/><b>Not yet recruiting</b> - verified February 2008
Safety and Efficacy Study of Stem Cell Transplantation to Treat Dilated Cardiomyopathy <b>Condition</b>: Dilated Cardiomyopathy<br/><b>Intervention</b>: Biological: CD34+ autologous stem cell transplantation<br/><b>Sponsors</b>: University Medical Centre Ljubljana; Blood Transfusion Center of Republic of Slovenia<br/><b>Recruiting</b> - verified February 2008
Trial to Assess the Ocular Safety of SCH 530348 in Patients With Atherosclerosis (Study P05183) <b>Conditions</b>: Atherosclerosis; Ischemia; Myocardial Infarction; Cerebrovascular Accident<br/><b>Interventions</b>: Drug: SCH 530348; Drug: Placebo<br/><b>Sponsors</b>: Schering-Plough; The TIMI Study Group; Duke University<br/><b>Not yet recruiting</b> - verified February 2008
Perioperative Depression and Postoperative Arrhythmia in Elective Coronary Bypass Graft Surgery <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University Health Network, Toronto<br/><b>Recruiting</b> - verified January 2008
Stem Cell Study for Subjects With CHF <b>Conditions</b>: Myocardial Ischemia; Congestive Heart Failure; Cardiovascular Disease<br/><b>Intervention</b>: Biological: Autologous Stem Cells<br/><b>Sponsor</b>: Losordo, Douglas, M.D.<br/><b>Not yet recruiting</b> - verified February 2008
Survival of Patients With Primary Prophylactic ICD Indication <b>Conditions</b>: Death From Any Cause; Sudden Cardiac Death; Non-Sudden Cardiac Death<br/><b>Interventions</b>: Other: Intensified diagnostic and treatment measures following 1st appropriate ICD therapy; Other: Standard follow-up<br/><b>Sponsor</b>: Biotronik GmbH & Co. KG<br/><b>Recruiting</b> - verified February 2008
The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: tirofiban<br/><b>Sponsor</b>: Samsung Medical Center<br/><b>Completed</b> - verified August 2007
Prophylactic Intra-Coronary Adenosine to Prevent Post Coronary Artery Stenting Myonecrosis <b>Conditions</b>: Coronary Artery Stenosis; Coronary Artery Disease<br/><b>Intervention</b>: Drug: Adenosine<br/><b>Sponsor</b>: University of Ottawa Heart Institute<br/><b>Recruiting</b> - verified January 2008
Italian Registry on Unprotected Left Main <b>Conditions</b>: Cardiovascular Disease; Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University of Turin, Italy<br/><b>Not yet recruiting</b> - verified January 2008
Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-Aortic Balloon Counterpulsation <b>Conditions</b>: Shock, Cardiogenic; Heart Failure; Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Pyruvate<br/><b>Sponsor</b>: Herzzentrum Goettingen<br/><b>Not yet recruiting</b> - verified January 2008
Bare Metal Bifurcation Stent Clinical Trial in Humans <b>Conditions</b>: Coronary Artery Disease; Myocardial Ischemia<br/><b>Intervention</b>: Device: Medtronic Bifurcation Stent System<br/><b>Sponsor</b>: Medtronic Vascular<br/><b>Not yet recruiting</b> - verified January 2008
Randomized Multi-Center Comparison of the Conor Sirolimus-Eluting Coronary Stent to the Taxus Liberte Paclitaxel-Eluting Coronary Stent in the Treatment of Coronary Artery Lesions <b>Condition</b>: Coronary Atherosclerosis<br/><b>Interventions</b>: Device: Drug-eluting stent (Conor Cobalt Chromium Sirolimus-eluting Coronary Stent System); Device: Drug-eluting stent (TAXUS Liberte Paclitaxel-eluting Coronary Stent System)<br/><b>Sponsor</b>: Conor Medsystems<br/><b>Not yet recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccination in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified February 2008
Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™ <b>Conditions</b>: Transient Ischemic Attack; Thromboembolic Stroke; Stroke Prevention<br/><b>Interventions</b>: Device: EndoTex™ NexStent™; Device: Filter Wire EZ™<br/><b>Sponsor</b>: Boston Scientific Corporation<br/><b>Completed</b> - verified January 2008
Examining Heart Attacks in Young Women (The Variation In Recovery: Role of Gender on Outcomes in Young AMI Patients [VIRGO] Study) <b>Condition</b>: Myocardial Infarction<br/><b>Intervention</b>: <br/><b>Sponsor</b>: National Heart, Lung, and Blood Institute (NHLBI)<br/><b>Active, not recruiting</b> - verified January 2008
Study of 99mTc-Glucarate to Detect Acute Coronary Syndrome in Chest Pain Patients. <b>Condition</b>: Acute Coronary Syndrome<br/><b>Intervention</b>: Drug: 99mTc-glucarate solution<br/><b>Sponsors</b>: Molecular Targeting Technologies, Inc.; National Heart, Lung, and Blood Institute (NHLBI); Yale University<br/><b>Not yet recruiting</b> - verified February 2008
A Safety/Efficacy Study of Intra-Coronary Tenecteplase During Balloon Angioplasty to Treat Heart Attacks <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Tenecteplase<br/><b>Sponsors</b>: Brigham and Women's Hospital; Genentech<br/><b>Not yet recruiting</b> - verified January 2008
Drug Eluting Stents for In-Stent Restenosis 2 <b>Condition</b>: Coronary Disease<br/><b>Interventions</b>: Device: Sirolimus eluting stent (Cypher); Device: Paclitaxel-eluting stent (Taxus)<br/><b>Sponsors</b>: Deutsches Herzzentrum Muenchen; Technische Universität München<br/><b>Recruiting</b> - verified January 2008
Efficacy Study of Rapamycin- and Zotarolimus-Eluting Stents to Reduce Coronary Restenosis <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: rapamycin+probucol-eluting stent (ISAR stent); Device: polymer based Zotarolimus-eluting stent (Endeavor Resolute)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Not yet recruiting</b> - verified January 2008
3 Limus Agent Eluting Stents With Different Polymer Coating <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: biodegradable polymer Rapamycin-eluting stent (ISAR stent); Device: permanent polymer rapamycin-eluting stent (Cypher); Device: permanent polymer everolimus-eluting stent (Xience, Promus)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Efficacy Study of Drug-Eluting and Bare Metal Stents in Bypass Graft Lesions <b>Condition</b>: Coronary Artery Bypass<br/><b>Interventions</b>: Device: Cypher drug-eluting stent; Device: Taxus drug-eluting stent; Device: ISAR drug-eluting stent; Device: bare metal stents<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008

'); document.write('

'); document.write('

'); document.write('

ClinicalTrials.gov: Myocardial infarction AND Ischemia

'); document.write('

Evaluating the Effectiveness of the LifeVest Defibrillator and Improving Methods for Determining the Use of Implantable Cardioverter Defibrillators (The VEST/PREDICTS Study) <b>Conditions</b>: Death, Sudden, Cardiac; Myocardial Infarction; Arrhythmias, Cardiac<br/><b>Intervention</b>: Device: LifeVest<br/><b>Sponsors</b>: National Heart, Lung, and Blood Institute (NHLBI); Medtronic; ZOLL Lifecor; General Electric<br/><b>Not yet recruiting</b> - verified February 2008
Effect of Adjunctive Intracoronary Streptokinase on Late Term Left Ventricular Infarct Size and Volumes in Patients With Acute Myocardial Infarction <b>Conditions</b>: Acute Coronary Syndromes; Acute Myocardial Infarction; Reperfusion Injury<br/><b>Interventions</b>: Drug: Streptokinase; Procedure: primary percutanaeous coronary intervention<br/><b>Sponsor</b>: Istanbul University<br/><b>Completed</b> - verified February 2008
Beta-Cell Function in Glucose Abnormalities and Acute Myocardial Infarction <b>Conditions</b>: Myocardial Infarction; Unstable Angina Pectoris; Diabetes Mellitus; Impaired Glucose Tolerance<br/><b>Intervention</b>: Drug: Vildagliptin<br/><b>Sponsor</b>: Karolinska Institutet<br/><b>Not yet recruiting</b> - verified January 2008
Long Term Follow-up of Autologous Bone Marrow Mononuclear Cells Therapy in STEMI <b>Condition</b>: Myocardial Infarction<br/><b>Interventions</b>: Procedure: saline infusion; Procedure: autologous bone marrow mononuclear cells infusion<br/><b>Sponsor</b>: Xijing Hospital<br/><b>Active, not recruiting</b> - verified February 2008
Do You Need to Assess Myocardial Ischemia in Type 2 Diabetes <b>Condition</b>: Type 2 Diabetes<br/><b>Intervention</b>: Other: a bicycle exercise test<br/><b>Sponsor</b>: Hospices Civils de Lyon<br/><b>Terminated</b> - verified February 2008
3 Nehb Precordial Leads Anterior, Dorsalis and Inferior Allow Accurate Diagnostics of Different Heart Conditions <b>Condition</b>: Acute Myocardial Infarction With ST Segment Elevation<br/><b>Intervention</b>: <br/><b>Sponsor</b>: Assaf-Harofeh Medical Center<br/><b>Recruiting</b> - verified June 2007
STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction <b>Condition</b>: Myocardial Infarction<br/><b>Interventions</b>: Drug: Tenecteplase; Drug: Clopidogrel, Enoxaparin; Procedure: Catheterisation<br/><b>Sponsor</b>: Boehringer Ingelheim Pharmaceuticals<br/><b>Not yet recruiting</b> - verified February 2008
Cost-Effectiveness Study in the Reduction of Coronary Restenosis With Sirolimus-Eluting Stents <b>Condition</b>: Coronary Artery Disease<br/><b>Interventions</b>: Device: bare metal stent; Device: Cypher-Stent (Implantation of a sirolimus-eluting stent)<br/><b>Sponsors</b>: Charite University, Berlin, Germany; Techniker Krankenkasse<br/><b>Completed</b> - verified February 2008
Left Ventricular Function Assessment After Acute Myocardial Infarction: Comparison Between Bi-, Three-Dimensional and Cardiac Magnetic Resonance <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Other: compare measurements of left ventricular volumes and LVEF (by Cardiac Magnetic Resonance and Echocardiography)<br/><b>Sponsor</b>: Assistance Publique Hopitaux De Marseille<br/><b>Not yet recruiting</b> - verified February 2008
Safety and Efficacy Study of Stem Cell Transplantation to Treat Dilated Cardiomyopathy <b>Condition</b>: Dilated Cardiomyopathy<br/><b>Intervention</b>: Biological: CD34+ autologous stem cell transplantation<br/><b>Sponsors</b>: University Medical Centre Ljubljana; Blood Transfusion Center of Republic of Slovenia<br/><b>Recruiting</b> - verified February 2008
Trial to Assess the Ocular Safety of SCH 530348 in Patients With Atherosclerosis (Study P05183) <b>Conditions</b>: Atherosclerosis; Ischemia; Myocardial Infarction; Cerebrovascular Accident<br/><b>Interventions</b>: Drug: SCH 530348; Drug: Placebo<br/><b>Sponsors</b>: Schering-Plough; The TIMI Study Group; Duke University<br/><b>Not yet recruiting</b> - verified February 2008
Perioperative Depression and Postoperative Arrhythmia in Elective Coronary Bypass Graft Surgery <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University Health Network, Toronto<br/><b>Recruiting</b> - verified January 2008
Stem Cell Study for Subjects With CHF <b>Conditions</b>: Myocardial Ischemia; Congestive Heart Failure; Cardiovascular Disease<br/><b>Intervention</b>: Biological: Autologous Stem Cells<br/><b>Sponsor</b>: Losordo, Douglas, M.D.<br/><b>Not yet recruiting</b> - verified February 2008
Survival of Patients With Primary Prophylactic ICD Indication <b>Conditions</b>: Death From Any Cause; Sudden Cardiac Death; Non-Sudden Cardiac Death<br/><b>Interventions</b>: Other: Intensified diagnostic and treatment measures following 1st appropriate ICD therapy; Other: Standard follow-up<br/><b>Sponsor</b>: Biotronik GmbH & Co. KG<br/><b>Recruiting</b> - verified February 2008
The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: tirofiban<br/><b>Sponsor</b>: Samsung Medical Center<br/><b>Completed</b> - verified August 2007
Prophylactic Intra-Coronary Adenosine to Prevent Post Coronary Artery Stenting Myonecrosis <b>Conditions</b>: Coronary Artery Stenosis; Coronary Artery Disease<br/><b>Intervention</b>: Drug: Adenosine<br/><b>Sponsor</b>: University of Ottawa Heart Institute<br/><b>Recruiting</b> - verified January 2008
Italian Registry on Unprotected Left Main <b>Conditions</b>: Cardiovascular Disease; Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University of Turin, Italy<br/><b>Not yet recruiting</b> - verified January 2008
Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-Aortic Balloon Counterpulsation <b>Conditions</b>: Shock, Cardiogenic; Heart Failure; Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Pyruvate<br/><b>Sponsor</b>: Herzzentrum Goettingen<br/><b>Not yet recruiting</b> - verified January 2008
Bare Metal Bifurcation Stent Clinical Trial in Humans <b>Conditions</b>: Coronary Artery Disease; Myocardial Ischemia<br/><b>Intervention</b>: Device: Medtronic Bifurcation Stent System<br/><b>Sponsor</b>: Medtronic Vascular<br/><b>Not yet recruiting</b> - verified January 2008
Randomized Multi-Center Comparison of the Conor Sirolimus-Eluting Coronary Stent to the Taxus Liberte Paclitaxel-Eluting Coronary Stent in the Treatment of Coronary Artery Lesions <b>Condition</b>: Coronary Atherosclerosis<br/><b>Interventions</b>: Device: Drug-eluting stent (Conor Cobalt Chromium Sirolimus-eluting Coronary Stent System); Device: Drug-eluting stent (TAXUS Liberte Paclitaxel-eluting Coronary Stent System)<br/><b>Sponsor</b>: Conor Medsystems<br/><b>Not yet recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccination in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified February 2008
Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™ <b>Conditions</b>: Transient Ischemic Attack; Thromboembolic Stroke; Stroke Prevention<br/><b>Interventions</b>: Device: EndoTex™ NexStent™; Device: Filter Wire EZ™<br/><b>Sponsor</b>: Boston Scientific Corporation<br/><b>Completed</b> - verified January 2008
Examining Heart Attacks in Young Women (The Variation In Recovery: Role of Gender on Outcomes in Young AMI Patients [VIRGO] Study) <b>Condition</b>: Myocardial Infarction<br/><b>Intervention</b>: <br/><b>Sponsor</b>: National Heart, Lung, and Blood Institute (NHLBI)<br/><b>Active, not recruiting</b> - verified January 2008
Study of 99mTc-Glucarate to Detect Acute Coronary Syndrome in Chest Pain Patients. <b>Condition</b>: Acute Coronary Syndrome<br/><b>Intervention</b>: Drug: 99mTc-glucarate solution<br/><b>Sponsors</b>: Molecular Targeting Technologies, Inc.; National Heart, Lung, and Blood Institute (NHLBI); Yale University<br/><b>Not yet recruiting</b> - verified February 2008
A Safety/Efficacy Study of Intra-Coronary Tenecteplase During Balloon Angioplasty to Treat Heart Attacks <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Tenecteplase<br/><b>Sponsors</b>: Brigham and Women's Hospital; Genentech<br/><b>Not yet recruiting</b> - verified January 2008
Drug Eluting Stents for In-Stent Restenosis 2 <b>Condition</b>: Coronary Disease<br/><b>Interventions</b>: Device: Sirolimus eluting stent (Cypher); Device: Paclitaxel-eluting stent (Taxus)<br/><b>Sponsors</b>: Deutsches Herzzentrum Muenchen; Technische Universität München<br/><b>Recruiting</b> - verified January 2008
Efficacy Study of Rapamycin- and Zotarolimus-Eluting Stents to Reduce Coronary Restenosis <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: rapamycin+probucol-eluting stent (ISAR stent); Device: polymer based Zotarolimus-eluting stent (Endeavor Resolute)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Not yet recruiting</b> - verified January 2008
3 Limus Agent Eluting Stents With Different Polymer Coating <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: biodegradable polymer Rapamycin-eluting stent (ISAR stent); Device: permanent polymer rapamycin-eluting stent (Cypher); Device: permanent polymer everolimus-eluting stent (Xience, Promus)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Efficacy Study of Drug-Eluting and Bare Metal Stents in Bypass Graft Lesions <b>Condition</b>: Coronary Artery Bypass<br/><b>Interventions</b>: Device: Cypher drug-eluting stent; Device: Taxus drug-eluting stent; Device: ISAR drug-eluting stent; Device: bare metal stents<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008

'); document.write('

'); document.write('

'); document.write('

ClinicalTrials.gov: Myocardial infarction AND Ischemia

'); document.write('

Effect of Adjunctive Intracoronary Streptokinase on Late Term Left Ventricular Infarct Size and Volumes in Patients With Acute Myocardial Infarction <b>Conditions</b>: Acute Coronary Syndromes; Acute Myocardial Infarction; Reperfusion Injury<br/><b>Interventions</b>: Drug: Streptokinase; Procedure: primary percutanaeous coronary intervention<br/><b>Sponsor</b>: Istanbul University<br/><b>Completed</b> - verified February 2008
Beta-Cell Function in Glucose Abnormalities and Acute Myocardial Infarction <b>Conditions</b>: Myocardial Infarction; Unstable Angina Pectoris; Diabetes Mellitus; Impaired Glucose Tolerance<br/><b>Intervention</b>: Drug: Vildagliptin<br/><b>Sponsor</b>: Karolinska Institutet<br/><b>Not yet recruiting</b> - verified January 2008
Long Term Follow-up of Autologous Bone Marrow Mononuclear Cells Therapy in STEMI <b>Condition</b>: Myocardial Infarction<br/><b>Interventions</b>: Procedure: saline infusion; Procedure: autologous bone marrow mononuclear cells infusion<br/><b>Sponsor</b>: Xijing Hospital<br/><b>Active, not recruiting</b> - verified February 2008
Do You Need to Assess Myocardial Ischemia in Type 2 Diabetes <b>Condition</b>: Type 2 Diabetes<br/><b>Intervention</b>: Other: a bicycle exercise test<br/><b>Sponsor</b>: Hospices Civils de Lyon<br/><b>Terminated</b> - verified February 2008
3 Nehb Precordial Leads Anterior, Dorsalis and Inferior Allow Accurate Diagnostics of Different Heart Conditions <b>Condition</b>: Acute Myocardial Infarction With ST Segment Elevation<br/><b>Intervention</b>: <br/><b>Sponsor</b>: Assaf-Harofeh Medical Center<br/><b>Recruiting</b> - verified June 2007
STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction <b>Condition</b>: Myocardial Infarction<br/><b>Interventions</b>: Drug: Tenecteplase; Drug: Clopidogrel, Enoxaparin; Procedure: Catheterisation<br/><b>Sponsor</b>: Boehringer Ingelheim Pharmaceuticals<br/><b>Not yet recruiting</b> - verified February 2008
Cost-Effectiveness Study in the Reduction of Coronary Restenosis With Sirolimus-Eluting Stents <b>Condition</b>: Coronary Artery Disease<br/><b>Interventions</b>: Device: bare metal stent; Device: Cypher-Stent (Implantation of a sirolimus-eluting stent)<br/><b>Sponsors</b>: Charite University, Berlin, Germany; Techniker Krankenkasse<br/><b>Completed</b> - verified February 2008
Left Ventricular Function Assessment After Acute Myocardial Infarction: Comparison Between Bi-, Three-Dimensional and Cardiac Magnetic Resonance <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Other: compare measurements of left ventricular volumes and LVEF (by Cardiac Magnetic Resonance and Echocardiography)<br/><b>Sponsor</b>: Assistance Publique Hopitaux De Marseille<br/><b>Not yet recruiting</b> - verified February 2008
Trial to Assess the Ocular Safety of SCH 530348 in Patients With Atherosclerosis (Study P05183) <b>Conditions</b>: Atherosclerosis; Ischemia; Myocardial Infarction; Cerebrovascular Accident<br/><b>Interventions</b>: Drug: SCH 530348; Drug: Placebo<br/><b>Sponsors</b>: Schering-Plough; The TIMI Study Group; Duke University<br/><b>Not yet recruiting</b> - verified February 2008
Perioperative Depression and Postoperative Arrhythmia in Elective Coronary Bypass Graft Surgery <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University Health Network, Toronto<br/><b>Recruiting</b> - verified January 2008
Stem Cell Study for Subjects With CHF <b>Conditions</b>: Myocardial Ischemia; Congestive Heart Failure; Cardiovascular Disease<br/><b>Intervention</b>: Biological: Autologous Stem Cells<br/><b>Sponsor</b>: Losordo, Douglas, M.D.<br/><b>Not yet recruiting</b> - verified February 2008
Survival of Patients With Primary Prophylactic ICD Indication <b>Conditions</b>: Death From Any Cause; Sudden Cardiac Death; Non-Sudden Cardiac Death<br/><b>Interventions</b>: Other: Intensified diagnostic and treatment measures following 1st appropriate ICD therapy; Other: Standard follow-up<br/><b>Sponsor</b>: Biotronik GmbH & Co. KG<br/><b>Recruiting</b> - verified February 2008
The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: tirofiban<br/><b>Sponsor</b>: Samsung Medical Center<br/><b>Completed</b> - verified August 2007
Prophylactic Intra-Coronary Adenosine to Prevent Post Coronary Artery Stenting Myonecrosis <b>Conditions</b>: Coronary Artery Stenosis; Coronary Artery Disease<br/><b>Intervention</b>: Drug: Adenosine<br/><b>Sponsor</b>: University of Ottawa Heart Institute<br/><b>Recruiting</b> - verified January 2008
Italian Registry on Unprotected Left Main <b>Conditions</b>: Cardiovascular Disease; Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University of Turin, Italy<br/><b>Not yet recruiting</b> - verified January 2008
Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-Aortic Balloon Counterpulsation <b>Conditions</b>: Shock, Cardiogenic; Heart Failure; Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Pyruvate<br/><b>Sponsor</b>: Herzzentrum Goettingen<br/><b>Not yet recruiting</b> - verified January 2008
Bare Metal Bifurcation Stent Clinical Trial in Humans <b>Conditions</b>: Coronary Artery Disease; Myocardial Ischemia<br/><b>Intervention</b>: Device: Medtronic Bifurcation Stent System<br/><b>Sponsor</b>: Medtronic Vascular<br/><b>Not yet recruiting</b> - verified January 2008
Randomized Multi-Center Comparison of the Conor Sirolimus-Eluting Coronary Stent to the Taxus Liberte Paclitaxel-Eluting Coronary Stent in the Treatment of Coronary Artery Lesions <b>Condition</b>: Coronary Atherosclerosis<br/><b>Interventions</b>: Device: Drug-eluting stent (Conor Cobalt Chromium Sirolimus-eluting Coronary Stent System); Device: Drug-eluting stent (TAXUS Liberte Paclitaxel-eluting Coronary Stent System)<br/><b>Sponsor</b>: Conor Medsystems<br/><b>Not yet recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccination in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified February 2008
Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™ <b>Conditions</b>: Transient Ischemic Attack; Thromboembolic Stroke; Stroke Prevention<br/><b>Interventions</b>: Device: EndoTex™ NexStent™; Device: Filter Wire EZ™<br/><b>Sponsor</b>: Boston Scientific Corporation<br/><b>Completed</b> - verified January 2008
Examining Heart Attacks in Young Women (The Variation In Recovery: Role of Gender on Outcomes in Young AMI Patients [VIRGO] Study) <b>Condition</b>: Myocardial Infarction<br/><b>Intervention</b>: <br/><b>Sponsor</b>: National Heart, Lung, and Blood Institute (NHLBI)<br/><b>Active, not recruiting</b> - verified January 2008
Study of 99mTc-Glucarate to Detect Acute Coronary Syndrome in Chest Pain Patients. <b>Condition</b>: Acute Coronary Syndrome<br/><b>Intervention</b>: Drug: 99mTc-glucarate solution<br/><b>Sponsors</b>: Molecular Targeting Technologies, Inc.; National Heart, Lung, and Blood Institute (NHLBI); Yale University<br/><b>Not yet recruiting</b> - verified February 2008
A Safety/Efficacy Study of Intra-Coronary Tenecteplase During Balloon Angioplasty to Treat Heart Attacks <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Tenecteplase<br/><b>Sponsors</b>: Brigham and Women's Hospital; Genentech<br/><b>Not yet recruiting</b> - verified January 2008
Drug Eluting Stents for In-Stent Restenosis 2 <b>Condition</b>: Coronary Disease<br/><b>Interventions</b>: Device: Sirolimus eluting stent (Cypher); Device: Paclitaxel-eluting stent (Taxus)<br/><b>Sponsors</b>: Deutsches Herzzentrum Muenchen; Technische Universität München<br/><b>Recruiting</b> - verified January 2008
Efficacy Study of Rapamycin- and Zotarolimus-Eluting Stents to Reduce Coronary Restenosis <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: rapamycin+probucol-eluting stent (ISAR stent); Device: polymer based Zotarolimus-eluting stent (Endeavor Resolute)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Not yet recruiting</b> - verified January 2008
3 Limus Agent Eluting Stents With Different Polymer Coating <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: biodegradable polymer Rapamycin-eluting stent (ISAR stent); Device: permanent polymer rapamycin-eluting stent (Cypher); Device: permanent polymer everolimus-eluting stent (Xience, Promus)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Efficacy Study of Drug-Eluting and Bare Metal Stents in Bypass Graft Lesions <b>Condition</b>: Coronary Artery Bypass<br/><b>Interventions</b>: Device: Cypher drug-eluting stent; Device: Taxus drug-eluting stent; Device: ISAR drug-eluting stent; Device: bare metal stents<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Study to Test the Efficacy and Safety of Drug Eluting vs. Bare-Metal Stents for Saphenous Vein Graft Interventions <b>Condition</b>: Coronary Artery Disease<br/><b>Interventions</b>: Device: TAXUS Liberté (Drug eluting stent); Device: Liberté (Bare metal stent)<br/><b>Sponsors</b>: University Hospital, Basel, Switzerland; University of Leipzig<br/><b>Not yet recruiting</b> - verified January 2008

'); document.write('

'); document.write('

'); document.write('

ClinicalTrials.gov: Myocardial infarction AND Ischemia

'); document.write('

Long Term Follow-up of Autologous Bone Marrow Mononuclear Cells Therapy in STEMI <b>Condition</b>: Myocardial Infarction<br/><b>Interventions</b>: Procedure: saline infusion; Procedure: autologous bone marrow mononuclear cells infusion<br/><b>Sponsor</b>: Xijing Hospital<br/><b>Active, not recruiting</b> - verified February 2008
3 Nehb Precordial Leads Anterior, Dorsalis and Inferior Allow Accurate Diagnostics of Different Heart Conditions <b>Condition</b>: Acute Myocardial Infarction With ST Segment Elevation<br/><b>Intervention</b>: <br/><b>Sponsor</b>: Assaf-Harofeh Medical Center<br/><b>Recruiting</b> - verified June 2007
STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction <b>Condition</b>: Myocardial Infarction<br/><b>Interventions</b>: Drug: Tenecteplase; Drug: Clopidogrel, Enoxaparin; Procedure: Catheterisation<br/><b>Sponsor</b>: Boehringer Ingelheim Pharmaceuticals<br/><b>Not yet recruiting</b> - verified February 2008
Left Ventricular Function Assessment After Acute Myocardial Infarction: Comparison Between Bi-, Three-Dimensional and Cardiac Magnetic Resonance <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Other: compare measurements of left ventricular volumes and LVEF (by Cardiac Magnetic Resonance and Echocardiography)<br/><b>Sponsor</b>: Assistance Publique Hopitaux De Marseille<br/><b>Not yet recruiting</b> - verified February 2008
Trial to Assess the Ocular Safety of SCH 530348 in Patients With Atherosclerosis (Study P05183) <b>Conditions</b>: Atherosclerosis; Ischemia; Myocardial Infarction; Cerebrovascular Accident<br/><b>Interventions</b>: Drug: SCH 530348; Drug: Placebo<br/><b>Sponsors</b>: Schering-Plough; The TIMI Study Group; Duke University<br/><b>Not yet recruiting</b> - verified February 2008
Perioperative Depression and Postoperative Arrhythmia in Elective Coronary Bypass Graft Surgery <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University Health Network, Toronto<br/><b>Recruiting</b> - verified January 2008
Stem Cell Study for Subjects With CHF <b>Conditions</b>: Myocardial Ischemia; Congestive Heart Failure; Cardiovascular Disease<br/><b>Intervention</b>: Biological: Autologous Stem Cells<br/><b>Sponsor</b>: Losordo, Douglas, M.D.<br/><b>Not yet recruiting</b> - verified February 2008
Survival of Patients With Primary Prophylactic ICD Indication <b>Conditions</b>: Death From Any Cause; Sudden Cardiac Death; Non-Sudden Cardiac Death<br/><b>Interventions</b>: Other: Intensified diagnostic and treatment measures following 1st appropriate ICD therapy; Other: Standard follow-up<br/><b>Sponsor</b>: Biotronik GmbH & Co. KG<br/><b>Recruiting</b> - verified February 2008
The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: tirofiban<br/><b>Sponsor</b>: Samsung Medical Center<br/><b>Completed</b> - verified August 2007
Prophylactic Intra-Coronary Adenosine to Prevent Post Coronary Artery Stenting Myonecrosis <b>Conditions</b>: Coronary Artery Stenosis; Coronary Artery Disease<br/><b>Intervention</b>: Drug: Adenosine<br/><b>Sponsor</b>: University of Ottawa Heart Institute<br/><b>Recruiting</b> - verified January 2008
Italian Registry on Unprotected Left Main <b>Conditions</b>: Cardiovascular Disease; Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University of Turin, Italy<br/><b>Not yet recruiting</b> - verified January 2008
Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-Aortic Balloon Counterpulsation <b>Conditions</b>: Shock, Cardiogenic; Heart Failure; Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Pyruvate<br/><b>Sponsor</b>: Herzzentrum Goettingen<br/><b>Not yet recruiting</b> - verified January 2008
Bare Metal Bifurcation Stent Clinical Trial in Humans <b>Conditions</b>: Coronary Artery Disease; Myocardial Ischemia<br/><b>Intervention</b>: Device: Medtronic Bifurcation Stent System<br/><b>Sponsor</b>: Medtronic Vascular<br/><b>Not yet recruiting</b> - verified January 2008
Randomized Multi-Center Comparison of the Conor Sirolimus-Eluting Coronary Stent to the Taxus Liberte Paclitaxel-Eluting Coronary Stent in the Treatment of Coronary Artery Lesions <b>Condition</b>: Coronary Atherosclerosis<br/><b>Interventions</b>: Device: Drug-eluting stent (Conor Cobalt Chromium Sirolimus-eluting Coronary Stent System); Device: Drug-eluting stent (TAXUS Liberte Paclitaxel-eluting Coronary Stent System)<br/><b>Sponsor</b>: Conor Medsystems<br/><b>Not yet recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccination in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™ <b>Conditions</b>: Transient Ischemic Attack; Thromboembolic Stroke; Stroke Prevention<br/><b>Interventions</b>: Device: EndoTex™ NexStent™; Device: Filter Wire EZ™<br/><b>Sponsor</b>: Boston Scientific Corporation<br/><b>Completed</b> - verified January 2008
Examining Heart Attacks in Young Women (The Variation In Recovery: Role of Gender on Outcomes in Young AMI Patients [VIRGO] Study) <b>Condition</b>: Myocardial Infarction<br/><b>Intervention</b>: <br/><b>Sponsor</b>: National Heart, Lung, and Blood Institute (NHLBI)<br/><b>Active, not recruiting</b> - verified January 2008
Study of 99mTc-Glucarate to Detect Acute Coronary Syndrome in Chest Pain Patients. <b>Condition</b>: Acute Coronary Syndrome<br/><b>Intervention</b>: Drug: 99mTc-glucarate solution<br/><b>Sponsors</b>: Molecular Targeting Technologies, Inc.; National Heart, Lung, and Blood Institute (NHLBI); Yale University<br/><b>Not yet recruiting</b> - verified February 2008
A Safety/Efficacy Study of Intra-Coronary Tenecteplase During Balloon Angioplasty to Treat Heart Attacks <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Tenecteplase<br/><b>Sponsors</b>: Brigham and Women's Hospital; Genentech<br/><b>Not yet recruiting</b> - verified January 2008
Drug Eluting Stents for In-Stent Restenosis 2 <b>Condition</b>: Coronary Disease<br/><b>Interventions</b>: Device: Sirolimus eluting stent (Cypher); Device: Paclitaxel-eluting stent (Taxus)<br/><b>Sponsors</b>: Deutsches Herzzentrum Muenchen; Technische Universität München<br/><b>Recruiting</b> - verified January 2008
Efficacy Study of Rapamycin- and Zotarolimus-Eluting Stents to Reduce Coronary Restenosis <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: rapamycin+probucol-eluting stent (ISAR stent); Device: polymer based Zotarolimus-eluting stent (Endeavor Resolute)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Not yet recruiting</b> - verified January 2008
3 Limus Agent Eluting Stents With Different Polymer Coating <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: biodegradable polymer Rapamycin-eluting stent (ISAR stent); Device: permanent polymer rapamycin-eluting stent (Cypher); Device: permanent polymer everolimus-eluting stent (Xience, Promus)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Efficacy Study of Drug-Eluting and Bare Metal Stents in Bypass Graft Lesions <b>Condition</b>: Coronary Artery Bypass<br/><b>Interventions</b>: Device: Cypher drug-eluting stent; Device: Taxus drug-eluting stent; Device: ISAR drug-eluting stent; Device: bare metal stents<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Study to Test the Efficacy and Safety of Drug Eluting vs. Bare-Metal Stents for Saphenous Vein Graft Interventions <b>Condition</b>: Coronary Artery Disease<br/><b>Interventions</b>: Device: TAXUS Liberté (Drug eluting stent); Device: Liberté (Bare metal stent)<br/><b>Sponsors</b>: University Hospital, Basel, Switzerland; University of Leipzig<br/><b>Not yet recruiting</b> - verified January 2008

'); document.write('

'); document.write('

'); document.write('

ClinicalTrials.gov: Myocardial infarction AND Ischemia

'); document.write('

Long Term Follow-up of Autologous Bone Marrow Mononuclear Cells Therapy in STEMI <b>Condition</b>: Myocardial Infarction<br/><b>Interventions</b>: Procedure: saline infusion; Procedure: autologous bone marrow mononuclear cells infusion<br/><b>Sponsor</b>: Xijing Hospital<br/><b>Active, not recruiting</b> - verified February 2008
3 Nehb Precordial Leads Anterior, Dorsalis and Inferior Allow Accurate Diagnostics of Different Heart Conditions <b>Condition</b>: Acute Myocardial Infarction With ST Segment Elevation<br/><b>Intervention</b>: <br/><b>Sponsor</b>: Assaf-Harofeh Medical Center<br/><b>Recruiting</b> - verified June 2007
STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction <b>Condition</b>: Myocardial Infarction<br/><b>Interventions</b>: Drug: Tenecteplase; Drug: Clopidogrel, Enoxaparin; Procedure: Catheterisation<br/><b>Sponsor</b>: Boehringer Ingelheim Pharmaceuticals<br/><b>Not yet recruiting</b> - verified February 2008
Left Ventricular Function Assessment After Acute Myocardial Infarction: Comparison Between Bi-, Three-Dimensional and Cardiac Magnetic Resonance <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Other: compare measurements of left ventricular volumes and LVEF (by Cardiac Magnetic Resonance and Echocardiography)<br/><b>Sponsor</b>: Assistance Publique Hopitaux De Marseille<br/><b>Not yet recruiting</b> - verified February 2008
Trial to Assess the Ocular Safety of SCH 530348 in Patients With Atherosclerosis (Study P05183) <b>Conditions</b>: Atherosclerosis; Ischemia; Myocardial Infarction; Cerebrovascular Accident<br/><b>Interventions</b>: Drug: SCH 530348; Drug: Placebo<br/><b>Sponsors</b>: Schering-Plough; The TIMI Study Group; Duke University<br/><b>Not yet recruiting</b> - verified February 2008
Perioperative Depression and Postoperative Arrhythmia in Elective Coronary Bypass Graft Surgery <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University Health Network, Toronto<br/><b>Recruiting</b> - verified January 2008
Stem Cell Study for Subjects With CHF <b>Conditions</b>: Myocardial Ischemia; Congestive Heart Failure; Cardiovascular Disease<br/><b>Intervention</b>: Biological: Autologous Stem Cells<br/><b>Sponsor</b>: Losordo, Douglas, M.D.<br/><b>Not yet recruiting</b> - verified February 2008
Survival of Patients With Primary Prophylactic ICD Indication <b>Conditions</b>: Death From Any Cause; Sudden Cardiac Death; Non-Sudden Cardiac Death<br/><b>Interventions</b>: Other: Intensified diagnostic and treatment measures following 1st appropriate ICD therapy; Other: Standard follow-up<br/><b>Sponsor</b>: Biotronik GmbH & Co. KG<br/><b>Recruiting</b> - verified February 2008
The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: tirofiban<br/><b>Sponsor</b>: Samsung Medical Center<br/><b>Completed</b> - verified August 2007
Prophylactic Intra-Coronary Adenosine to Prevent Post Coronary Artery Stenting Myonecrosis <b>Conditions</b>: Coronary Artery Stenosis; Coronary Artery Disease<br/><b>Intervention</b>: Drug: Adenosine<br/><b>Sponsor</b>: University of Ottawa Heart Institute<br/><b>Recruiting</b> - verified January 2008
Italian Registry on Unprotected Left Main <b>Conditions</b>: Cardiovascular Disease; Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University of Turin, Italy<br/><b>Not yet recruiting</b> - verified January 2008
Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-Aortic Balloon Counterpulsation <b>Conditions</b>: Shock, Cardiogenic; Heart Failure; Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Pyruvate<br/><b>Sponsor</b>: Herzzentrum Goettingen<br/><b>Not yet recruiting</b> - verified January 2008
Bare Metal Bifurcation Stent Clinical Trial in Humans <b>Conditions</b>: Coronary Artery Disease; Myocardial Ischemia<br/><b>Intervention</b>: Device: Medtronic Bifurcation Stent System<br/><b>Sponsor</b>: Medtronic Vascular<br/><b>Not yet recruiting</b> - verified January 2008
Randomized Multi-Center Comparison of the Conor Sirolimus-Eluting Coronary Stent to the Taxus Liberte Paclitaxel-Eluting Coronary Stent in the Treatment of Coronary Artery Lesions <b>Condition</b>: Coronary Atherosclerosis<br/><b>Interventions</b>: Device: Drug-eluting stent (Conor Cobalt Chromium Sirolimus-eluting Coronary Stent System); Device: Drug-eluting stent (TAXUS Liberte Paclitaxel-eluting Coronary Stent System)<br/><b>Sponsor</b>: Conor Medsystems<br/><b>Not yet recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccination in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™ <b>Conditions</b>: Transient Ischemic Attack; Thromboembolic Stroke; Stroke Prevention<br/><b>Interventions</b>: Device: EndoTex™ NexStent™; Device: Filter Wire EZ™<br/><b>Sponsor</b>: Boston Scientific Corporation<br/><b>Completed</b> - verified January 2008
Examining Heart Attacks in Young Women (The Variation In Recovery: Role of Gender on Outcomes in Young AMI Patients [VIRGO] Study) <b>Condition</b>: Myocardial Infarction<br/><b>Intervention</b>: <br/><b>Sponsor</b>: National Heart, Lung, and Blood Institute (NHLBI)<br/><b>Active, not recruiting</b> - verified January 2008
Study of 99mTc-Glucarate to Detect Acute Coronary Syndrome in Chest Pain Patients. <b>Condition</b>: Acute Coronary Syndrome<br/><b>Intervention</b>: Drug: 99mTc-glucarate solution<br/><b>Sponsors</b>: Molecular Targeting Technologies, Inc.; National Heart, Lung, and Blood Institute (NHLBI); Yale University<br/><b>Not yet recruiting</b> - verified February 2008
A Safety/Efficacy Study of Intra-Coronary Tenecteplase During Balloon Angioplasty to Treat Heart Attacks <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Tenecteplase<br/><b>Sponsors</b>: Brigham and Women's Hospital; Genentech<br/><b>Not yet recruiting</b> - verified January 2008
Drug Eluting Stents for In-Stent Restenosis 2 <b>Condition</b>: Coronary Disease<br/><b>Interventions</b>: Device: Sirolimus eluting stent (Cypher); Device: Paclitaxel-eluting stent (Taxus)<br/><b>Sponsors</b>: Deutsches Herzzentrum Muenchen; Technische Universität München<br/><b>Recruiting</b> - verified January 2008
Efficacy Study of Rapamycin- and Zotarolimus-Eluting Stents to Reduce Coronary Restenosis <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: rapamycin+probucol-eluting stent (ISAR stent); Device: polymer based Zotarolimus-eluting stent (Endeavor Resolute)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Not yet recruiting</b> - verified January 2008
3 Limus Agent Eluting Stents With Different Polymer Coating <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: biodegradable polymer Rapamycin-eluting stent (ISAR stent); Device: permanent polymer rapamycin-eluting stent (Cypher); Device: permanent polymer everolimus-eluting stent (Xience, Promus)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Safety and Effectiveness of Human Mesenchymal Stem Cell Injections for Repairing Heart Damage in People Who Have Had a Heart Attack and Are Undergoing Surgery for Coronary Artery Bypass Grafting <b>Conditions</b>: Stem Cell Transplantation; Ventricular Dysfunction, Left<br/><b>Interventions</b>: Genetic: Lower dose mesenchymal stem cell (MSC) injection; Genetic: Placebo; Genetic: Higher dose MSC injection<br/><b>Sponsors</b>: National Heart, Lung, and Blood Institute (NHLBI); Johns Hopkins University Specialized Center for Cell Based Therapy<br/><b>Recruiting</b> - verified February 2008
Efficacy Study of Drug-Eluting and Bare Metal Stents in Bypass Graft Lesions <b>Condition</b>: Coronary Artery Bypass<br/><b>Interventions</b>: Device: Cypher drug-eluting stent; Device: Taxus drug-eluting stent; Device: ISAR drug-eluting stent; Device: bare metal stents<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Study to Test the Efficacy and Safety of Drug Eluting vs. Bare-Metal Stents for Saphenous Vein Graft Interventions <b>Condition</b>: Coronary Artery Disease<br/><b>Interventions</b>: Device: TAXUS Liberté (Drug eluting stent); Device: Liberté (Bare metal stent)<br/><b>Sponsors</b>: University Hospital, Basel, Switzerland; University of Leipzig<br/><b>Not yet recruiting</b> - verified January 2008

'); document.write('

'); document.write('

'); document.write('

ClinicalTrials.gov: Myocardial infarction AND Ischemia

'); document.write('

Long Term Follow-up of Autologous Bone Marrow Mononuclear Cells Therapy in STEMI <b>Condition</b>: Myocardial Infarction<br/><b>Interventions</b>: Procedure: saline infusion; Procedure: autologous bone marrow mononuclear cells infusion<br/><b>Sponsor</b>: Xijing Hospital<br/><b>Active, not recruiting</b> - verified February 2008
3 Nehb Precordial Leads Anterior, Dorsalis and Inferior Allow Accurate Diagnostics of Different Heart Conditions <b>Condition</b>: Acute Myocardial Infarction With ST Segment Elevation<br/><b>Intervention</b>: <br/><b>Sponsor</b>: Assaf-Harofeh Medical Center<br/><b>Recruiting</b> - verified June 2007
STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction <b>Condition</b>: Myocardial Infarction<br/><b>Interventions</b>: Drug: Tenecteplase; Drug: Clopidogrel, Enoxaparin; Procedure: Catheterisation<br/><b>Sponsor</b>: Boehringer Ingelheim Pharmaceuticals<br/><b>Not yet recruiting</b> - verified February 2008
Left Ventricular Function Assessment After Acute Myocardial Infarction: Comparison Between Bi-, Three-Dimensional and Cardiac Magnetic Resonance <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Other: compare measurements of left ventricular volumes and LVEF (by Cardiac Magnetic Resonance and Echocardiography)<br/><b>Sponsor</b>: Assistance Publique Hopitaux De Marseille<br/><b>Not yet recruiting</b> - verified February 2008
Trial to Assess the Ocular Safety of SCH 530348 in Patients With Atherosclerosis (Study P05183) <b>Conditions</b>: Atherosclerosis; Ischemia; Myocardial Infarction; Cerebrovascular Accident<br/><b>Interventions</b>: Drug: SCH 530348; Drug: Placebo<br/><b>Sponsors</b>: Schering-Plough; The TIMI Study Group; Duke University<br/><b>Not yet recruiting</b> - verified February 2008
Perioperative Depression and Postoperative Arrhythmia in Elective Coronary Bypass Graft Surgery <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University Health Network, Toronto<br/><b>Recruiting</b> - verified January 2008
Stem Cell Study for Subjects With CHF <b>Conditions</b>: Myocardial Ischemia; Congestive Heart Failure; Cardiovascular Disease<br/><b>Intervention</b>: Biological: Autologous Stem Cells<br/><b>Sponsor</b>: Losordo, Douglas, M.D.<br/><b>Not yet recruiting</b> - verified February 2008
Survival of Patients With Primary Prophylactic ICD Indication <b>Conditions</b>: Death From Any Cause; Sudden Cardiac Death; Non-Sudden Cardiac Death<br/><b>Interventions</b>: Other: Intensified diagnostic and treatment measures following 1st appropriate ICD therapy; Other: Standard follow-up<br/><b>Sponsor</b>: Biotronik GmbH & Co. KG<br/><b>Recruiting</b> - verified February 2008
The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: tirofiban<br/><b>Sponsor</b>: Samsung Medical Center<br/><b>Completed</b> - verified August 2007
Prophylactic Intra-Coronary Adenosine to Prevent Post Coronary Artery Stenting Myonecrosis <b>Conditions</b>: Coronary Artery Stenosis; Coronary Artery Disease<br/><b>Intervention</b>: Drug: Adenosine<br/><b>Sponsor</b>: University of Ottawa Heart Institute<br/><b>Recruiting</b> - verified January 2008
Italian Registry on Unprotected Left Main <b>Conditions</b>: Cardiovascular Disease; Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University of Turin, Italy<br/><b>Not yet recruiting</b> - verified January 2008
Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-Aortic Balloon Counterpulsation <b>Conditions</b>: Shock, Cardiogenic; Heart Failure; Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Pyruvate<br/><b>Sponsor</b>: Herzzentrum Goettingen<br/><b>Not yet recruiting</b> - verified January 2008
Bare Metal Bifurcation Stent Clinical Trial in Humans <b>Conditions</b>: Coronary Artery Disease; Myocardial Ischemia<br/><b>Intervention</b>: Device: Medtronic Bifurcation Stent System<br/><b>Sponsor</b>: Medtronic Vascular<br/><b>Not yet recruiting</b> - verified January 2008
Randomized Multi-Center Comparison of the Conor Sirolimus-Eluting Coronary Stent to the Taxus Liberte Paclitaxel-Eluting Coronary Stent in the Treatment of Coronary Artery Lesions <b>Condition</b>: Coronary Atherosclerosis<br/><b>Interventions</b>: Device: Drug-eluting stent (Conor Cobalt Chromium Sirolimus-eluting Coronary Stent System); Device: Drug-eluting stent (TAXUS Liberte Paclitaxel-eluting Coronary Stent System)<br/><b>Sponsor</b>: Conor Medsystems<br/><b>Not yet recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccination in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™ <b>Conditions</b>: Transient Ischemic Attack; Thromboembolic Stroke; Stroke Prevention<br/><b>Interventions</b>: Device: EndoTex™ NexStent™; Device: Filter Wire EZ™<br/><b>Sponsor</b>: Boston Scientific Corporation<br/><b>Completed</b> - verified January 2008
Examining Heart Attacks in Young Women (The Variation In Recovery: Role of Gender on Outcomes in Young AMI Patients [VIRGO] Study) <b>Condition</b>: Myocardial Infarction<br/><b>Intervention</b>: <br/><b>Sponsor</b>: National Heart, Lung, and Blood Institute (NHLBI)<br/><b>Active, not recruiting</b> - verified January 2008
Study of 99mTc-Glucarate to Detect Acute Coronary Syndrome in Chest Pain Patients. <b>Condition</b>: Acute Coronary Syndrome<br/><b>Intervention</b>: Drug: 99mTc-glucarate solution<br/><b>Sponsors</b>: Molecular Targeting Technologies, Inc.; National Heart, Lung, and Blood Institute (NHLBI); Yale University<br/><b>Not yet recruiting</b> - verified February 2008
A Safety/Efficacy Study of Intra-Coronary Tenecteplase During Balloon Angioplasty to Treat Heart Attacks <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Tenecteplase<br/><b>Sponsors</b>: Brigham and Women's Hospital; Genentech<br/><b>Not yet recruiting</b> - verified January 2008
Drug Eluting Stents for In-Stent Restenosis 2 <b>Condition</b>: Coronary Disease<br/><b>Interventions</b>: Device: Sirolimus eluting stent (Cypher); Device: Paclitaxel-eluting stent (Taxus)<br/><b>Sponsors</b>: Deutsches Herzzentrum Muenchen; Technische Universität München<br/><b>Recruiting</b> - verified January 2008
Efficacy Study of Rapamycin- and Zotarolimus-Eluting Stents to Reduce Coronary Restenosis <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: rapamycin+probucol-eluting stent (ISAR stent); Device: polymer based Zotarolimus-eluting stent (Endeavor Resolute)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Not yet recruiting</b> - verified January 2008
3 Limus Agent Eluting Stents With Different Polymer Coating <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: biodegradable polymer Rapamycin-eluting stent (ISAR stent); Device: permanent polymer rapamycin-eluting stent (Cypher); Device: permanent polymer everolimus-eluting stent (Xience, Promus)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Safety and Effectiveness of Human Mesenchymal Stem Cell Injections for Repairing Heart Damage in People Who Have Had a Heart Attack and Are Undergoing Surgery for Coronary Artery Bypass Grafting <b>Conditions</b>: Stem Cell Transplantation; Ventricular Dysfunction, Left<br/><b>Interventions</b>: Genetic: Lower dose mesenchymal stem cell (MSC) injection; Genetic: Placebo; Genetic: Higher dose MSC injection<br/><b>Sponsors</b>: National Heart, Lung, and Blood Institute (NHLBI); Johns Hopkins University Specialized Center for Cell Based Therapy<br/><b>Recruiting</b> - verified February 2008
Efficacy Study of Drug-Eluting and Bare Metal Stents in Bypass Graft Lesions <b>Condition</b>: Coronary Artery Bypass<br/><b>Interventions</b>: Device: Cypher drug-eluting stent; Device: Taxus drug-eluting stent; Device: ISAR drug-eluting stent; Device: bare metal stents<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Study to Test the Efficacy and Safety of Drug Eluting vs. Bare-Metal Stents for Saphenous Vein Graft Interventions <b>Condition</b>: Coronary Artery Disease<br/><b>Interventions</b>: Device: TAXUS Liberté (Drug eluting stent); Device: Liberté (Bare metal stent)<br/><b>Sponsors</b>: University Hospital, Basel, Switzerland; University of Leipzig<br/><b>Not yet recruiting</b> - verified January 2008

'); document.write('

'); document.write('

'); document.write('

ClinicalTrials.gov: Myocardial infarction AND Ischemia

'); document.write('

Long Term Follow-up of Autologous Bone Marrow Mononuclear Cells Therapy in STEMI <b>Condition</b>: Myocardial Infarction<br/><b>Interventions</b>: Procedure: saline infusion; Procedure: autologous bone marrow mononuclear cells infusion<br/><b>Sponsor</b>: Xijing Hospital<br/><b>Active, not recruiting</b> - verified February 2008
3 Nehb Precordial Leads Anterior, Dorsalis and Inferior Allow Accurate Diagnostics of Different Heart Conditions <b>Condition</b>: Acute Myocardial Infarction With ST Segment Elevation<br/><b>Intervention</b>: <br/><b>Sponsor</b>: Assaf-Harofeh Medical Center<br/><b>Recruiting</b> - verified June 2007
STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction <b>Condition</b>: Myocardial Infarction<br/><b>Interventions</b>: Drug: Tenecteplase; Drug: Clopidogrel, Enoxaparin; Procedure: Catheterisation<br/><b>Sponsor</b>: Boehringer Ingelheim Pharmaceuticals<br/><b>Not yet recruiting</b> - verified February 2008
Left Ventricular Function Assessment After Acute Myocardial Infarction: Comparison Between Bi-, Three-Dimensional and Cardiac Magnetic Resonance <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Other: compare measurements of left ventricular volumes and LVEF (by Cardiac Magnetic Resonance and Echocardiography)<br/><b>Sponsor</b>: Assistance Publique Hopitaux De Marseille<br/><b>Not yet recruiting</b> - verified February 2008
Trial to Assess the Ocular Safety of SCH 530348 in Patients With Atherosclerosis (Study P05183) <b>Conditions</b>: Atherosclerosis; Ischemia; Myocardial Infarction; Cerebrovascular Accident<br/><b>Interventions</b>: Drug: SCH 530348; Drug: Placebo<br/><b>Sponsors</b>: Schering-Plough; The TIMI Study Group; Duke University<br/><b>Not yet recruiting</b> - verified February 2008
Perioperative Depression and Postoperative Arrhythmia in Elective Coronary Bypass Graft Surgery <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University Health Network, Toronto<br/><b>Recruiting</b> - verified January 2008
Stem Cell Study for Subjects With CHF <b>Conditions</b>: Myocardial Ischemia; Congestive Heart Failure; Cardiovascular Disease<br/><b>Intervention</b>: Biological: Autologous Stem Cells<br/><b>Sponsor</b>: Losordo, Douglas, M.D.<br/><b>Not yet recruiting</b> - verified February 2008
Survival of Patients With Primary Prophylactic ICD Indication <b>Conditions</b>: Death From Any Cause; Sudden Cardiac Death; Non-Sudden Cardiac Death<br/><b>Interventions</b>: Other: Intensified diagnostic and treatment measures following 1st appropriate ICD therapy; Other: Standard follow-up<br/><b>Sponsor</b>: Biotronik GmbH & Co. KG<br/><b>Recruiting</b> - verified February 2008
The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: tirofiban<br/><b>Sponsor</b>: Samsung Medical Center<br/><b>Completed</b> - verified August 2007
Prophylactic Intra-Coronary Adenosine to Prevent Post Coronary Artery Stenting Myonecrosis <b>Conditions</b>: Coronary Artery Stenosis; Coronary Artery Disease<br/><b>Intervention</b>: Drug: Adenosine<br/><b>Sponsor</b>: University of Ottawa Heart Institute<br/><b>Recruiting</b> - verified January 2008
Italian Registry on Unprotected Left Main <b>Conditions</b>: Cardiovascular Disease; Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University of Turin, Italy<br/><b>Not yet recruiting</b> - verified January 2008
Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-Aortic Balloon Counterpulsation <b>Conditions</b>: Shock, Cardiogenic; Heart Failure; Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Pyruvate<br/><b>Sponsor</b>: Herzzentrum Goettingen<br/><b>Not yet recruiting</b> - verified January 2008
Bare Metal Bifurcation Stent Clinical Trial in Humans <b>Conditions</b>: Coronary Artery Disease; Myocardial Ischemia<br/><b>Intervention</b>: Device: Medtronic Bifurcation Stent System<br/><b>Sponsor</b>: Medtronic Vascular<br/><b>Not yet recruiting</b> - verified January 2008
Randomized Multi-Center Comparison of the Conor Sirolimus-Eluting Coronary Stent to the Taxus Liberte Paclitaxel-Eluting Coronary Stent in the Treatment of Coronary Artery Lesions <b>Condition</b>: Coronary Atherosclerosis<br/><b>Interventions</b>: Device: Drug-eluting stent (Conor Cobalt Chromium Sirolimus-eluting Coronary Stent System); Device: Drug-eluting stent (TAXUS Liberte Paclitaxel-eluting Coronary Stent System)<br/><b>Sponsor</b>: Conor Medsystems<br/><b>Not yet recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccination in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™ <b>Conditions</b>: Transient Ischemic Attack; Thromboembolic Stroke; Stroke Prevention<br/><b>Interventions</b>: Device: EndoTex™ NexStent™; Device: Filter Wire EZ™<br/><b>Sponsor</b>: Boston Scientific Corporation<br/><b>Completed</b> - verified January 2008
Examining Heart Attacks in Young Women (The Variation In Recovery: Role of Gender on Outcomes in Young AMI Patients [VIRGO] Study) <b>Condition</b>: Myocardial Infarction<br/><b>Intervention</b>: <br/><b>Sponsor</b>: National Heart, Lung, and Blood Institute (NHLBI)<br/><b>Active, not recruiting</b> - verified January 2008
Study of 99mTc-Glucarate to Detect Acute Coronary Syndrome in Chest Pain Patients. <b>Condition</b>: Acute Coronary Syndrome<br/><b>Intervention</b>: Drug: 99mTc-glucarate solution<br/><b>Sponsors</b>: Molecular Targeting Technologies, Inc.; National Heart, Lung, and Blood Institute (NHLBI); Yale University<br/><b>Not yet recruiting</b> - verified February 2008
A Safety/Efficacy Study of Intra-Coronary Tenecteplase During Balloon Angioplasty to Treat Heart Attacks <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Tenecteplase<br/><b>Sponsors</b>: Brigham and Women's Hospital; Genentech<br/><b>Not yet recruiting</b> - verified January 2008
THE REOPEN-AMI STUDY - Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction <b>Condition</b>: Myocardial Infarction<br/><b>Interventions</b>: Drug: adenosine; Drug: nitroprusside; Drug: placebo<br/><b>Sponsor</b>: Catholic University of the Sacred Heart<br/><b>Not yet recruiting</b> - verified December 2007
Drug Eluting Stents for In-Stent Restenosis 2 <b>Condition</b>: Coronary Disease<br/><b>Interventions</b>: Device: Sirolimus eluting stent (Cypher); Device: Paclitaxel-eluting stent (Taxus)<br/><b>Sponsors</b>: Deutsches Herzzentrum Muenchen; Technische Universität München<br/><b>Recruiting</b> - verified January 2008
Efficacy Study of Rapamycin- and Zotarolimus-Eluting Stents to Reduce Coronary Restenosis <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: rapamycin+probucol-eluting stent (ISAR stent); Device: polymer based Zotarolimus-eluting stent (Endeavor Resolute)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Not yet recruiting</b> - verified January 2008
3 Limus Agent Eluting Stents With Different Polymer Coating <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: biodegradable polymer Rapamycin-eluting stent (ISAR stent); Device: permanent polymer rapamycin-eluting stent (Cypher); Device: permanent polymer everolimus-eluting stent (Xience, Promus)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Safety and Effectiveness of Human Mesenchymal Stem Cell Injections for Repairing Heart Damage in People Who Have Had a Heart Attack and Are Undergoing Surgery for Coronary Artery Bypass Grafting <b>Conditions</b>: Stem Cell Transplantation; Ventricular Dysfunction, Left<br/><b>Interventions</b>: Genetic: Lower dose mesenchymal stem cell (MSC) injection; Genetic: Placebo; Genetic: Higher dose MSC injection<br/><b>Sponsors</b>: National Heart, Lung, and Blood Institute (NHLBI); Johns Hopkins University Specialized Center for Cell Based Therapy<br/><b>Recruiting</b> - verified February 2008
Efficacy Study of Drug-Eluting and Bare Metal Stents in Bypass Graft Lesions <b>Condition</b>: Coronary Artery Bypass<br/><b>Interventions</b>: Device: Cypher drug-eluting stent; Device: Taxus drug-eluting stent; Device: ISAR drug-eluting stent; Device: bare metal stents<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Clopidogrel Use and Long-Term Safety After Drug-Eluting Stents Implantation <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: Other: Stopping clopidogrel<br/><b>Sponsor</b>: CardioVascular Research Foundation, Korea<br/><b>Recruiting</b> - verified October 2007
Study to Test the Efficacy and Safety of Drug Eluting vs. Bare-Metal Stents for Saphenous Vein Graft Interventions <b>Condition</b>: Coronary Artery Disease<br/><b>Interventions</b>: Device: TAXUS Liberté (Drug eluting stent); Device: Liberté (Bare metal stent)<br/><b>Sponsors</b>: University Hospital, Basel, Switzerland; University of Leipzig<br/><b>Not yet recruiting</b> - verified January 2008

'); document.write('

'); document.write('

'); document.write('

ClinicalTrials.gov: Myocardial infarction AND Ischemia

'); document.write('

3 Nehb Precordial Leads Anterior, Dorsalis and Inferior Allow Accurate Diagnostics of Different Heart Conditions <b>Condition</b>: Acute Myocardial Infarction With ST Segment Elevation<br/><b>Intervention</b>: <br/><b>Sponsor</b>: Assaf-Harofeh Medical Center<br/><b>Recruiting</b> - verified June 2007
STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction <b>Condition</b>: Myocardial Infarction<br/><b>Interventions</b>: Drug: Tenecteplase; Drug: Clopidogrel, Enoxaparin; Procedure: Catheterisation<br/><b>Sponsor</b>: Boehringer Ingelheim Pharmaceuticals<br/><b>Not yet recruiting</b> - verified February 2008
Left Ventricular Function Assessment After Acute Myocardial Infarction: Comparison Between Bi-, Three-Dimensional and Cardiac Magnetic Resonance <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Other: compare measurements of left ventricular volumes and LVEF (by Cardiac Magnetic Resonance and Echocardiography)<br/><b>Sponsor</b>: Assistance Publique Hopitaux De Marseille<br/><b>Not yet recruiting</b> - verified February 2008
Trial to Assess the Ocular Safety of SCH 530348 in Patients With Atherosclerosis (Study P05183) <b>Conditions</b>: Atherosclerosis; Ischemia; Myocardial Infarction; Cerebrovascular Accident<br/><b>Interventions</b>: Drug: SCH 530348; Drug: Placebo<br/><b>Sponsors</b>: Schering-Plough; The TIMI Study Group; Duke University<br/><b>Not yet recruiting</b> - verified February 2008
Perioperative Depression and Postoperative Arrhythmia in Elective Coronary Bypass Graft Surgery <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University Health Network, Toronto<br/><b>Recruiting</b> - verified January 2008
Stem Cell Study for Subjects With CHF <b>Conditions</b>: Myocardial Ischemia; Congestive Heart Failure; Cardiovascular Disease<br/><b>Intervention</b>: Biological: Autologous Stem Cells<br/><b>Sponsor</b>: Losordo, Douglas, M.D.<br/><b>Not yet recruiting</b> - verified February 2008
Survival of Patients With Primary Prophylactic ICD Indication <b>Conditions</b>: Death From Any Cause; Sudden Cardiac Death; Non-Sudden Cardiac Death<br/><b>Interventions</b>: Other: Intensified diagnostic and treatment measures following 1st appropriate ICD therapy; Other: Standard follow-up<br/><b>Sponsor</b>: Biotronik GmbH & Co. KG<br/><b>Recruiting</b> - verified February 2008
The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: tirofiban<br/><b>Sponsor</b>: Samsung Medical Center<br/><b>Completed</b> - verified August 2007
Prophylactic Intra-Coronary Adenosine to Prevent Post Coronary Artery Stenting Myonecrosis <b>Conditions</b>: Coronary Artery Stenosis; Coronary Artery Disease<br/><b>Intervention</b>: Drug: Adenosine<br/><b>Sponsor</b>: University of Ottawa Heart Institute<br/><b>Recruiting</b> - verified January 2008
Italian Registry on Unprotected Left Main <b>Conditions</b>: Cardiovascular Disease; Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University of Turin, Italy<br/><b>Not yet recruiting</b> - verified January 2008
Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-Aortic Balloon Counterpulsation <b>Conditions</b>: Shock, Cardiogenic; Heart Failure; Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Pyruvate<br/><b>Sponsor</b>: Herzzentrum Goettingen<br/><b>Not yet recruiting</b> - verified January 2008
Bare Metal Bifurcation Stent Clinical Trial in Humans <b>Conditions</b>: Coronary Artery Disease; Myocardial Ischemia<br/><b>Intervention</b>: Device: Medtronic Bifurcation Stent System<br/><b>Sponsor</b>: Medtronic Vascular<br/><b>Not yet recruiting</b> - verified January 2008
Randomized Multi-Center Comparison of the Conor Sirolimus-Eluting Coronary Stent to the Taxus Liberte Paclitaxel-Eluting Coronary Stent in the Treatment of Coronary Artery Lesions <b>Condition</b>: Coronary Atherosclerosis<br/><b>Interventions</b>: Device: Drug-eluting stent (Conor Cobalt Chromium Sirolimus-eluting Coronary Stent System); Device: Drug-eluting stent (TAXUS Liberte Paclitaxel-eluting Coronary Stent System)<br/><b>Sponsor</b>: Conor Medsystems<br/><b>Not yet recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccination in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™ <b>Conditions</b>: Transient Ischemic Attack; Thromboembolic Stroke; Stroke Prevention<br/><b>Interventions</b>: Device: EndoTex™ NexStent™; Device: Filter Wire EZ™<br/><b>Sponsor</b>: Boston Scientific Corporation<br/><b>Completed</b> - verified January 2008
Examining Heart Attacks in Young Women (The Variation In Recovery: Role of Gender on Outcomes in Young AMI Patients [VIRGO] Study) <b>Condition</b>: Myocardial Infarction<br/><b>Intervention</b>: <br/><b>Sponsor</b>: National Heart, Lung, and Blood Institute (NHLBI)<br/><b>Active, not recruiting</b> - verified January 2008
Study of 99mTc-Glucarate to Detect Acute Coronary Syndrome in Chest Pain Patients. <b>Condition</b>: Acute Coronary Syndrome<br/><b>Intervention</b>: Drug: 99mTc-glucarate solution<br/><b>Sponsors</b>: Molecular Targeting Technologies, Inc.; National Heart, Lung, and Blood Institute (NHLBI); Yale University<br/><b>Not yet recruiting</b> - verified February 2008
A Safety/Efficacy Study of Intra-Coronary Tenecteplase During Balloon Angioplasty to Treat Heart Attacks <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Tenecteplase<br/><b>Sponsors</b>: Brigham and Women's Hospital; Genentech<br/><b>Not yet recruiting</b> - verified January 2008
THE REOPEN-AMI STUDY - Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction <b>Condition</b>: Myocardial Infarction<br/><b>Interventions</b>: Drug: adenosine; Drug: nitroprusside; Drug: placebo<br/><b>Sponsor</b>: Catholic University of the Sacred Heart<br/><b>Not yet recruiting</b> - verified December 2007
Drug Eluting Stents for In-Stent Restenosis 2 <b>Condition</b>: Coronary Disease<br/><b>Interventions</b>: Device: Sirolimus eluting stent (Cypher); Device: Paclitaxel-eluting stent (Taxus)<br/><b>Sponsors</b>: Deutsches Herzzentrum Muenchen; Technische Universität München<br/><b>Recruiting</b> - verified January 2008
Efficacy Study of Rapamycin- and Zotarolimus-Eluting Stents to Reduce Coronary Restenosis <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: rapamycin+probucol-eluting stent (ISAR stent); Device: polymer based Zotarolimus-eluting stent (Endeavor Resolute)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Not yet recruiting</b> - verified January 2008
3 Limus Agent Eluting Stents With Different Polymer Coating <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: biodegradable polymer Rapamycin-eluting stent (ISAR stent); Device: permanent polymer rapamycin-eluting stent (Cypher); Device: permanent polymer everolimus-eluting stent (Xience, Promus)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Safety and Effectiveness of Human Mesenchymal Stem Cell Injections for Repairing Heart Damage in People Who Have Had a Heart Attack and Are Undergoing Surgery for Coronary Artery Bypass Grafting <b>Conditions</b>: Stem Cell Transplantation; Ventricular Dysfunction, Left<br/><b>Interventions</b>: Genetic: Lower dose mesenchymal stem cell (MSC) injection; Genetic: Placebo; Genetic: Higher dose MSC injection<br/><b>Sponsors</b>: National Heart, Lung, and Blood Institute (NHLBI); Johns Hopkins University Specialized Center for Cell Based Therapy<br/><b>Recruiting</b> - verified February 2008
Efficacy Study of Drug-Eluting and Bare Metal Stents in Bypass Graft Lesions <b>Condition</b>: Coronary Artery Bypass<br/><b>Interventions</b>: Device: Cypher drug-eluting stent; Device: Taxus drug-eluting stent; Device: ISAR drug-eluting stent; Device: bare metal stents<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Clopidogrel Use and Long-Term Safety After Drug-Eluting Stents Implantation <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: Other: Stopping clopidogrel<br/><b>Sponsor</b>: CardioVascular Research Foundation, Korea<br/><b>Recruiting</b> - verified October 2007
Study to Test the Efficacy and Safety of Drug Eluting vs. Bare-Metal Stents for Saphenous Vein Graft Interventions <b>Condition</b>: Coronary Artery Disease<br/><b>Interventions</b>: Device: TAXUS Liberté (Drug eluting stent); Device: Liberté (Bare metal stent)<br/><b>Sponsors</b>: University Hospital, Basel, Switzerland; University of Leipzig<br/><b>Not yet recruiting</b> - verified January 2008

'); document.write('

'); document.write('

'); document.write('

ClinicalTrials.gov: Myocardial infarction AND Ischemia

'); document.write('

3 Nehb Precordial Leads Anterior, Dorsalis and Inferior Allow Accurate Diagnostics of Different Heart Conditions <b>Condition</b>: Acute Myocardial Infarction With ST Segment Elevation<br/><b>Intervention</b>: <br/><b>Sponsor</b>: Assaf-Harofeh Medical Center<br/><b>Recruiting</b> - verified June 2007
STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction <b>Condition</b>: Myocardial Infarction<br/><b>Interventions</b>: Drug: Tenecteplase; Drug: Clopidogrel, Enoxaparin; Procedure: Catheterisation<br/><b>Sponsor</b>: Boehringer Ingelheim Pharmaceuticals<br/><b>Not yet recruiting</b> - verified February 2008
Left Ventricular Function Assessment After Acute Myocardial Infarction: Comparison Between Bi-, Three-Dimensional and Cardiac Magnetic Resonance <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Other: compare measurements of left ventricular volumes and LVEF (by Cardiac Magnetic Resonance and Echocardiography)<br/><b>Sponsor</b>: Assistance Publique Hopitaux De Marseille<br/><b>Not yet recruiting</b> - verified February 2008
Trial to Assess the Ocular Safety of SCH 530348 in Patients With Atherosclerosis (Study P05183) <b>Conditions</b>: Atherosclerosis; Ischemia; Myocardial Infarction; Cerebrovascular Accident<br/><b>Interventions</b>: Drug: SCH 530348; Drug: Placebo<br/><b>Sponsors</b>: Schering-Plough; The TIMI Study Group; Duke University<br/><b>Not yet recruiting</b> - verified February 2008
Perioperative Depression and Postoperative Arrhythmia in Elective Coronary Bypass Graft Surgery <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University Health Network, Toronto<br/><b>Recruiting</b> - verified January 2008
Stem Cell Study for Subjects With CHF <b>Conditions</b>: Myocardial Ischemia; Congestive Heart Failure; Cardiovascular Disease<br/><b>Intervention</b>: Biological: Autologous Stem Cells<br/><b>Sponsor</b>: Losordo, Douglas, M.D.<br/><b>Not yet recruiting</b> - verified February 2008
Survival of Patients With Primary Prophylactic ICD Indication <b>Conditions</b>: Death From Any Cause; Sudden Cardiac Death; Non-Sudden Cardiac Death<br/><b>Interventions</b>: Other: Intensified diagnostic and treatment measures following 1st appropriate ICD therapy; Other: Standard follow-up<br/><b>Sponsor</b>: Biotronik GmbH & Co. KG<br/><b>Recruiting</b> - verified February 2008
The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: tirofiban<br/><b>Sponsor</b>: Samsung Medical Center<br/><b>Completed</b> - verified August 2007
Prophylactic Intra-Coronary Adenosine to Prevent Post Coronary Artery Stenting Myonecrosis <b>Conditions</b>: Coronary Artery Stenosis; Coronary Artery Disease<br/><b>Intervention</b>: Drug: Adenosine<br/><b>Sponsor</b>: University of Ottawa Heart Institute<br/><b>Recruiting</b> - verified January 2008
Italian Registry on Unprotected Left Main <b>Conditions</b>: Cardiovascular Disease; Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University of Turin, Italy<br/><b>Not yet recruiting</b> - verified January 2008
Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-Aortic Balloon Counterpulsation <b>Conditions</b>: Shock, Cardiogenic; Heart Failure; Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Pyruvate<br/><b>Sponsor</b>: Herzzentrum Goettingen<br/><b>Not yet recruiting</b> - verified January 2008
Bare Metal Bifurcation Stent Clinical Trial in Humans <b>Conditions</b>: Coronary Artery Disease; Myocardial Ischemia<br/><b>Intervention</b>: Device: Medtronic Bifurcation Stent System<br/><b>Sponsor</b>: Medtronic Vascular<br/><b>Not yet recruiting</b> - verified January 2008
Randomized Multi-Center Comparison of the Conor Sirolimus-Eluting Coronary Stent to the Taxus Liberte Paclitaxel-Eluting Coronary Stent in the Treatment of Coronary Artery Lesions <b>Condition</b>: Coronary Atherosclerosis<br/><b>Interventions</b>: Device: Drug-eluting stent (Conor Cobalt Chromium Sirolimus-eluting Coronary Stent System); Device: Drug-eluting stent (TAXUS Liberte Paclitaxel-eluting Coronary Stent System)<br/><b>Sponsor</b>: Conor Medsystems<br/><b>Not yet recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccination in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™ <b>Conditions</b>: Transient Ischemic Attack; Thromboembolic Stroke; Stroke Prevention<br/><b>Interventions</b>: Device: EndoTex™ NexStent™; Device: Filter Wire EZ™<br/><b>Sponsor</b>: Boston Scientific Corporation<br/><b>Completed</b> - verified January 2008
Examining Heart Attacks in Young Women (The Variation In Recovery: Role of Gender on Outcomes in Young AMI Patients [VIRGO] Study) <b>Condition</b>: Myocardial Infarction<br/><b>Intervention</b>: <br/><b>Sponsor</b>: National Heart, Lung, and Blood Institute (NHLBI)<br/><b>Active, not recruiting</b> - verified January 2008
Study of 99mTc-Glucarate to Detect Acute Coronary Syndrome in Chest Pain Patients. <b>Condition</b>: Acute Coronary Syndrome<br/><b>Intervention</b>: Drug: 99mTc-glucarate solution<br/><b>Sponsors</b>: Molecular Targeting Technologies, Inc.; National Heart, Lung, and Blood Institute (NHLBI); Yale University<br/><b>Not yet recruiting</b> - verified February 2008
A Safety/Efficacy Study of Intra-Coronary Tenecteplase During Balloon Angioplasty to Treat Heart Attacks <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Tenecteplase<br/><b>Sponsors</b>: Brigham and Women's Hospital; Genentech<br/><b>Not yet recruiting</b> - verified January 2008
THE REOPEN-AMI STUDY - Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction <b>Condition</b>: Myocardial Infarction<br/><b>Interventions</b>: Drug: adenosine; Drug: nitroprusside; Drug: placebo<br/><b>Sponsor</b>: Catholic University of the Sacred Heart<br/><b>Not yet recruiting</b> - verified December 2007
Drug Eluting Stents for In-Stent Restenosis 2 <b>Condition</b>: Coronary Disease<br/><b>Interventions</b>: Device: Sirolimus eluting stent (Cypher); Device: Paclitaxel-eluting stent (Taxus)<br/><b>Sponsors</b>: Deutsches Herzzentrum Muenchen; Technische Universität München<br/><b>Recruiting</b> - verified January 2008
Efficacy Study of Rapamycin- and Zotarolimus-Eluting Stents to Reduce Coronary Restenosis <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: rapamycin+probucol-eluting stent (ISAR stent); Device: polymer based Zotarolimus-eluting stent (Endeavor Resolute)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Not yet recruiting</b> - verified January 2008
3 Limus Agent Eluting Stents With Different Polymer Coating <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: biodegradable polymer Rapamycin-eluting stent (ISAR stent); Device: permanent polymer rapamycin-eluting stent (Cypher); Device: permanent polymer everolimus-eluting stent (Xience, Promus)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Safety and Effectiveness of Human Mesenchymal Stem Cell Injections for Repairing Heart Damage in People Who Have Had a Heart Attack and Are Undergoing Surgery for Coronary Artery Bypass Grafting <b>Conditions</b>: Stem Cell Transplantation; Ventricular Dysfunction, Left<br/><b>Interventions</b>: Genetic: Lower dose mesenchymal stem cell (MSC) injection; Genetic: Placebo; Genetic: Higher dose MSC injection<br/><b>Sponsors</b>: National Heart, Lung, and Blood Institute (NHLBI); Johns Hopkins University Specialized Center for Cell Based Therapy<br/><b>Recruiting</b> - verified February 2008
Efficacy Study of Drug-Eluting and Bare Metal Stents in Bypass Graft Lesions <b>Condition</b>: Coronary Artery Bypass<br/><b>Interventions</b>: Device: Cypher drug-eluting stent; Device: Taxus drug-eluting stent; Device: ISAR drug-eluting stent; Device: bare metal stents<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Clopidogrel Use and Long-Term Safety After Drug-Eluting Stents Implantation <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: Other: Stopping clopidogrel<br/><b>Sponsor</b>: CardioVascular Research Foundation, Korea<br/><b>Recruiting</b> - verified October 2007
Study to Test the Efficacy and Safety of Drug Eluting vs. Bare-Metal Stents for Saphenous Vein Graft Interventions <b>Condition</b>: Coronary Artery Disease<br/><b>Interventions</b>: Device: TAXUS Liberté (Drug eluting stent); Device: Liberté (Bare metal stent)<br/><b>Sponsors</b>: University Hospital, Basel, Switzerland; University of Leipzig<br/><b>Not yet recruiting</b> - verified January 2008

'); document.write('

'); document.write('

'); document.write('

ClinicalTrials.gov: Myocardial infarction AND Ischemia

'); document.write('

3 Nehb Precordial Leads Anterior, Dorsalis and Inferior Allow Accurate Diagnostics of Different Heart Conditions <b>Condition</b>: Acute Myocardial Infarction With ST Segment Elevation<br/><b>Intervention</b>: <br/><b>Sponsor</b>: Assaf-Harofeh Medical Center<br/><b>Recruiting</b> - verified June 2007
STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction <b>Condition</b>: Myocardial Infarction<br/><b>Interventions</b>: Drug: Tenecteplase; Drug: Clopidogrel, Enoxaparin; Procedure: Catheterisation<br/><b>Sponsor</b>: Boehringer Ingelheim Pharmaceuticals<br/><b>Not yet recruiting</b> - verified February 2008
Left Ventricular Function Assessment After Acute Myocardial Infarction: Comparison Between Bi-, Three-Dimensional and Cardiac Magnetic Resonance <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Other: compare measurements of left ventricular volumes and LVEF (by Cardiac Magnetic Resonance and Echocardiography)<br/><b>Sponsor</b>: Assistance Publique Hopitaux De Marseille<br/><b>Not yet recruiting</b> - verified February 2008
Trial to Assess the Ocular Safety of SCH 530348 in Patients With Atherosclerosis (Study P05183) <b>Conditions</b>: Atherosclerosis; Ischemia; Myocardial Infarction; Cerebrovascular Accident<br/><b>Interventions</b>: Drug: SCH 530348; Drug: Placebo<br/><b>Sponsors</b>: Schering-Plough; The TIMI Study Group; Duke University<br/><b>Not yet recruiting</b> - verified February 2008
Perioperative Depression and Postoperative Arrhythmia in Elective Coronary Bypass Graft Surgery <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University Health Network, Toronto<br/><b>Recruiting</b> - verified January 2008
Stem Cell Study for Subjects With CHF <b>Conditions</b>: Myocardial Ischemia; Congestive Heart Failure; Cardiovascular Disease<br/><b>Intervention</b>: Biological: Autologous Stem Cells<br/><b>Sponsor</b>: Losordo, Douglas, M.D.<br/><b>Not yet recruiting</b> - verified February 2008
Survival of Patients With Primary Prophylactic ICD Indication <b>Conditions</b>: Death From Any Cause; Sudden Cardiac Death; Non-Sudden Cardiac Death<br/><b>Interventions</b>: Other: Intensified diagnostic and treatment measures following 1st appropriate ICD therapy; Other: Standard follow-up<br/><b>Sponsor</b>: Biotronik GmbH & Co. KG<br/><b>Recruiting</b> - verified February 2008
The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: tirofiban<br/><b>Sponsor</b>: Samsung Medical Center<br/><b>Completed</b> - verified August 2007
Prophylactic Intra-Coronary Adenosine to Prevent Post Coronary Artery Stenting Myonecrosis <b>Conditions</b>: Coronary Artery Stenosis; Coronary Artery Disease<br/><b>Intervention</b>: Drug: Adenosine<br/><b>Sponsor</b>: University of Ottawa Heart Institute<br/><b>Recruiting</b> - verified January 2008
Italian Registry on Unprotected Left Main <b>Conditions</b>: Cardiovascular Disease; Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University of Turin, Italy<br/><b>Not yet recruiting</b> - verified January 2008
Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-Aortic Balloon Counterpulsation <b>Conditions</b>: Shock, Cardiogenic; Heart Failure; Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Pyruvate<br/><b>Sponsor</b>: Herzzentrum Goettingen<br/><b>Not yet recruiting</b> - verified January 2008
Bare Metal Bifurcation Stent Clinical Trial in Humans <b>Conditions</b>: Coronary Artery Disease; Myocardial Ischemia<br/><b>Intervention</b>: Device: Medtronic Bifurcation Stent System<br/><b>Sponsor</b>: Medtronic Vascular<br/><b>Not yet recruiting</b> - verified January 2008
Randomized Multi-Center Comparison of the Conor Sirolimus-Eluting Coronary Stent to the Taxus Liberte Paclitaxel-Eluting Coronary Stent in the Treatment of Coronary Artery Lesions <b>Condition</b>: Coronary Atherosclerosis<br/><b>Interventions</b>: Device: Drug-eluting stent (Conor Cobalt Chromium Sirolimus-eluting Coronary Stent System); Device: Drug-eluting stent (TAXUS Liberte Paclitaxel-eluting Coronary Stent System)<br/><b>Sponsor</b>: Conor Medsystems<br/><b>Not yet recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccination in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™ <b>Conditions</b>: Transient Ischemic Attack; Thromboembolic Stroke; Stroke Prevention<br/><b>Interventions</b>: Device: EndoTex™ NexStent™; Device: Filter Wire EZ™<br/><b>Sponsor</b>: Boston Scientific Corporation<br/><b>Completed</b> - verified January 2008
Examining Heart Attacks in Young Women (The Variation In Recovery: Role of Gender on Outcomes in Young AMI Patients [VIRGO] Study) <b>Condition</b>: Myocardial Infarction<br/><b>Intervention</b>: <br/><b>Sponsor</b>: National Heart, Lung, and Blood Institute (NHLBI)<br/><b>Active, not recruiting</b> - verified January 2008
Study of 99mTc-Glucarate to Detect Acute Coronary Syndrome in Chest Pain Patients. <b>Condition</b>: Acute Coronary Syndrome<br/><b>Intervention</b>: Drug: 99mTc-glucarate solution<br/><b>Sponsors</b>: Molecular Targeting Technologies, Inc.; National Heart, Lung, and Blood Institute (NHLBI); Yale University<br/><b>Not yet recruiting</b> - verified February 2008
A Safety/Efficacy Study of Intra-Coronary Tenecteplase During Balloon Angioplasty to Treat Heart Attacks <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Tenecteplase<br/><b>Sponsors</b>: Brigham and Women's Hospital; Genentech<br/><b>Not yet recruiting</b> - verified January 2008
THE REOPEN-AMI STUDY - Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction <b>Condition</b>: Myocardial Infarction<br/><b>Interventions</b>: Drug: adenosine; Drug: nitroprusside; Drug: placebo<br/><b>Sponsor</b>: Catholic University of the Sacred Heart<br/><b>Not yet recruiting</b> - verified December 2007
Drug Eluting Stents for In-Stent Restenosis 2 <b>Condition</b>: Coronary Disease<br/><b>Interventions</b>: Device: Sirolimus eluting stent (Cypher); Device: Paclitaxel-eluting stent (Taxus)<br/><b>Sponsors</b>: Deutsches Herzzentrum Muenchen; Technische Universität München<br/><b>Recruiting</b> - verified January 2008
Efficacy Study of Rapamycin- and Zotarolimus-Eluting Stents to Reduce Coronary Restenosis <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: rapamycin+probucol-eluting stent (ISAR stent); Device: polymer based Zotarolimus-eluting stent (Endeavor Resolute)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Not yet recruiting</b> - verified January 2008
3 Limus Agent Eluting Stents With Different Polymer Coating <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: biodegradable polymer Rapamycin-eluting stent (ISAR stent); Device: permanent polymer rapamycin-eluting stent (Cypher); Device: permanent polymer everolimus-eluting stent (Xience, Promus)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Safety and Effectiveness of Human Mesenchymal Stem Cell Injections for Repairing Heart Damage in People Who Have Had a Heart Attack and Are Undergoing Surgery for Coronary Artery Bypass Grafting <b>Conditions</b>: Stem Cell Transplantation; Ventricular Dysfunction, Left<br/><b>Interventions</b>: Genetic: Lower dose mesenchymal stem cell (MSC) injection; Genetic: Placebo; Genetic: Higher dose MSC injection<br/><b>Sponsors</b>: National Heart, Lung, and Blood Institute (NHLBI); Johns Hopkins University Specialized Center for Cell Based Therapy<br/><b>Recruiting</b> - verified February 2008
Efficacy Study of Drug-Eluting and Bare Metal Stents in Bypass Graft Lesions <b>Condition</b>: Coronary Artery Bypass<br/><b>Interventions</b>: Device: Cypher drug-eluting stent; Device: Taxus drug-eluting stent; Device: ISAR drug-eluting stent; Device: bare metal stents<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Clopidogrel Use and Long-Term Safety After Drug-Eluting Stents Implantation <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: Other: Stopping clopidogrel<br/><b>Sponsor</b>: CardioVascular Research Foundation, Korea<br/><b>Recruiting</b> - verified October 2007
T-Wave Alternans in Acute Myocardial Infarction: An Evaluation of the Time of Testing on Its Prognostic Accuracy <b>Conditions</b>: Myocardial Infarction; Arrhythmias<br/><b>Intervention</b>: Procedure: T-wave Alternans<br/><b>Sponsor</b>: Creighton University<br/><b>Recruiting</b> - verified December 2007
Study to Test the Efficacy and Safety of Drug Eluting vs. Bare-Metal Stents for Saphenous Vein Graft Interventions <b>Condition</b>: Coronary Artery Disease<br/><b>Interventions</b>: Device: TAXUS Liberté (Drug eluting stent); Device: Liberté (Bare metal stent)<br/><b>Sponsors</b>: University Hospital, Basel, Switzerland; University of Leipzig<br/><b>Not yet recruiting</b> - verified January 2008
Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS) <b>Conditions</b>: Vertebrobasilar Insufficiency; Ischemic Attack, Transient; Cerebrovascular Disorder; Brain Ischemia; Stroke<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University of Illinois<br/><b>Not yet recruiting</b> - verified December 2007
Clinical Management of Antiplatelet Drug Resistance in Patients With Drug Eluting Coronary Stents <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: Drug: Plavix (Clopidogrel)<br/><b>Sponsor</b>: Creighton University<br/><b>Recruiting</b> - verified January 2008

'); document.write('

'); document.write('

'); document.write('

ClinicalTrials.gov: Myocardial infarction AND Ischemia

'); document.write('

Trial to Assess the Ocular Safety of SCH 530348 in Patients With Atherosclerosis (Study P05183) <b>Conditions</b>: Atherosclerosis; Ischemia; Myocardial Infarction; Cerebrovascular Accident<br/><b>Interventions</b>: Drug: SCH 530348; Drug: Placebo<br/><b>Sponsors</b>: Schering-Plough; The TIMI Study Group; Duke University<br/><b>Not yet recruiting</b> - verified February 2008
Perioperative Depression and Postoperative Arrhythmia in Elective Coronary Bypass Graft Surgery <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University Health Network, Toronto<br/><b>Recruiting</b> - verified January 2008
Stem Cell Study for Subjects With CHF <b>Conditions</b>: Myocardial Ischemia; Congestive Heart Failure; Cardiovascular Disease<br/><b>Intervention</b>: Biological: Autologous Stem Cells<br/><b>Sponsor</b>: Losordo, Douglas, M.D.<br/><b>Not yet recruiting</b> - verified February 2008
Survival of Patients With Primary Prophylactic ICD Indication <b>Conditions</b>: Death From Any Cause; Sudden Cardiac Death; Non-Sudden Cardiac Death<br/><b>Interventions</b>: Other: Intensified diagnostic and treatment measures following 1st appropriate ICD therapy; Other: Standard follow-up<br/><b>Sponsor</b>: Biotronik GmbH & Co. KG<br/><b>Recruiting</b> - verified February 2008
The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: tirofiban<br/><b>Sponsor</b>: Samsung Medical Center<br/><b>Completed</b> - verified August 2007
Prophylactic Intra-Coronary Adenosine to Prevent Post Coronary Artery Stenting Myonecrosis <b>Conditions</b>: Coronary Artery Stenosis; Coronary Artery Disease<br/><b>Intervention</b>: Drug: Adenosine<br/><b>Sponsor</b>: University of Ottawa Heart Institute<br/><b>Recruiting</b> - verified January 2008
Italian Registry on Unprotected Left Main <b>Conditions</b>: Cardiovascular Disease; Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University of Turin, Italy<br/><b>Not yet recruiting</b> - verified January 2008
Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-Aortic Balloon Counterpulsation <b>Conditions</b>: Shock, Cardiogenic; Heart Failure; Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Pyruvate<br/><b>Sponsor</b>: Herzzentrum Goettingen<br/><b>Not yet recruiting</b> - verified January 2008
Bare Metal Bifurcation Stent Clinical Trial in Humans <b>Conditions</b>: Coronary Artery Disease; Myocardial Ischemia<br/><b>Intervention</b>: Device: Medtronic Bifurcation Stent System<br/><b>Sponsor</b>: Medtronic Vascular<br/><b>Not yet recruiting</b> - verified January 2008
Randomized Multi-Center Comparison of the Conor Sirolimus-Eluting Coronary Stent to the Taxus Liberte Paclitaxel-Eluting Coronary Stent in the Treatment of Coronary Artery Lesions <b>Condition</b>: Coronary Atherosclerosis<br/><b>Interventions</b>: Device: Drug-eluting stent (Conor Cobalt Chromium Sirolimus-eluting Coronary Stent System); Device: Drug-eluting stent (TAXUS Liberte Paclitaxel-eluting Coronary Stent System)<br/><b>Sponsor</b>: Conor Medsystems<br/><b>Not yet recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccination in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™ <b>Conditions</b>: Transient Ischemic Attack; Thromboembolic Stroke; Stroke Prevention<br/><b>Interventions</b>: Device: EndoTex™ NexStent™; Device: Filter Wire EZ™<br/><b>Sponsor</b>: Boston Scientific Corporation<br/><b>Completed</b> - verified January 2008
Examining Heart Attacks in Young Women (The Variation In Recovery: Role of Gender on Outcomes in Young AMI Patients [VIRGO] Study) <b>Condition</b>: Myocardial Infarction<br/><b>Intervention</b>: <br/><b>Sponsor</b>: National Heart, Lung, and Blood Institute (NHLBI)<br/><b>Active, not recruiting</b> - verified January 2008
A Safety/Efficacy Study of Intra-Coronary Tenecteplase During Balloon Angioplasty to Treat Heart Attacks <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Tenecteplase<br/><b>Sponsors</b>: Brigham and Women's Hospital; Genentech<br/><b>Not yet recruiting</b> - verified January 2008
Drug Eluting Stents for In-Stent Restenosis 2 <b>Condition</b>: Coronary Disease<br/><b>Interventions</b>: Device: Sirolimus eluting stent (Cypher); Device: Paclitaxel-eluting stent (Taxus)<br/><b>Sponsors</b>: Deutsches Herzzentrum Muenchen; Technische Universität München<br/><b>Recruiting</b> - verified January 2008
THE REOPEN-AMI STUDY - Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction <b>Condition</b>: Myocardial Infarction<br/><b>Interventions</b>: Drug: adenosine; Drug: nitroprusside; Drug: placebo<br/><b>Sponsor</b>: Catholic University of the Sacred Heart<br/><b>Not yet recruiting</b> - verified December 2007
Efficacy Study of Rapamycin- and Zotarolimus-Eluting Stents to Reduce Coronary Restenosis <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: rapamycin+probucol-eluting stent (ISAR stent); Device: polymer based Zotarolimus-eluting stent (Endeavor Resolute)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Not yet recruiting</b> - verified January 2008
3 Limus Agent Eluting Stents With Different Polymer Coating <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: biodegradable polymer Rapamycin-eluting stent (ISAR stent); Device: permanent polymer rapamycin-eluting stent (Cypher); Device: permanent polymer everolimus-eluting stent (Xience, Promus)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Safety and Effectiveness of Human Mesenchymal Stem Cell Injections for Repairing Heart Damage in People Who Have Had a Heart Attack and Are Undergoing Surgery for Coronary Artery Bypass Grafting <b>Conditions</b>: Stem Cell Transplantation; Ventricular Dysfunction, Left<br/><b>Interventions</b>: Genetic: Lower dose mesenchymal stem cell (MSC) injection; Genetic: Placebo; Genetic: Higher dose MSC injection<br/><b>Sponsors</b>: National Heart, Lung, and Blood Institute (NHLBI); Johns Hopkins University Specialized Center for Cell Based Therapy<br/><b>Recruiting</b> - verified February 2008
Efficacy Study of Drug-Eluting and Bare Metal Stents in Bypass Graft Lesions <b>Condition</b>: Coronary Artery Bypass<br/><b>Interventions</b>: Device: Cypher drug-eluting stent; Device: Taxus drug-eluting stent; Device: ISAR drug-eluting stent; Device: bare metal stents<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Clopidogrel Use and Long-Term Safety After Drug-Eluting Stents Implantation <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: Other: Stopping clopidogrel<br/><b>Sponsor</b>: CardioVascular Research Foundation, Korea<br/><b>Recruiting</b> - verified October 2007
T-Wave Alternans in Acute Myocardial Infarction: An Evaluation of the Time of Testing on Its Prognostic Accuracy <b>Conditions</b>: Myocardial Infarction; Arrhythmias<br/><b>Intervention</b>: Procedure: T-wave Alternans<br/><b>Sponsor</b>: Creighton University<br/><b>Recruiting</b> - verified December 2007
Molecular Determinants of Coronaruy Artery Disease <b>Conditions</b>: Coronary Artery Disease; Arteriovenous Malformations; Myocardial Infarction<br/><b>Intervention</b>: <br/><b>Sponsors</b>: The Cleveland Clinic; National Heart, Lung, and Blood Institute (NHLBI)<br/><b>Active, not recruiting</b> - verified August 2006
Study to Test the Efficacy and Safety of Drug Eluting vs. Bare-Metal Stents for Saphenous Vein Graft Interventions <b>Condition</b>: Coronary Artery Disease<br/><b>Interventions</b>: Device: TAXUS Liberté (Drug eluting stent); Device: Liberté (Bare metal stent)<br/><b>Sponsors</b>: University Hospital, Basel, Switzerland; University of Leipzig<br/><b>Not yet recruiting</b> - verified January 2008
Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS) <b>Conditions</b>: Vertebrobasilar Insufficiency; Ischemic Attack, Transient; Cerebrovascular Disorder; Brain Ischemia; Stroke<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University of Illinois<br/><b>Not yet recruiting</b> - verified December 2007
Clinical Management of Antiplatelet Drug Resistance in Patients With Drug Eluting Coronary Stents <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: Drug: Plavix (Clopidogrel)<br/><b>Sponsor</b>: Creighton University<br/><b>Recruiting</b> - verified January 2008

'); document.write('

'); document.write('

'); document.write('

ClinicalTrials.gov: Myocardial infarction AND Ischemia

'); document.write('

Trial to Assess the Ocular Safety of SCH 530348 in Patients With Atherosclerosis (Study P05183) <b>Conditions</b>: Atherosclerosis; Ischemia; Myocardial Infarction; Cerebrovascular Accident<br/><b>Interventions</b>: Drug: SCH 530348; Drug: Placebo<br/><b>Sponsors</b>: Schering-Plough; The TIMI Study Group; Duke University<br/><b>Not yet recruiting</b> - verified February 2008
Perioperative Depression and Postoperative Arrhythmia in Elective Coronary Bypass Graft Surgery <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University Health Network, Toronto<br/><b>Recruiting</b> - verified January 2008
Stem Cell Study for Subjects With CHF <b>Conditions</b>: Myocardial Ischemia; Congestive Heart Failure; Cardiovascular Disease<br/><b>Intervention</b>: Biological: Autologous Stem Cells<br/><b>Sponsor</b>: Losordo, Douglas, M.D.<br/><b>Not yet recruiting</b> - verified February 2008
Survival of Patients With Primary Prophylactic ICD Indication <b>Conditions</b>: Death From Any Cause; Sudden Cardiac Death; Non-Sudden Cardiac Death<br/><b>Interventions</b>: Other: Intensified diagnostic and treatment measures following 1st appropriate ICD therapy; Other: Standard follow-up<br/><b>Sponsor</b>: Biotronik GmbH & Co. KG<br/><b>Recruiting</b> - verified February 2008
The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: tirofiban<br/><b>Sponsor</b>: Samsung Medical Center<br/><b>Completed</b> - verified August 2007
Prophylactic Intra-Coronary Adenosine to Prevent Post Coronary Artery Stenting Myonecrosis <b>Conditions</b>: Coronary Artery Stenosis; Coronary Artery Disease<br/><b>Intervention</b>: Drug: Adenosine<br/><b>Sponsor</b>: University of Ottawa Heart Institute<br/><b>Recruiting</b> - verified January 2008
Italian Registry on Unprotected Left Main <b>Conditions</b>: Cardiovascular Disease; Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University of Turin, Italy<br/><b>Not yet recruiting</b> - verified January 2008
Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-Aortic Balloon Counterpulsation <b>Conditions</b>: Shock, Cardiogenic; Heart Failure; Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Pyruvate<br/><b>Sponsor</b>: Herzzentrum Goettingen<br/><b>Not yet recruiting</b> - verified January 2008
Bare Metal Bifurcation Stent Clinical Trial in Humans <b>Conditions</b>: Coronary Artery Disease; Myocardial Ischemia<br/><b>Intervention</b>: Device: Medtronic Bifurcation Stent System<br/><b>Sponsor</b>: Medtronic Vascular<br/><b>Not yet recruiting</b> - verified January 2008
Randomized Multi-Center Comparison of the Conor Sirolimus-Eluting Coronary Stent to the Taxus Liberte Paclitaxel-Eluting Coronary Stent in the Treatment of Coronary Artery Lesions <b>Condition</b>: Coronary Atherosclerosis<br/><b>Interventions</b>: Device: Drug-eluting stent (Conor Cobalt Chromium Sirolimus-eluting Coronary Stent System); Device: Drug-eluting stent (TAXUS Liberte Paclitaxel-eluting Coronary Stent System)<br/><b>Sponsor</b>: Conor Medsystems<br/><b>Not yet recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccination in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™ <b>Conditions</b>: Transient Ischemic Attack; Thromboembolic Stroke; Stroke Prevention<br/><b>Interventions</b>: Device: EndoTex™ NexStent™; Device: Filter Wire EZ™<br/><b>Sponsor</b>: Boston Scientific Corporation<br/><b>Completed</b> - verified January 2008
Examining Heart Attacks in Young Women (The Variation In Recovery: Role of Gender on Outcomes in Young AMI Patients [VIRGO] Study) <b>Condition</b>: Myocardial Infarction<br/><b>Intervention</b>: <br/><b>Sponsor</b>: National Heart, Lung, and Blood Institute (NHLBI)<br/><b>Active, not recruiting</b> - verified January 2008
A Safety/Efficacy Study of Intra-Coronary Tenecteplase During Balloon Angioplasty to Treat Heart Attacks <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Tenecteplase<br/><b>Sponsors</b>: Brigham and Women's Hospital; Genentech<br/><b>Not yet recruiting</b> - verified January 2008
Drug Eluting Stents for In-Stent Restenosis 2 <b>Condition</b>: Coronary Disease<br/><b>Interventions</b>: Device: Sirolimus eluting stent (Cypher); Device: Paclitaxel-eluting stent (Taxus)<br/><b>Sponsors</b>: Deutsches Herzzentrum Muenchen; Technische Universität München<br/><b>Recruiting</b> - verified January 2008
THE REOPEN-AMI STUDY - Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction <b>Condition</b>: Myocardial Infarction<br/><b>Interventions</b>: Drug: adenosine; Drug: nitroprusside; Drug: placebo<br/><b>Sponsor</b>: Catholic University of the Sacred Heart<br/><b>Not yet recruiting</b> - verified December 2007
Efficacy Study of Rapamycin- and Zotarolimus-Eluting Stents to Reduce Coronary Restenosis <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: rapamycin+probucol-eluting stent (ISAR stent); Device: polymer based Zotarolimus-eluting stent (Endeavor Resolute)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Not yet recruiting</b> - verified January 2008
3 Limus Agent Eluting Stents With Different Polymer Coating <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: biodegradable polymer Rapamycin-eluting stent (ISAR stent); Device: permanent polymer rapamycin-eluting stent (Cypher); Device: permanent polymer everolimus-eluting stent (Xience, Promus)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Safety and Effectiveness of Human Mesenchymal Stem Cell Injections for Repairing Heart Damage in People Who Have Had a Heart Attack and Are Undergoing Surgery for Coronary Artery Bypass Grafting <b>Conditions</b>: Stem Cell Transplantation; Ventricular Dysfunction, Left<br/><b>Interventions</b>: Genetic: Lower dose mesenchymal stem cell (MSC) injection; Genetic: Placebo; Genetic: Higher dose MSC injection<br/><b>Sponsors</b>: National Heart, Lung, and Blood Institute (NHLBI); Johns Hopkins University Specialized Center for Cell Based Therapy<br/><b>Recruiting</b> - verified February 2008
Efficacy Study of Drug-Eluting and Bare Metal Stents in Bypass Graft Lesions <b>Condition</b>: Coronary Artery Bypass<br/><b>Interventions</b>: Device: Cypher drug-eluting stent; Device: Taxus drug-eluting stent; Device: ISAR drug-eluting stent; Device: bare metal stents<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Clopidogrel Use and Long-Term Safety After Drug-Eluting Stents Implantation <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: Other: Stopping clopidogrel<br/><b>Sponsor</b>: CardioVascular Research Foundation, Korea<br/><b>Recruiting</b> - verified October 2007
T-Wave Alternans in Acute Myocardial Infarction: An Evaluation of the Time of Testing on Its Prognostic Accuracy <b>Conditions</b>: Myocardial Infarction; Arrhythmias<br/><b>Intervention</b>: Procedure: T-wave Alternans<br/><b>Sponsor</b>: Creighton University<br/><b>Recruiting</b> - verified December 2007
Molecular Determinants of Coronaruy Artery Disease <b>Conditions</b>: Coronary Artery Disease; Arteriovenous Malformations; Myocardial Infarction<br/><b>Intervention</b>: <br/><b>Sponsors</b>: The Cleveland Clinic; National Heart, Lung, and Blood Institute (NHLBI)<br/><b>Active, not recruiting</b> - verified August 2006
Study to Test the Efficacy and Safety of Drug Eluting vs. Bare-Metal Stents for Saphenous Vein Graft Interventions <b>Condition</b>: Coronary Artery Disease<br/><b>Interventions</b>: Device: TAXUS Liberté (Drug eluting stent); Device: Liberté (Bare metal stent)<br/><b>Sponsors</b>: University Hospital, Basel, Switzerland; University of Leipzig<br/><b>Not yet recruiting</b> - verified January 2008
Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary Intervention <b>Condition</b>: Coronary Artery Disease<br/><b>Interventions</b>: Drug: clopidogrel treatment after bare metal stent implantation; Drug: clopidogrel treatment after bare metal stent implantation; Drug: clopidogrel after zotarolimus-eluting stent implantation; Drug: clopidogrel after paclitaxel-eluting stent implantation; Drug: clopidogrel after everolimus-eluting stent implantation; Drug: clopidogrel after zotarolimus-eluting stent implantation; Drug: clopidogrel after paclitaxel-eluting stent implantation; Drug: clopidogrel after everolimus-eluting stent implantation<br/><b>Sponsor</b>: Universitaria di Ferrara<br/><b>Recruiting</b> - verified November 2007
Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS) <b>Conditions</b>: Vertebrobasilar Insufficiency; Ischemic Attack, Transient; Cerebrovascular Disorder; Brain Ischemia; Stroke<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University of Illinois<br/><b>Not yet recruiting</b> - verified December 2007
Clinical Management of Antiplatelet Drug Resistance in Patients With Drug Eluting Coronary Stents <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: Drug: Plavix (Clopidogrel)<br/><b>Sponsor</b>: Creighton University<br/><b>Recruiting</b> - verified January 2008
GeneBank at the Cleveland Clinic: Molecular Determinants of Coronary Artery Disease <b>Condition</b>: Cardiovascular Diseases<br/><b>Intervention</b>: <br/><b>Sponsors</b>: The Cleveland Clinic; National Institutes of Health (NIH); Millennium Pharmaceuticals<br/><b>Active, not recruiting</b> - verified December 2007

'); document.write('

'); document.write('

'); document.write('

ClinicalTrials.gov: Myocardial infarction AND Ischemia

'); document.write('

Trial to Assess the Ocular Safety of SCH 530348 in Patients With Atherosclerosis (Study P05183) <b>Conditions</b>: Atherosclerosis; Ischemia; Myocardial Infarction; Cerebrovascular Accident<br/><b>Interventions</b>: Drug: SCH 530348; Drug: Placebo<br/><b>Sponsors</b>: Schering-Plough; The TIMI Study Group; Duke University<br/><b>Not yet recruiting</b> - verified February 2008
Perioperative Depression and Postoperative Arrhythmia in Elective Coronary Bypass Graft Surgery <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University Health Network, Toronto<br/><b>Recruiting</b> - verified January 2008
Stem Cell Study for Subjects With CHF <b>Conditions</b>: Myocardial Ischemia; Congestive Heart Failure; Cardiovascular Disease<br/><b>Intervention</b>: Biological: Autologous Stem Cells<br/><b>Sponsor</b>: Losordo, Douglas, M.D.<br/><b>Not yet recruiting</b> - verified February 2008
Survival of Patients With Primary Prophylactic ICD Indication <b>Conditions</b>: Death From Any Cause; Sudden Cardiac Death; Non-Sudden Cardiac Death<br/><b>Interventions</b>: Other: Intensified diagnostic and treatment measures following 1st appropriate ICD therapy; Other: Standard follow-up<br/><b>Sponsor</b>: Biotronik GmbH & Co. KG<br/><b>Recruiting</b> - verified February 2008
The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: tirofiban<br/><b>Sponsor</b>: Samsung Medical Center<br/><b>Completed</b> - verified August 2007
Prophylactic Intra-Coronary Adenosine to Prevent Post Coronary Artery Stenting Myonecrosis <b>Conditions</b>: Coronary Artery Stenosis; Coronary Artery Disease<br/><b>Intervention</b>: Drug: Adenosine<br/><b>Sponsor</b>: University of Ottawa Heart Institute<br/><b>Recruiting</b> - verified January 2008
Italian Registry on Unprotected Left Main <b>Conditions</b>: Cardiovascular Disease; Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University of Turin, Italy<br/><b>Not yet recruiting</b> - verified January 2008
Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-Aortic Balloon Counterpulsation <b>Conditions</b>: Shock, Cardiogenic; Heart Failure; Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Pyruvate<br/><b>Sponsor</b>: Herzzentrum Goettingen<br/><b>Not yet recruiting</b> - verified January 2008
Bare Metal Bifurcation Stent Clinical Trial in Humans <b>Conditions</b>: Coronary Artery Disease; Myocardial Ischemia<br/><b>Intervention</b>: Device: Medtronic Bifurcation Stent System<br/><b>Sponsor</b>: Medtronic Vascular<br/><b>Not yet recruiting</b> - verified January 2008
Randomized Multi-Center Comparison of the Conor Sirolimus-Eluting Coronary Stent to the Taxus Liberte Paclitaxel-Eluting Coronary Stent in the Treatment of Coronary Artery Lesions <b>Condition</b>: Coronary Atherosclerosis<br/><b>Interventions</b>: Device: Drug-eluting stent (Conor Cobalt Chromium Sirolimus-eluting Coronary Stent System); Device: Drug-eluting stent (TAXUS Liberte Paclitaxel-eluting Coronary Stent System)<br/><b>Sponsor</b>: Conor Medsystems<br/><b>Not yet recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccination in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™ <b>Conditions</b>: Transient Ischemic Attack; Thromboembolic Stroke; Stroke Prevention<br/><b>Interventions</b>: Device: EndoTex™ NexStent™; Device: Filter Wire EZ™<br/><b>Sponsor</b>: Boston Scientific Corporation<br/><b>Completed</b> - verified January 2008
Examining Heart Attacks in Young Women (The Variation In Recovery: Role of Gender on Outcomes in Young AMI Patients [VIRGO] Study) <b>Condition</b>: Myocardial Infarction<br/><b>Intervention</b>: <br/><b>Sponsor</b>: National Heart, Lung, and Blood Institute (NHLBI)<br/><b>Active, not recruiting</b> - verified January 2008
A Safety/Efficacy Study of Intra-Coronary Tenecteplase During Balloon Angioplasty to Treat Heart Attacks <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Tenecteplase<br/><b>Sponsors</b>: Brigham and Women's Hospital; Genentech<br/><b>Not yet recruiting</b> - verified January 2008
Drug Eluting Stents for In-Stent Restenosis 2 <b>Condition</b>: Coronary Disease<br/><b>Interventions</b>: Device: Sirolimus eluting stent (Cypher); Device: Paclitaxel-eluting stent (Taxus)<br/><b>Sponsors</b>: Deutsches Herzzentrum Muenchen; Technische Universität München<br/><b>Recruiting</b> - verified January 2008
THE REOPEN-AMI STUDY - Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction <b>Condition</b>: Myocardial Infarction<br/><b>Interventions</b>: Drug: adenosine; Drug: nitroprusside; Drug: placebo<br/><b>Sponsor</b>: Catholic University of the Sacred Heart<br/><b>Not yet recruiting</b> - verified December 2007
Efficacy Study of Rapamycin- and Zotarolimus-Eluting Stents to Reduce Coronary Restenosis <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: rapamycin+probucol-eluting stent (ISAR stent); Device: polymer based Zotarolimus-eluting stent (Endeavor Resolute)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Not yet recruiting</b> - verified January 2008
3 Limus Agent Eluting Stents With Different Polymer Coating <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: biodegradable polymer Rapamycin-eluting stent (ISAR stent); Device: permanent polymer rapamycin-eluting stent (Cypher); Device: permanent polymer everolimus-eluting stent (Xience, Promus)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Safety and Effectiveness of Human Mesenchymal Stem Cell Injections for Repairing Heart Damage in People Who Have Had a Heart Attack and Are Undergoing Surgery for Coronary Artery Bypass Grafting <b>Conditions</b>: Stem Cell Transplantation; Ventricular Dysfunction, Left<br/><b>Interventions</b>: Genetic: Lower dose mesenchymal stem cell (MSC) injection; Genetic: Placebo; Genetic: Higher dose MSC injection<br/><b>Sponsors</b>: National Heart, Lung, and Blood Institute (NHLBI); Johns Hopkins University Specialized Center for Cell Based Therapy<br/><b>Recruiting</b> - verified February 2008
Efficacy Study of Drug-Eluting and Bare Metal Stents in Bypass Graft Lesions <b>Condition</b>: Coronary Artery Bypass<br/><b>Interventions</b>: Device: Cypher drug-eluting stent; Device: Taxus drug-eluting stent; Device: ISAR drug-eluting stent; Device: bare metal stents<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Clopidogrel Use and Long-Term Safety After Drug-Eluting Stents Implantation <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: Other: Stopping clopidogrel<br/><b>Sponsor</b>: CardioVascular Research Foundation, Korea<br/><b>Recruiting</b> - verified October 2007
T-Wave Alternans in Acute Myocardial Infarction: An Evaluation of the Time of Testing on Its Prognostic Accuracy <b>Conditions</b>: Myocardial Infarction; Arrhythmias<br/><b>Intervention</b>: Procedure: T-wave Alternans<br/><b>Sponsor</b>: Creighton University<br/><b>Recruiting</b> - verified December 2007
Molecular Determinants of Coronaruy Artery Disease <b>Conditions</b>: Coronary Artery Disease; Arteriovenous Malformations; Myocardial Infarction<br/><b>Intervention</b>: <br/><b>Sponsors</b>: The Cleveland Clinic; National Heart, Lung, and Blood Institute (NHLBI)<br/><b>Active, not recruiting</b> - verified August 2006
Study to Test the Efficacy and Safety of Drug Eluting vs. Bare-Metal Stents for Saphenous Vein Graft Interventions <b>Condition</b>: Coronary Artery Disease<br/><b>Interventions</b>: Device: TAXUS Liberté (Drug eluting stent); Device: Liberté (Bare metal stent)<br/><b>Sponsors</b>: University Hospital, Basel, Switzerland; University of Leipzig<br/><b>Not yet recruiting</b> - verified January 2008
Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary Intervention <b>Condition</b>: Coronary Artery Disease<br/><b>Interventions</b>: Drug: clopidogrel treatment after bare metal stent implantation; Drug: clopidogrel treatment after bare metal stent implantation; Drug: clopidogrel after zotarolimus-eluting stent implantation; Drug: clopidogrel after paclitaxel-eluting stent implantation; Drug: clopidogrel after everolimus-eluting stent implantation; Drug: clopidogrel after zotarolimus-eluting stent implantation; Drug: clopidogrel after paclitaxel-eluting stent implantation; Drug: clopidogrel after everolimus-eluting stent implantation<br/><b>Sponsor</b>: Universitaria di Ferrara<br/><b>Recruiting</b> - verified November 2007
Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS) <b>Conditions</b>: Vertebrobasilar Insufficiency; Ischemic Attack, Transient; Cerebrovascular Disorder; Brain Ischemia; Stroke<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University of Illinois<br/><b>Not yet recruiting</b> - verified December 2007
Clinical Management of Antiplatelet Drug Resistance in Patients With Drug Eluting Coronary Stents <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: Drug: Plavix (Clopidogrel)<br/><b>Sponsor</b>: Creighton University<br/><b>Recruiting</b> - verified January 2008
GeneBank at the Cleveland Clinic: Molecular Determinants of Coronary Artery Disease <b>Condition</b>: Cardiovascular Diseases<br/><b>Intervention</b>: <br/><b>Sponsors</b>: The Cleveland Clinic; National Institutes of Health (NIH); Millennium Pharmaceuticals<br/><b>Active, not recruiting</b> - verified December 2007

'); document.write('

'); document.write('

'); document.write('

ClinicalTrials.gov: Myocardial infarction AND Ischemia

'); document.write('

Trial to Assess the Ocular Safety of SCH 530348 in Patients With Atherosclerosis (Study P05183) <b>Conditions</b>: Atherosclerosis; Ischemia; Myocardial Infarction; Cerebrovascular Accident<br/><b>Interventions</b>: Drug: SCH 530348; Drug: Placebo<br/><b>Sponsors</b>: Schering-Plough; The TIMI Study Group; Duke University<br/><b>Not yet recruiting</b> - verified February 2008
Perioperative Depression and Postoperative Arrhythmia in Elective Coronary Bypass Graft Surgery <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University Health Network, Toronto<br/><b>Recruiting</b> - verified January 2008
Stem Cell Study for Subjects With CHF <b>Conditions</b>: Myocardial Ischemia; Congestive Heart Failure; Cardiovascular Disease<br/><b>Intervention</b>: Biological: Autologous Stem Cells<br/><b>Sponsor</b>: Losordo, Douglas, M.D.<br/><b>Not yet recruiting</b> - verified February 2008
Survival of Patients With Primary Prophylactic ICD Indication <b>Conditions</b>: Death From Any Cause; Sudden Cardiac Death; Non-Sudden Cardiac Death<br/><b>Interventions</b>: Other: Intensified diagnostic and treatment measures following 1st appropriate ICD therapy; Other: Standard follow-up<br/><b>Sponsor</b>: Biotronik GmbH & Co. KG<br/><b>Recruiting</b> - verified February 2008
The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: tirofiban<br/><b>Sponsor</b>: Samsung Medical Center<br/><b>Completed</b> - verified August 2007
Prophylactic Intra-Coronary Adenosine to Prevent Post Coronary Artery Stenting Myonecrosis <b>Conditions</b>: Coronary Artery Stenosis; Coronary Artery Disease<br/><b>Intervention</b>: Drug: Adenosine<br/><b>Sponsor</b>: University of Ottawa Heart Institute<br/><b>Recruiting</b> - verified January 2008
Italian Registry on Unprotected Left Main <b>Conditions</b>: Cardiovascular Disease; Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University of Turin, Italy<br/><b>Not yet recruiting</b> - verified January 2008
Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-Aortic Balloon Counterpulsation <b>Conditions</b>: Shock, Cardiogenic; Heart Failure; Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Pyruvate<br/><b>Sponsor</b>: Herzzentrum Goettingen<br/><b>Not yet recruiting</b> - verified January 2008
Bare Metal Bifurcation Stent Clinical Trial in Humans <b>Conditions</b>: Coronary Artery Disease; Myocardial Ischemia<br/><b>Intervention</b>: Device: Medtronic Bifurcation Stent System<br/><b>Sponsor</b>: Medtronic Vascular<br/><b>Not yet recruiting</b> - verified January 2008
Randomized Multi-Center Comparison of the Conor Sirolimus-Eluting Coronary Stent to the Taxus Liberte Paclitaxel-Eluting Coronary Stent in the Treatment of Coronary Artery Lesions <b>Condition</b>: Coronary Atherosclerosis<br/><b>Interventions</b>: Device: Drug-eluting stent (Conor Cobalt Chromium Sirolimus-eluting Coronary Stent System); Device: Drug-eluting stent (TAXUS Liberte Paclitaxel-eluting Coronary Stent System)<br/><b>Sponsor</b>: Conor Medsystems<br/><b>Not yet recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccination in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™ <b>Conditions</b>: Transient Ischemic Attack; Thromboembolic Stroke; Stroke Prevention<br/><b>Interventions</b>: Device: EndoTex™ NexStent™; Device: Filter Wire EZ™<br/><b>Sponsor</b>: Boston Scientific Corporation<br/><b>Completed</b> - verified January 2008
Examining Heart Attacks in Young Women (The Variation In Recovery: Role of Gender on Outcomes in Young AMI Patients [VIRGO] Study) <b>Condition</b>: Myocardial Infarction<br/><b>Intervention</b>: <br/><b>Sponsor</b>: National Heart, Lung, and Blood Institute (NHLBI)<br/><b>Active, not recruiting</b> - verified January 2008
A Safety/Efficacy Study of Intra-Coronary Tenecteplase During Balloon Angioplasty to Treat Heart Attacks <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Tenecteplase<br/><b>Sponsors</b>: Brigham and Women's Hospital; Genentech<br/><b>Not yet recruiting</b> - verified January 2008
Drug Eluting Stents for In-Stent Restenosis 2 <b>Condition</b>: Coronary Disease<br/><b>Interventions</b>: Device: Sirolimus eluting stent (Cypher); Device: Paclitaxel-eluting stent (Taxus)<br/><b>Sponsors</b>: Deutsches Herzzentrum Muenchen; Technische Universität München<br/><b>Recruiting</b> - verified January 2008
THE REOPEN-AMI STUDY - Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction <b>Condition</b>: Myocardial Infarction<br/><b>Interventions</b>: Drug: adenosine; Drug: nitroprusside; Drug: placebo<br/><b>Sponsor</b>: Catholic University of the Sacred Heart<br/><b>Not yet recruiting</b> - verified December 2007
Efficacy Study of Rapamycin- and Zotarolimus-Eluting Stents to Reduce Coronary Restenosis <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: rapamycin+probucol-eluting stent (ISAR stent); Device: polymer based Zotarolimus-eluting stent (Endeavor Resolute)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Not yet recruiting</b> - verified January 2008
3 Limus Agent Eluting Stents With Different Polymer Coating <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: biodegradable polymer Rapamycin-eluting stent (ISAR stent); Device: permanent polymer rapamycin-eluting stent (Cypher); Device: permanent polymer everolimus-eluting stent (Xience, Promus)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Safety and Effectiveness of Human Mesenchymal Stem Cell Injections for Repairing Heart Damage in People Who Have Had a Heart Attack and Are Undergoing Surgery for Coronary Artery Bypass Grafting <b>Conditions</b>: Stem Cell Transplantation; Ventricular Dysfunction, Left<br/><b>Interventions</b>: Genetic: Lower dose mesenchymal stem cell (MSC) injection; Genetic: Placebo; Genetic: Higher dose MSC injection<br/><b>Sponsors</b>: National Heart, Lung, and Blood Institute (NHLBI); Johns Hopkins University Specialized Center for Cell Based Therapy<br/><b>Recruiting</b> - verified February 2008
Efficacy Study of Drug-Eluting and Bare Metal Stents in Bypass Graft Lesions <b>Condition</b>: Coronary Artery Bypass<br/><b>Interventions</b>: Device: Cypher drug-eluting stent; Device: Taxus drug-eluting stent; Device: ISAR drug-eluting stent; Device: bare metal stents<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Clopidogrel Use and Long-Term Safety After Drug-Eluting Stents Implantation <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: Other: Stopping clopidogrel<br/><b>Sponsor</b>: CardioVascular Research Foundation, Korea<br/><b>Recruiting</b> - verified October 2007
T-Wave Alternans in Acute Myocardial Infarction: An Evaluation of the Time of Testing on Its Prognostic Accuracy <b>Conditions</b>: Myocardial Infarction; Arrhythmias<br/><b>Intervention</b>: Procedure: T-wave Alternans<br/><b>Sponsor</b>: Creighton University<br/><b>Recruiting</b> - verified December 2007
Molecular Determinants of Coronaruy Artery Disease <b>Conditions</b>: Coronary Artery Disease; Arteriovenous Malformations; Myocardial Infarction<br/><b>Intervention</b>: <br/><b>Sponsors</b>: The Cleveland Clinic; National Heart, Lung, and Blood Institute (NHLBI)<br/><b>Active, not recruiting</b> - verified August 2006
Study to Test the Efficacy and Safety of Drug Eluting vs. Bare-Metal Stents for Saphenous Vein Graft Interventions <b>Condition</b>: Coronary Artery Disease<br/><b>Interventions</b>: Device: TAXUS Liberté (Drug eluting stent); Device: Liberté (Bare metal stent)<br/><b>Sponsors</b>: University Hospital, Basel, Switzerland; University of Leipzig<br/><b>Not yet recruiting</b> - verified January 2008
Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary Intervention <b>Condition</b>: Coronary Artery Disease<br/><b>Interventions</b>: Drug: clopidogrel treatment after bare metal stent implantation; Drug: clopidogrel treatment after bare metal stent implantation; Drug: clopidogrel after zotarolimus-eluting stent implantation; Drug: clopidogrel after paclitaxel-eluting stent implantation; Drug: clopidogrel after everolimus-eluting stent implantation; Drug: clopidogrel after zotarolimus-eluting stent implantation; Drug: clopidogrel after paclitaxel-eluting stent implantation; Drug: clopidogrel after everolimus-eluting stent implantation<br/><b>Sponsor</b>: Universitaria di Ferrara<br/><b>Recruiting</b> - verified November 2007
Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS) <b>Conditions</b>: Vertebrobasilar Insufficiency; Ischemic Attack, Transient; Cerebrovascular Disorder; Brain Ischemia; Stroke<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University of Illinois<br/><b>Not yet recruiting</b> - verified December 2007
Clinical Management of Antiplatelet Drug Resistance in Patients With Drug Eluting Coronary Stents <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: Drug: Plavix (Clopidogrel)<br/><b>Sponsor</b>: Creighton University<br/><b>Recruiting</b> - verified January 2008
GeneBank at the Cleveland Clinic: Molecular Determinants of Coronary Artery Disease <b>Condition</b>: Cardiovascular Diseases<br/><b>Intervention</b>: <br/><b>Sponsors</b>: The Cleveland Clinic; National Institutes of Health (NIH); Millennium Pharmaceuticals<br/><b>Active, not recruiting</b> - verified December 2007

'); document.write('

'); document.write('

'); document.write('

ClinicalTrials.gov: Myocardial infarction AND Ischemia

'); document.write('

Trial to Assess the Ocular Safety of SCH 530348 in Patients With Atherosclerosis (Study P05183) <b>Conditions</b>: Atherosclerosis; Ischemia; Myocardial Infarction; Cerebrovascular Accident<br/><b>Interventions</b>: Drug: SCH 530348; Drug: Placebo<br/><b>Sponsors</b>: Schering-Plough; The TIMI Study Group; Duke University<br/><b>Not yet recruiting</b> - verified February 2008
Stem Cell Study for Subjects With CHF <b>Conditions</b>: Myocardial Ischemia; Congestive Heart Failure; Cardiovascular Disease<br/><b>Intervention</b>: Biological: Autologous Stem Cells<br/><b>Sponsor</b>: Losordo, Douglas, M.D.<br/><b>Not yet recruiting</b> - verified February 2008
Survival of Patients With Primary Prophylactic ICD Indication <b>Conditions</b>: Death From Any Cause; Sudden Cardiac Death; Non-Sudden Cardiac Death<br/><b>Interventions</b>: Other: Intensified diagnostic and treatment measures following 1st appropriate ICD therapy; Other: Standard follow-up<br/><b>Sponsor</b>: Biotronik GmbH & Co. KG<br/><b>Recruiting</b> - verified February 2008
The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: tirofiban<br/><b>Sponsor</b>: Samsung Medical Center<br/><b>Completed</b> - verified August 2007
Prophylactic Intra-Coronary Adenosine to Prevent Post Coronary Artery Stenting Myonecrosis <b>Conditions</b>: Coronary Artery Stenosis; Coronary Artery Disease<br/><b>Intervention</b>: Drug: Adenosine<br/><b>Sponsor</b>: University of Ottawa Heart Institute<br/><b>Recruiting</b> - verified January 2008
Italian Registry on Unprotected Left Main <b>Conditions</b>: Cardiovascular Disease; Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University of Turin, Italy<br/><b>Not yet recruiting</b> - verified January 2008
Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-Aortic Balloon Counterpulsation <b>Conditions</b>: Shock, Cardiogenic; Heart Failure; Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Pyruvate<br/><b>Sponsor</b>: Herzzentrum Goettingen<br/><b>Not yet recruiting</b> - verified January 2008
Bare Metal Bifurcation Stent Clinical Trial in Humans <b>Conditions</b>: Coronary Artery Disease; Myocardial Ischemia<br/><b>Intervention</b>: Device: Medtronic Bifurcation Stent System<br/><b>Sponsor</b>: Medtronic Vascular<br/><b>Not yet recruiting</b> - verified January 2008
Randomized Multi-Center Comparison of the Conor Sirolimus-Eluting Coronary Stent to the Taxus Liberte Paclitaxel-Eluting Coronary Stent in the Treatment of Coronary Artery Lesions <b>Condition</b>: Coronary Atherosclerosis<br/><b>Interventions</b>: Device: Drug-eluting stent (Conor Cobalt Chromium Sirolimus-eluting Coronary Stent System); Device: Drug-eluting stent (TAXUS Liberte Paclitaxel-eluting Coronary Stent System)<br/><b>Sponsor</b>: Conor Medsystems<br/><b>Not yet recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccination in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™ <b>Conditions</b>: Transient Ischemic Attack; Thromboembolic Stroke; Stroke Prevention<br/><b>Interventions</b>: Device: EndoTex™ NexStent™; Device: Filter Wire EZ™<br/><b>Sponsor</b>: Boston Scientific Corporation<br/><b>Completed</b> - verified January 2008
Examining Heart Attacks in Young Women (The Variation In Recovery: Role of Gender on Outcomes in Young AMI Patients [VIRGO] Study) <b>Condition</b>: Myocardial Infarction<br/><b>Intervention</b>: <br/><b>Sponsor</b>: National Heart, Lung, and Blood Institute (NHLBI)<br/><b>Active, not recruiting</b> - verified January 2008
A Safety/Efficacy Study of Intra-Coronary Tenecteplase During Balloon Angioplasty to Treat Heart Attacks <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Tenecteplase<br/><b>Sponsors</b>: Brigham and Women's Hospital; Genentech<br/><b>Not yet recruiting</b> - verified January 2008
Drug Eluting Stents for In-Stent Restenosis 2 <b>Condition</b>: Coronary Disease<br/><b>Interventions</b>: Device: Sirolimus eluting stent (Cypher); Device: Paclitaxel-eluting stent (Taxus)<br/><b>Sponsors</b>: Deutsches Herzzentrum Muenchen; Technische Universität München<br/><b>Recruiting</b> - verified January 2008
THE REOPEN-AMI STUDY - Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction <b>Condition</b>: Myocardial Infarction<br/><b>Interventions</b>: Drug: adenosine; Drug: nitroprusside; Drug: placebo<br/><b>Sponsor</b>: Catholic University of the Sacred Heart<br/><b>Not yet recruiting</b> - verified December 2007
Efficacy Study of Rapamycin- and Zotarolimus-Eluting Stents to Reduce Coronary Restenosis <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: rapamycin+probucol-eluting stent (ISAR stent); Device: polymer based Zotarolimus-eluting stent (Endeavor Resolute)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Not yet recruiting</b> - verified January 2008
3 Limus Agent Eluting Stents With Different Polymer Coating <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: biodegradable polymer Rapamycin-eluting stent (ISAR stent); Device: permanent polymer rapamycin-eluting stent (Cypher); Device: permanent polymer everolimus-eluting stent (Xience, Promus)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Safety and Effectiveness of Human Mesenchymal Stem Cell Injections for Repairing Heart Damage in People Who Have Had a Heart Attack and Are Undergoing Surgery for Coronary Artery Bypass Grafting <b>Conditions</b>: Stem Cell Transplantation; Ventricular Dysfunction, Left<br/><b>Interventions</b>: Genetic: Lower dose mesenchymal stem cell (MSC) injection; Genetic: Placebo; Genetic: Higher dose MSC injection<br/><b>Sponsors</b>: National Heart, Lung, and Blood Institute (NHLBI); Johns Hopkins University Specialized Center for Cell Based Therapy<br/><b>Recruiting</b> - verified February 2008
Efficacy Study of Drug-Eluting and Bare Metal Stents in Bypass Graft Lesions <b>Condition</b>: Coronary Artery Bypass<br/><b>Interventions</b>: Device: Cypher drug-eluting stent; Device: Taxus drug-eluting stent; Device: ISAR drug-eluting stent; Device: bare metal stents<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Clopidogrel Use and Long-Term Safety After Drug-Eluting Stents Implantation <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: Other: Stopping clopidogrel<br/><b>Sponsor</b>: CardioVascular Research Foundation, Korea<br/><b>Recruiting</b> - verified October 2007
T-Wave Alternans in Acute Myocardial Infarction: An Evaluation of the Time of Testing on Its Prognostic Accuracy <b>Conditions</b>: Myocardial Infarction; Arrhythmias<br/><b>Intervention</b>: Procedure: T-wave Alternans<br/><b>Sponsor</b>: Creighton University<br/><b>Recruiting</b> - verified December 2007
Molecular Determinants of Coronaruy Artery Disease <b>Conditions</b>: Coronary Artery Disease; Arteriovenous Malformations; Myocardial Infarction<br/><b>Intervention</b>: <br/><b>Sponsors</b>: The Cleveland Clinic; National Heart, Lung, and Blood Institute (NHLBI)<br/><b>Active, not recruiting</b> - verified August 2006
Study to Test the Efficacy and Safety of Drug Eluting vs. Bare-Metal Stents for Saphenous Vein Graft Interventions <b>Condition</b>: Coronary Artery Disease<br/><b>Interventions</b>: Device: TAXUS Liberté (Drug eluting stent); Device: Liberté (Bare metal stent)<br/><b>Sponsors</b>: University Hospital, Basel, Switzerland; University of Leipzig<br/><b>Not yet recruiting</b> - verified January 2008
Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary Intervention <b>Condition</b>: Coronary Artery Disease<br/><b>Interventions</b>: Drug: clopidogrel treatment after bare metal stent implantation; Drug: clopidogrel treatment after bare metal stent implantation; Drug: clopidogrel after zotarolimus-eluting stent implantation; Drug: clopidogrel after paclitaxel-eluting stent implantation; Drug: clopidogrel after everolimus-eluting stent implantation; Drug: clopidogrel after zotarolimus-eluting stent implantation; Drug: clopidogrel after paclitaxel-eluting stent implantation; Drug: clopidogrel after everolimus-eluting stent implantation<br/><b>Sponsor</b>: Universitaria di Ferrara<br/><b>Recruiting</b> - verified November 2007
Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS) <b>Conditions</b>: Vertebrobasilar Insufficiency; Ischemic Attack, Transient; Cerebrovascular Disorder; Brain Ischemia; Stroke<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University of Illinois<br/><b>Not yet recruiting</b> - verified December 2007
Clinical Management of Antiplatelet Drug Resistance in Patients With Drug Eluting Coronary Stents <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: Drug: Plavix (Clopidogrel)<br/><b>Sponsor</b>: Creighton University<br/><b>Recruiting</b> - verified January 2008
GeneBank at the Cleveland Clinic: Molecular Determinants of Coronary Artery Disease <b>Condition</b>: Cardiovascular Diseases<br/><b>Intervention</b>: <br/><b>Sponsors</b>: The Cleveland Clinic; National Institutes of Health (NIH); Millennium Pharmaceuticals<br/><b>Active, not recruiting</b> - verified December 2007

'); document.write('

'); document.write('

'); document.write('

ClinicalTrials.gov: Myocardial infarction AND Ischemia

'); document.write('

Trial to Assess the Ocular Safety of SCH 530348 in Patients With Atherosclerosis (Study P05183) <b>Conditions</b>: Atherosclerosis; Ischemia; Myocardial Infarction; Cerebrovascular Accident<br/><b>Interventions</b>: Drug: SCH 530348; Drug: Placebo<br/><b>Sponsors</b>: Schering-Plough; The TIMI Study Group; Duke University<br/><b>Not yet recruiting</b> - verified February 2008
The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: tirofiban<br/><b>Sponsor</b>: Samsung Medical Center<br/><b>Completed</b> - verified August 2007
Prophylactic Intra-Coronary Adenosine to Prevent Post Coronary Artery Stenting Myonecrosis <b>Conditions</b>: Coronary Artery Stenosis; Coronary Artery Disease<br/><b>Intervention</b>: Drug: Adenosine<br/><b>Sponsor</b>: University of Ottawa Heart Institute<br/><b>Recruiting</b> - verified January 2008
Italian Registry on Unprotected Left Main <b>Conditions</b>: Cardiovascular Disease; Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University of Turin, Italy<br/><b>Not yet recruiting</b> - verified January 2008
Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-Aortic Balloon Counterpulsation <b>Conditions</b>: Shock, Cardiogenic; Heart Failure; Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Pyruvate<br/><b>Sponsor</b>: Herzzentrum Goettingen<br/><b>Not yet recruiting</b> - verified January 2008
Bare Metal Bifurcation Stent Clinical Trial in Humans <b>Conditions</b>: Coronary Artery Disease; Myocardial Ischemia<br/><b>Intervention</b>: Device: Medtronic Bifurcation Stent System<br/><b>Sponsor</b>: Medtronic Vascular<br/><b>Not yet recruiting</b> - verified January 2008
Randomized Multi-Center Comparison of the Conor Sirolimus-Eluting Coronary Stent to the Taxus Liberte Paclitaxel-Eluting Coronary Stent in the Treatment of Coronary Artery Lesions <b>Condition</b>: Coronary Atherosclerosis<br/><b>Interventions</b>: Device: Drug-eluting stent (Conor Cobalt Chromium Sirolimus-eluting Coronary Stent System); Device: Drug-eluting stent (TAXUS Liberte Paclitaxel-eluting Coronary Stent System)<br/><b>Sponsor</b>: Conor Medsystems<br/><b>Not yet recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccination in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™ <b>Conditions</b>: Transient Ischemic Attack; Thromboembolic Stroke; Stroke Prevention<br/><b>Interventions</b>: Device: EndoTex™ NexStent™; Device: Filter Wire EZ™<br/><b>Sponsor</b>: Boston Scientific Corporation<br/><b>Completed</b> - verified January 2008
Examining Heart Attacks in Young Women (The Variation In Recovery: Role of Gender on Outcomes in Young AMI Patients [VIRGO] Study) <b>Condition</b>: Myocardial Infarction<br/><b>Intervention</b>: <br/><b>Sponsor</b>: National Heart, Lung, and Blood Institute (NHLBI)<br/><b>Active, not recruiting</b> - verified January 2008
A Safety/Efficacy Study of Intra-Coronary Tenecteplase During Balloon Angioplasty to Treat Heart Attacks <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Tenecteplase<br/><b>Sponsors</b>: Brigham and Women's Hospital; Genentech<br/><b>Not yet recruiting</b> - verified January 2008
Drug Eluting Stents for In-Stent Restenosis 2 <b>Condition</b>: Coronary Disease<br/><b>Interventions</b>: Device: Sirolimus eluting stent (Cypher); Device: Paclitaxel-eluting stent (Taxus)<br/><b>Sponsors</b>: Deutsches Herzzentrum Muenchen; Technische Universität München<br/><b>Recruiting</b> - verified January 2008
THE REOPEN-AMI STUDY - Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction <b>Condition</b>: Myocardial Infarction<br/><b>Interventions</b>: Drug: adenosine; Drug: nitroprusside; Drug: placebo<br/><b>Sponsor</b>: Catholic University of the Sacred Heart<br/><b>Not yet recruiting</b> - verified December 2007
Efficacy Study of Rapamycin- and Zotarolimus-Eluting Stents to Reduce Coronary Restenosis <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: rapamycin+probucol-eluting stent (ISAR stent); Device: polymer based Zotarolimus-eluting stent (Endeavor Resolute)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Not yet recruiting</b> - verified January 2008
3 Limus Agent Eluting Stents With Different Polymer Coating <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: biodegradable polymer Rapamycin-eluting stent (ISAR stent); Device: permanent polymer rapamycin-eluting stent (Cypher); Device: permanent polymer everolimus-eluting stent (Xience, Promus)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Safety and Effectiveness of Human Mesenchymal Stem Cell Injections for Repairing Heart Damage in People Who Have Had a Heart Attack and Are Undergoing Surgery for Coronary Artery Bypass Grafting <b>Conditions</b>: Stem Cell Transplantation; Ventricular Dysfunction, Left<br/><b>Interventions</b>: Genetic: Lower dose mesenchymal stem cell (MSC) injection; Genetic: Placebo; Genetic: Higher dose MSC injection<br/><b>Sponsors</b>: National Heart, Lung, and Blood Institute (NHLBI); Johns Hopkins University Specialized Center for Cell Based Therapy<br/><b>Recruiting</b> - verified February 2008
Efficacy Study of Drug-Eluting and Bare Metal Stents in Bypass Graft Lesions <b>Condition</b>: Coronary Artery Bypass<br/><b>Interventions</b>: Device: Cypher drug-eluting stent; Device: Taxus drug-eluting stent; Device: ISAR drug-eluting stent; Device: bare metal stents<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Clopidogrel Use and Long-Term Safety After Drug-Eluting Stents Implantation <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: Other: Stopping clopidogrel<br/><b>Sponsor</b>: CardioVascular Research Foundation, Korea<br/><b>Recruiting</b> - verified October 2007
T-Wave Alternans in Acute Myocardial Infarction: An Evaluation of the Time of Testing on Its Prognostic Accuracy <b>Conditions</b>: Myocardial Infarction; Arrhythmias<br/><b>Intervention</b>: Procedure: T-wave Alternans<br/><b>Sponsor</b>: Creighton University<br/><b>Recruiting</b> - verified December 2007
Molecular Determinants of Coronaruy Artery Disease <b>Conditions</b>: Coronary Artery Disease; Arteriovenous Malformations; Myocardial Infarction<br/><b>Intervention</b>: <br/><b>Sponsors</b>: The Cleveland Clinic; National Heart, Lung, and Blood Institute (NHLBI)<br/><b>Active, not recruiting</b> - verified August 2006
Study to Test the Efficacy and Safety of Drug Eluting vs. Bare-Metal Stents for Saphenous Vein Graft Interventions <b>Condition</b>: Coronary Artery Disease<br/><b>Interventions</b>: Device: TAXUS Liberté (Drug eluting stent); Device: Liberté (Bare metal stent)<br/><b>Sponsors</b>: University Hospital, Basel, Switzerland; University of Leipzig<br/><b>Not yet recruiting</b> - verified January 2008
Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary Intervention <b>Condition</b>: Coronary Artery Disease<br/><b>Interventions</b>: Drug: clopidogrel treatment after bare metal stent implantation; Drug: clopidogrel treatment after bare metal stent implantation; Drug: clopidogrel after zotarolimus-eluting stent implantation; Drug: clopidogrel after paclitaxel-eluting stent implantation; Drug: clopidogrel after everolimus-eluting stent implantation; Drug: clopidogrel after zotarolimus-eluting stent implantation; Drug: clopidogrel after paclitaxel-eluting stent implantation; Drug: clopidogrel after everolimus-eluting stent implantation<br/><b>Sponsor</b>: Universitaria di Ferrara<br/><b>Recruiting</b> - verified November 2007
Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS) <b>Conditions</b>: Vertebrobasilar Insufficiency; Ischemic Attack, Transient; Cerebrovascular Disorder; Brain Ischemia; Stroke<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University of Illinois<br/><b>Not yet recruiting</b> - verified December 2007
Clinical Management of Antiplatelet Drug Resistance in Patients With Drug Eluting Coronary Stents <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: Drug: Plavix (Clopidogrel)<br/><b>Sponsor</b>: Creighton University<br/><b>Recruiting</b> - verified January 2008
GeneBank at the Cleveland Clinic: Molecular Determinants of Coronary Artery Disease <b>Condition</b>: Cardiovascular Diseases<br/><b>Intervention</b>: <br/><b>Sponsors</b>: The Cleveland Clinic; National Institutes of Health (NIH); Millennium Pharmaceuticals<br/><b>Active, not recruiting</b> - verified December 2007

'); document.write('

'); document.write('

'); document.write('

ClinicalTrials.gov: Myocardial infarction AND Ischemia

'); document.write('

Trial to Assess the Ocular Safety of SCH 530348 in Patients With Atherosclerosis (Study P05183) <b>Conditions</b>: Atherosclerosis; Ischemia; Myocardial Infarction; Cerebrovascular Accident<br/><b>Interventions</b>: Drug: SCH 530348; Drug: Placebo<br/><b>Sponsors</b>: Schering-Plough; The TIMI Study Group; Duke University<br/><b>Not yet recruiting</b> - verified February 2008
The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: tirofiban<br/><b>Sponsor</b>: Samsung Medical Center<br/><b>Completed</b> - verified August 2007
Prophylactic Intra-Coronary Adenosine to Prevent Post Coronary Artery Stenting Myonecrosis <b>Conditions</b>: Coronary Artery Stenosis; Coronary Artery Disease<br/><b>Intervention</b>: Drug: Adenosine<br/><b>Sponsor</b>: University of Ottawa Heart Institute<br/><b>Recruiting</b> - verified January 2008
Italian Registry on Unprotected Left Main <b>Conditions</b>: Cardiovascular Disease; Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University of Turin, Italy<br/><b>Not yet recruiting</b> - verified January 2008
Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-Aortic Balloon Counterpulsation <b>Conditions</b>: Shock, Cardiogenic; Heart Failure; Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Pyruvate<br/><b>Sponsor</b>: Herzzentrum Goettingen<br/><b>Not yet recruiting</b> - verified January 2008
Bare Metal Bifurcation Stent Clinical Trial in Humans <b>Conditions</b>: Coronary Artery Disease; Myocardial Ischemia<br/><b>Intervention</b>: Device: Medtronic Bifurcation Stent System<br/><b>Sponsor</b>: Medtronic Vascular<br/><b>Not yet recruiting</b> - verified January 2008
Randomized Multi-Center Comparison of the Conor Sirolimus-Eluting Coronary Stent to the Taxus Liberte Paclitaxel-Eluting Coronary Stent in the Treatment of Coronary Artery Lesions <b>Condition</b>: Coronary Atherosclerosis<br/><b>Interventions</b>: Device: Drug-eluting stent (Conor Cobalt Chromium Sirolimus-eluting Coronary Stent System); Device: Drug-eluting stent (TAXUS Liberte Paclitaxel-eluting Coronary Stent System)<br/><b>Sponsor</b>: Conor Medsystems<br/><b>Not yet recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccination in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™ <b>Conditions</b>: Transient Ischemic Attack; Thromboembolic Stroke; Stroke Prevention<br/><b>Interventions</b>: Device: EndoTex™ NexStent™; Device: Filter Wire EZ™<br/><b>Sponsor</b>: Boston Scientific Corporation<br/><b>Completed</b> - verified January 2008
Examining Heart Attacks in Young Women (The Variation In Recovery: Role of Gender on Outcomes in Young AMI Patients [VIRGO] Study) <b>Condition</b>: Myocardial Infarction<br/><b>Intervention</b>: <br/><b>Sponsor</b>: National Heart, Lung, and Blood Institute (NHLBI)<br/><b>Active, not recruiting</b> - verified January 2008
A Safety/Efficacy Study of Intra-Coronary Tenecteplase During Balloon Angioplasty to Treat Heart Attacks <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Tenecteplase<br/><b>Sponsors</b>: Brigham and Women's Hospital; Genentech<br/><b>Not yet recruiting</b> - verified January 2008
Drug Eluting Stents for In-Stent Restenosis 2 <b>Condition</b>: Coronary Disease<br/><b>Interventions</b>: Device: Sirolimus eluting stent (Cypher); Device: Paclitaxel-eluting stent (Taxus)<br/><b>Sponsors</b>: Deutsches Herzzentrum Muenchen; Technische Universität München<br/><b>Recruiting</b> - verified January 2008
THE REOPEN-AMI STUDY - Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction <b>Condition</b>: Myocardial Infarction<br/><b>Interventions</b>: Drug: adenosine; Drug: nitroprusside; Drug: placebo<br/><b>Sponsor</b>: Catholic University of the Sacred Heart<br/><b>Not yet recruiting</b> - verified December 2007
Efficacy Study of Rapamycin- and Zotarolimus-Eluting Stents to Reduce Coronary Restenosis <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: rapamycin+probucol-eluting stent (ISAR stent); Device: polymer based Zotarolimus-eluting stent (Endeavor Resolute)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Not yet recruiting</b> - verified January 2008
3 Limus Agent Eluting Stents With Different Polymer Coating <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: biodegradable polymer Rapamycin-eluting stent (ISAR stent); Device: permanent polymer rapamycin-eluting stent (Cypher); Device: permanent polymer everolimus-eluting stent (Xience, Promus)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Safety and Effectiveness of Human Mesenchymal Stem Cell Injections for Repairing Heart Damage in People Who Have Had a Heart Attack and Are Undergoing Surgery for Coronary Artery Bypass Grafting <b>Conditions</b>: Stem Cell Transplantation; Ventricular Dysfunction, Left<br/><b>Interventions</b>: Genetic: Lower dose mesenchymal stem cell (MSC) injection; Genetic: Placebo; Genetic: Higher dose MSC injection<br/><b>Sponsors</b>: National Heart, Lung, and Blood Institute (NHLBI); Johns Hopkins University Specialized Center for Cell Based Therapy<br/><b>Recruiting</b> - verified February 2008
Efficacy Study of Drug-Eluting and Bare Metal Stents in Bypass Graft Lesions <b>Condition</b>: Coronary Artery Bypass<br/><b>Interventions</b>: Device: Cypher drug-eluting stent; Device: Taxus drug-eluting stent; Device: ISAR drug-eluting stent; Device: bare metal stents<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Clopidogrel Use and Long-Term Safety After Drug-Eluting Stents Implantation <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: Other: Stopping clopidogrel<br/><b>Sponsor</b>: CardioVascular Research Foundation, Korea<br/><b>Recruiting</b> - verified October 2007
T-Wave Alternans in Acute Myocardial Infarction: An Evaluation of the Time of Testing on Its Prognostic Accuracy <b>Conditions</b>: Myocardial Infarction; Arrhythmias<br/><b>Intervention</b>: Procedure: T-wave Alternans<br/><b>Sponsor</b>: Creighton University<br/><b>Recruiting</b> - verified December 2007
Molecular Determinants of Coronaruy Artery Disease <b>Conditions</b>: Coronary Artery Disease; Arteriovenous Malformations; Myocardial Infarction<br/><b>Intervention</b>: <br/><b>Sponsors</b>: The Cleveland Clinic; National Heart, Lung, and Blood Institute (NHLBI)<br/><b>Active, not recruiting</b> - verified August 2006
Study to Test the Efficacy and Safety of Drug Eluting vs. Bare-Metal Stents for Saphenous Vein Graft Interventions <b>Condition</b>: Coronary Artery Disease<br/><b>Interventions</b>: Device: TAXUS Liberté (Drug eluting stent); Device: Liberté (Bare metal stent)<br/><b>Sponsors</b>: University Hospital, Basel, Switzerland; University of Leipzig<br/><b>Not yet recruiting</b> - verified January 2008
Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary Intervention <b>Condition</b>: Coronary Artery Disease<br/><b>Interventions</b>: Drug: clopidogrel treatment after bare metal stent implantation; Drug: clopidogrel treatment after bare metal stent implantation; Drug: clopidogrel after zotarolimus-eluting stent implantation; Drug: clopidogrel after paclitaxel-eluting stent implantation; Drug: clopidogrel after everolimus-eluting stent implantation; Drug: clopidogrel after zotarolimus-eluting stent implantation; Drug: clopidogrel after paclitaxel-eluting stent implantation; Drug: clopidogrel after everolimus-eluting stent implantation<br/><b>Sponsor</b>: Universitaria di Ferrara<br/><b>Recruiting</b> - verified November 2007
Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS) <b>Conditions</b>: Vertebrobasilar Insufficiency; Ischemic Attack, Transient; Cerebrovascular Disorder; Brain Ischemia; Stroke<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University of Illinois<br/><b>Not yet recruiting</b> - verified December 2007
Differences in Epicardial Plaque and Microvascular Function in Women With an Acute Myocardial Infarction <b>Condition</b>: Myocardial Infarction<br/><b>Intervention</b>: Procedure: IVUS<br/><b>Sponsor</b>: Mayo Clinic<br/><b>Recruiting</b> - verified March 2007
Clinical Management of Antiplatelet Drug Resistance in Patients With Drug Eluting Coronary Stents <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: Drug: Plavix (Clopidogrel)<br/><b>Sponsor</b>: Creighton University<br/><b>Recruiting</b> - verified January 2008
GeneBank at the Cleveland Clinic: Molecular Determinants of Coronary Artery Disease <b>Condition</b>: Cardiovascular Diseases<br/><b>Intervention</b>: <br/><b>Sponsors</b>: The Cleveland Clinic; National Institutes of Health (NIH); Millennium Pharmaceuticals<br/><b>Active, not recruiting</b> - verified December 2007

'); document.write('

'); document.write('

'); document.write('

ClinicalTrials.gov: Myocardial infarction AND Ischemia

'); document.write('

Trial to Assess the Ocular Safety of SCH 530348 in Patients With Atherosclerosis (Study P05183) <b>Conditions</b>: Atherosclerosis; Ischemia; Myocardial Infarction; Cerebrovascular Accident<br/><b>Interventions</b>: Drug: SCH 530348; Drug: Placebo<br/><b>Sponsors</b>: Schering-Plough; The TIMI Study Group; Duke University<br/><b>Not yet recruiting</b> - verified February 2008
The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: tirofiban<br/><b>Sponsor</b>: Samsung Medical Center<br/><b>Completed</b> - verified August 2007
Prophylactic Intra-Coronary Adenosine to Prevent Post Coronary Artery Stenting Myonecrosis <b>Conditions</b>: Coronary Artery Stenosis; Coronary Artery Disease<br/><b>Intervention</b>: Drug: Adenosine<br/><b>Sponsor</b>: University of Ottawa Heart Institute<br/><b>Recruiting</b> - verified January 2008
Italian Registry on Unprotected Left Main <b>Conditions</b>: Cardiovascular Disease; Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University of Turin, Italy<br/><b>Not yet recruiting</b> - verified January 2008
Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-Aortic Balloon Counterpulsation <b>Conditions</b>: Shock, Cardiogenic; Heart Failure; Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Pyruvate<br/><b>Sponsor</b>: Herzzentrum Goettingen<br/><b>Not yet recruiting</b> - verified January 2008
Bare Metal Bifurcation Stent Clinical Trial in Humans <b>Conditions</b>: Coronary Artery Disease; Myocardial Ischemia<br/><b>Intervention</b>: Device: Medtronic Bifurcation Stent System<br/><b>Sponsor</b>: Medtronic Vascular<br/><b>Not yet recruiting</b> - verified January 2008
Randomized Multi-Center Comparison of the Conor Sirolimus-Eluting Coronary Stent to the Taxus Liberte Paclitaxel-Eluting Coronary Stent in the Treatment of Coronary Artery Lesions <b>Condition</b>: Coronary Atherosclerosis<br/><b>Interventions</b>: Device: Drug-eluting stent (Conor Cobalt Chromium Sirolimus-eluting Coronary Stent System); Device: Drug-eluting stent (TAXUS Liberte Paclitaxel-eluting Coronary Stent System)<br/><b>Sponsor</b>: Conor Medsystems<br/><b>Not yet recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccination in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™ <b>Conditions</b>: Transient Ischemic Attack; Thromboembolic Stroke; Stroke Prevention<br/><b>Interventions</b>: Device: EndoTex™ NexStent™; Device: Filter Wire EZ™<br/><b>Sponsor</b>: Boston Scientific Corporation<br/><b>Completed</b> - verified January 2008
Examining Heart Attacks in Young Women (The Variation In Recovery: Role of Gender on Outcomes in Young AMI Patients [VIRGO] Study) <b>Condition</b>: Myocardial Infarction<br/><b>Intervention</b>: <br/><b>Sponsor</b>: National Heart, Lung, and Blood Institute (NHLBI)<br/><b>Active, not recruiting</b> - verified January 2008
A Safety/Efficacy Study of Intra-Coronary Tenecteplase During Balloon Angioplasty to Treat Heart Attacks <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Tenecteplase<br/><b>Sponsors</b>: Brigham and Women's Hospital; Genentech<br/><b>Not yet recruiting</b> - verified January 2008
Drug Eluting Stents for In-Stent Restenosis 2 <b>Condition</b>: Coronary Disease<br/><b>Interventions</b>: Device: Sirolimus eluting stent (Cypher); Device: Paclitaxel-eluting stent (Taxus)<br/><b>Sponsors</b>: Deutsches Herzzentrum Muenchen; Technische Universität München<br/><b>Recruiting</b> - verified January 2008
THE REOPEN-AMI STUDY - Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction <b>Condition</b>: Myocardial Infarction<br/><b>Interventions</b>: Drug: adenosine; Drug: nitroprusside; Drug: placebo<br/><b>Sponsor</b>: Catholic University of the Sacred Heart<br/><b>Not yet recruiting</b> - verified December 2007
Efficacy Study of Rapamycin- and Zotarolimus-Eluting Stents to Reduce Coronary Restenosis <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: rapamycin+probucol-eluting stent (ISAR stent); Device: polymer based Zotarolimus-eluting stent (Endeavor Resolute)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Not yet recruiting</b> - verified January 2008
3 Limus Agent Eluting Stents With Different Polymer Coating <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: biodegradable polymer Rapamycin-eluting stent (ISAR stent); Device: permanent polymer rapamycin-eluting stent (Cypher); Device: permanent polymer everolimus-eluting stent (Xience, Promus)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Safety and Effectiveness of Human Mesenchymal Stem Cell Injections for Repairing Heart Damage in People Who Have Had a Heart Attack and Are Undergoing Surgery for Coronary Artery Bypass Grafting <b>Conditions</b>: Stem Cell Transplantation; Ventricular Dysfunction, Left<br/><b>Interventions</b>: Genetic: Lower dose mesenchymal stem cell (MSC) injection; Genetic: Placebo; Genetic: Higher dose MSC injection<br/><b>Sponsors</b>: National Heart, Lung, and Blood Institute (NHLBI); Johns Hopkins University Specialized Center for Cell Based Therapy<br/><b>Recruiting</b> - verified February 2008
Efficacy Study of Drug-Eluting and Bare Metal Stents in Bypass Graft Lesions <b>Condition</b>: Coronary Artery Bypass<br/><b>Interventions</b>: Device: Cypher drug-eluting stent; Device: Taxus drug-eluting stent; Device: ISAR drug-eluting stent; Device: bare metal stents<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Clopidogrel Use and Long-Term Safety After Drug-Eluting Stents Implantation <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: Other: Stopping clopidogrel<br/><b>Sponsor</b>: CardioVascular Research Foundation, Korea<br/><b>Recruiting</b> - verified October 2007
T-Wave Alternans in Acute Myocardial Infarction: An Evaluation of the Time of Testing on Its Prognostic Accuracy <b>Conditions</b>: Myocardial Infarction; Arrhythmias<br/><b>Intervention</b>: Procedure: T-wave Alternans<br/><b>Sponsor</b>: Creighton University<br/><b>Recruiting</b> - verified December 2007
Molecular Determinants of Coronaruy Artery Disease <b>Conditions</b>: Coronary Artery Disease; Arteriovenous Malformations; Myocardial Infarction<br/><b>Intervention</b>: <br/><b>Sponsors</b>: The Cleveland Clinic; National Heart, Lung, and Blood Institute (NHLBI)<br/><b>Active, not recruiting</b> - verified August 2006
Study to Test the Efficacy and Safety of Drug Eluting vs. Bare-Metal Stents for Saphenous Vein Graft Interventions <b>Condition</b>: Coronary Artery Disease<br/><b>Interventions</b>: Device: TAXUS Liberté (Drug eluting stent); Device: Liberté (Bare metal stent)<br/><b>Sponsors</b>: University Hospital, Basel, Switzerland; University of Leipzig<br/><b>Not yet recruiting</b> - verified January 2008
Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary Intervention <b>Condition</b>: Coronary Artery Disease<br/><b>Interventions</b>: Drug: clopidogrel treatment after bare metal stent implantation; Drug: clopidogrel treatment after bare metal stent implantation; Drug: clopidogrel after zotarolimus-eluting stent implantation; Drug: clopidogrel after paclitaxel-eluting stent implantation; Drug: clopidogrel after everolimus-eluting stent implantation; Drug: clopidogrel after zotarolimus-eluting stent implantation; Drug: clopidogrel after paclitaxel-eluting stent implantation; Drug: clopidogrel after everolimus-eluting stent implantation<br/><b>Sponsor</b>: Universitaria di Ferrara<br/><b>Recruiting</b> - verified November 2007
Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS) <b>Conditions</b>: Vertebrobasilar Insufficiency; Ischemic Attack, Transient; Cerebrovascular Disorder; Brain Ischemia; Stroke<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University of Illinois<br/><b>Not yet recruiting</b> - verified December 2007
Differences in Epicardial Plaque and Microvascular Function in Women With an Acute Myocardial Infarction <b>Condition</b>: Myocardial Infarction<br/><b>Intervention</b>: Procedure: IVUS<br/><b>Sponsor</b>: Mayo Clinic<br/><b>Recruiting</b> - verified March 2007
Clinical Management of Antiplatelet Drug Resistance in Patients With Drug Eluting Coronary Stents <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: Drug: Plavix (Clopidogrel)<br/><b>Sponsor</b>: Creighton University<br/><b>Recruiting</b> - verified January 2008
GeneBank at the Cleveland Clinic: Molecular Determinants of Coronary Artery Disease <b>Condition</b>: Cardiovascular Diseases<br/><b>Intervention</b>: <br/><b>Sponsors</b>: The Cleveland Clinic; National Institutes of Health (NIH); Millennium Pharmaceuticals<br/><b>Active, not recruiting</b> - verified December 2007
The Prevention of Myocardial Enlargement and Dilatation Post Myocardial Infarction Study <b>Condition</b>: Post Myocardial Infarction<br/><b>Intervention</b>: Device: Cardiac pacing using any Guidant/Boston Scientific Implantable ICD or CRT-D System and any Guidant/Boston Scientific Intracardiac Lead System<br/><b>Sponsor</b>: Boston Scientific Corporation<br/><b>Recruiting</b> - verified January 2008
Coronary CT Angiography as the Primary Initial Method of Evaluating Patients With Subacute Chest Pain (CT PRIME) <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: William Beaumont Hospitals<br/><b>Not yet recruiting</b> - verified December 2007
Levels of Inflammatory Markers in the Treatment of Stroke—An SPS3 Ancillary Study <b>Conditions</b>: Hypertension; Stroke<br/><b>Intervention</b>: <br/><b>Sponsors</b>: Columbia University; National Institute of Neurological Disorders and Stroke (NINDS)<br/><b>Recruiting</b> - verified December 2007

'); document.write('

'); document.write('

'); document.write('

ClinicalTrials.gov: Myocardial infarction AND Ischemia

'); document.write('

Trial to Assess the Ocular Safety of SCH 530348 in Patients With Atherosclerosis (Study P05183) <b>Conditions</b>: Atherosclerosis; Ischemia; Myocardial Infarction; Cerebrovascular Accident<br/><b>Interventions</b>: Drug: SCH 530348; Drug: Placebo<br/><b>Sponsors</b>: Schering-Plough; The TIMI Study Group; Duke University<br/><b>Not yet recruiting</b> - verified February 2008
The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: tirofiban<br/><b>Sponsor</b>: Samsung Medical Center<br/><b>Completed</b> - verified August 2007
Prophylactic Intra-Coronary Adenosine to Prevent Post Coronary Artery Stenting Myonecrosis <b>Conditions</b>: Coronary Artery Stenosis; Coronary Artery Disease<br/><b>Intervention</b>: Drug: Adenosine<br/><b>Sponsor</b>: University of Ottawa Heart Institute<br/><b>Recruiting</b> - verified January 2008
Italian Registry on Unprotected Left Main <b>Conditions</b>: Cardiovascular Disease; Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University of Turin, Italy<br/><b>Not yet recruiting</b> - verified January 2008
Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-Aortic Balloon Counterpulsation <b>Conditions</b>: Shock, Cardiogenic; Heart Failure; Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Pyruvate<br/><b>Sponsor</b>: Herzzentrum Goettingen<br/><b>Not yet recruiting</b> - verified January 2008
Bare Metal Bifurcation Stent Clinical Trial in Humans <b>Conditions</b>: Coronary Artery Disease; Myocardial Ischemia<br/><b>Intervention</b>: Device: Medtronic Bifurcation Stent System<br/><b>Sponsor</b>: Medtronic Vascular<br/><b>Not yet recruiting</b> - verified January 2008
Randomized Multi-Center Comparison of the Conor Sirolimus-Eluting Coronary Stent to the Taxus Liberte Paclitaxel-Eluting Coronary Stent in the Treatment of Coronary Artery Lesions <b>Condition</b>: Coronary Atherosclerosis<br/><b>Interventions</b>: Device: Drug-eluting stent (Conor Cobalt Chromium Sirolimus-eluting Coronary Stent System); Device: Drug-eluting stent (TAXUS Liberte Paclitaxel-eluting Coronary Stent System)<br/><b>Sponsor</b>: Conor Medsystems<br/><b>Not yet recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccination in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™ <b>Conditions</b>: Transient Ischemic Attack; Thromboembolic Stroke; Stroke Prevention<br/><b>Interventions</b>: Device: EndoTex™ NexStent™; Device: Filter Wire EZ™<br/><b>Sponsor</b>: Boston Scientific Corporation<br/><b>Completed</b> - verified January 2008
Examining Heart Attacks in Young Women (The Variation In Recovery: Role of Gender on Outcomes in Young AMI Patients [VIRGO] Study) <b>Condition</b>: Myocardial Infarction<br/><b>Intervention</b>: <br/><b>Sponsor</b>: National Heart, Lung, and Blood Institute (NHLBI)<br/><b>Active, not recruiting</b> - verified January 2008
A Safety/Efficacy Study of Intra-Coronary Tenecteplase During Balloon Angioplasty to Treat Heart Attacks <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Tenecteplase<br/><b>Sponsors</b>: Brigham and Women's Hospital; Genentech<br/><b>Not yet recruiting</b> - verified January 2008
Drug Eluting Stents for In-Stent Restenosis 2 <b>Condition</b>: Coronary Disease<br/><b>Interventions</b>: Device: Sirolimus eluting stent (Cypher); Device: Paclitaxel-eluting stent (Taxus)<br/><b>Sponsors</b>: Deutsches Herzzentrum Muenchen; Technische Universität München<br/><b>Recruiting</b> - verified January 2008
THE REOPEN-AMI STUDY - Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction <b>Condition</b>: Myocardial Infarction<br/><b>Interventions</b>: Drug: adenosine; Drug: nitroprusside; Drug: placebo<br/><b>Sponsor</b>: Catholic University of the Sacred Heart<br/><b>Not yet recruiting</b> - verified December 2007
Efficacy Study of Rapamycin- and Zotarolimus-Eluting Stents to Reduce Coronary Restenosis <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: rapamycin+probucol-eluting stent (ISAR stent); Device: polymer based Zotarolimus-eluting stent (Endeavor Resolute)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Not yet recruiting</b> - verified January 2008
3 Limus Agent Eluting Stents With Different Polymer Coating <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: biodegradable polymer Rapamycin-eluting stent (ISAR stent); Device: permanent polymer rapamycin-eluting stent (Cypher); Device: permanent polymer everolimus-eluting stent (Xience, Promus)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Safety and Effectiveness of Human Mesenchymal Stem Cell Injections for Repairing Heart Damage in People Who Have Had a Heart Attack and Are Undergoing Surgery for Coronary Artery Bypass Grafting <b>Conditions</b>: Stem Cell Transplantation; Ventricular Dysfunction, Left<br/><b>Interventions</b>: Genetic: Lower dose mesenchymal stem cell (MSC) injection; Genetic: Placebo; Genetic: Higher dose MSC injection<br/><b>Sponsors</b>: National Heart, Lung, and Blood Institute (NHLBI); Johns Hopkins University Specialized Center for Cell Based Therapy<br/><b>Recruiting</b> - verified February 2008
Efficacy Study of Drug-Eluting and Bare Metal Stents in Bypass Graft Lesions <b>Condition</b>: Coronary Artery Bypass<br/><b>Interventions</b>: Device: Cypher drug-eluting stent; Device: Taxus drug-eluting stent; Device: ISAR drug-eluting stent; Device: bare metal stents<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Clopidogrel Use and Long-Term Safety After Drug-Eluting Stents Implantation <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: Other: Stopping clopidogrel<br/><b>Sponsor</b>: CardioVascular Research Foundation, Korea<br/><b>Recruiting</b> - verified October 2007
T-Wave Alternans in Acute Myocardial Infarction: An Evaluation of the Time of Testing on Its Prognostic Accuracy <b>Conditions</b>: Myocardial Infarction; Arrhythmias<br/><b>Intervention</b>: Procedure: T-wave Alternans<br/><b>Sponsor</b>: Creighton University<br/><b>Recruiting</b> - verified December 2007
Molecular Determinants of Coronaruy Artery Disease <b>Conditions</b>: Coronary Artery Disease; Arteriovenous Malformations; Myocardial Infarction<br/><b>Intervention</b>: <br/><b>Sponsors</b>: The Cleveland Clinic; National Heart, Lung, and Blood Institute (NHLBI)<br/><b>Active, not recruiting</b> - verified August 2006
Study to Test the Efficacy and Safety of Drug Eluting vs. Bare-Metal Stents for Saphenous Vein Graft Interventions <b>Condition</b>: Coronary Artery Disease<br/><b>Interventions</b>: Device: TAXUS Liberté (Drug eluting stent); Device: Liberté (Bare metal stent)<br/><b>Sponsors</b>: University Hospital, Basel, Switzerland; University of Leipzig<br/><b>Not yet recruiting</b> - verified January 2008
Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary Intervention <b>Condition</b>: Coronary Artery Disease<br/><b>Interventions</b>: Drug: clopidogrel treatment after bare metal stent implantation; Drug: clopidogrel treatment after bare metal stent implantation; Drug: clopidogrel after zotarolimus-eluting stent implantation; Drug: clopidogrel after paclitaxel-eluting stent implantation; Drug: clopidogrel after everolimus-eluting stent implantation; Drug: clopidogrel after zotarolimus-eluting stent implantation; Drug: clopidogrel after paclitaxel-eluting stent implantation; Drug: clopidogrel after everolimus-eluting stent implantation<br/><b>Sponsor</b>: Universitaria di Ferrara<br/><b>Recruiting</b> - verified November 2007
Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS) <b>Conditions</b>: Vertebrobasilar Insufficiency; Ischemic Attack, Transient; Cerebrovascular Disorder; Brain Ischemia; Stroke<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University of Illinois<br/><b>Not yet recruiting</b> - verified December 2007
Differences in Epicardial Plaque and Microvascular Function in Women With an Acute Myocardial Infarction <b>Condition</b>: Myocardial Infarction<br/><b>Intervention</b>: Procedure: IVUS<br/><b>Sponsor</b>: Mayo Clinic<br/><b>Recruiting</b> - verified March 2007
Clinical Management of Antiplatelet Drug Resistance in Patients With Drug Eluting Coronary Stents <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: Drug: Plavix (Clopidogrel)<br/><b>Sponsor</b>: Creighton University<br/><b>Recruiting</b> - verified January 2008
GeneBank at the Cleveland Clinic: Molecular Determinants of Coronary Artery Disease <b>Condition</b>: Cardiovascular Diseases<br/><b>Intervention</b>: <br/><b>Sponsors</b>: The Cleveland Clinic; National Institutes of Health (NIH); Millennium Pharmaceuticals<br/><b>Active, not recruiting</b> - verified December 2007
The Prevention of Myocardial Enlargement and Dilatation Post Myocardial Infarction Study <b>Condition</b>: Post Myocardial Infarction<br/><b>Intervention</b>: Device: Cardiac pacing using any Guidant/Boston Scientific Implantable ICD or CRT-D System and any Guidant/Boston Scientific Intracardiac Lead System<br/><b>Sponsor</b>: Boston Scientific Corporation<br/><b>Recruiting</b> - verified January 2008
Coronary CT Angiography as the Primary Initial Method of Evaluating Patients With Subacute Chest Pain (CT PRIME) <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: William Beaumont Hospitals<br/><b>Not yet recruiting</b> - verified December 2007
Levels of Inflammatory Markers in the Treatment of Stroke—An SPS3 Ancillary Study <b>Conditions</b>: Hypertension; Stroke<br/><b>Intervention</b>: <br/><b>Sponsors</b>: Columbia University; National Institute of Neurological Disorders and Stroke (NINDS)<br/><b>Recruiting</b> - verified December 2007

'); document.write('

'); document.write('

'); document.write('

ClinicalTrials.gov: Myocardial infarction AND Ischemia

'); document.write('

Trial to Assess the Ocular Safety of SCH 530348 in Patients With Atherosclerosis (Study P05183) <b>Conditions</b>: Atherosclerosis; Ischemia; Myocardial Infarction; Cerebrovascular Accident<br/><b>Interventions</b>: Drug: SCH 530348; Drug: Placebo<br/><b>Sponsors</b>: Schering-Plough; The TIMI Study Group; Duke University<br/><b>Not yet recruiting</b> - verified February 2008
The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: tirofiban<br/><b>Sponsor</b>: Samsung Medical Center<br/><b>Completed</b> - verified August 2007
Prophylactic Intra-Coronary Adenosine to Prevent Post Coronary Artery Stenting Myonecrosis <b>Conditions</b>: Coronary Artery Stenosis; Coronary Artery Disease<br/><b>Intervention</b>: Drug: Adenosine<br/><b>Sponsor</b>: University of Ottawa Heart Institute<br/><b>Recruiting</b> - verified January 2008
Italian Registry on Unprotected Left Main <b>Conditions</b>: Cardiovascular Disease; Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University of Turin, Italy<br/><b>Not yet recruiting</b> - verified January 2008
Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-Aortic Balloon Counterpulsation <b>Conditions</b>: Shock, Cardiogenic; Heart Failure; Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Pyruvate<br/><b>Sponsor</b>: Herzzentrum Goettingen<br/><b>Not yet recruiting</b> - verified January 2008
Bare Metal Bifurcation Stent Clinical Trial in Humans <b>Conditions</b>: Coronary Artery Disease; Myocardial Ischemia<br/><b>Intervention</b>: Device: Medtronic Bifurcation Stent System<br/><b>Sponsor</b>: Medtronic Vascular<br/><b>Not yet recruiting</b> - verified January 2008
Randomized Multi-Center Comparison of the Conor Sirolimus-Eluting Coronary Stent to the Taxus Liberte Paclitaxel-Eluting Coronary Stent in the Treatment of Coronary Artery Lesions <b>Condition</b>: Coronary Atherosclerosis<br/><b>Interventions</b>: Device: Drug-eluting stent (Conor Cobalt Chromium Sirolimus-eluting Coronary Stent System); Device: Drug-eluting stent (TAXUS Liberte Paclitaxel-eluting Coronary Stent System)<br/><b>Sponsor</b>: Conor Medsystems<br/><b>Not yet recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccination in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™ <b>Conditions</b>: Transient Ischemic Attack; Thromboembolic Stroke; Stroke Prevention<br/><b>Interventions</b>: Device: EndoTex™ NexStent™; Device: Filter Wire EZ™<br/><b>Sponsor</b>: Boston Scientific Corporation<br/><b>Completed</b> - verified January 2008
Examining Heart Attacks in Young Women (The Variation In Recovery: Role of Gender on Outcomes in Young AMI Patients [VIRGO] Study) <b>Condition</b>: Myocardial Infarction<br/><b>Intervention</b>: <br/><b>Sponsor</b>: National Heart, Lung, and Blood Institute (NHLBI)<br/><b>Active, not recruiting</b> - verified January 2008
A Safety/Efficacy Study of Intra-Coronary Tenecteplase During Balloon Angioplasty to Treat Heart Attacks <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Tenecteplase<br/><b>Sponsors</b>: Brigham and Women's Hospital; Genentech<br/><b>Not yet recruiting</b> - verified January 2008
Drug Eluting Stents for In-Stent Restenosis 2 <b>Condition</b>: Coronary Disease<br/><b>Interventions</b>: Device: Sirolimus eluting stent (Cypher); Device: Paclitaxel-eluting stent (Taxus)<br/><b>Sponsors</b>: Deutsches Herzzentrum Muenchen; Technische Universität München<br/><b>Recruiting</b> - verified January 2008
THE REOPEN-AMI STUDY - Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction <b>Condition</b>: Myocardial Infarction<br/><b>Interventions</b>: Drug: adenosine; Drug: nitroprusside; Drug: placebo<br/><b>Sponsor</b>: Catholic University of the Sacred Heart<br/><b>Not yet recruiting</b> - verified December 2007
Efficacy Study of Rapamycin- and Zotarolimus-Eluting Stents to Reduce Coronary Restenosis <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: rapamycin+probucol-eluting stent (ISAR stent); Device: polymer based Zotarolimus-eluting stent (Endeavor Resolute)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Not yet recruiting</b> - verified January 2008
3 Limus Agent Eluting Stents With Different Polymer Coating <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: biodegradable polymer Rapamycin-eluting stent (ISAR stent); Device: permanent polymer rapamycin-eluting stent (Cypher); Device: permanent polymer everolimus-eluting stent (Xience, Promus)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Safety and Effectiveness of Human Mesenchymal Stem Cell Injections for Repairing Heart Damage in People Who Have Had a Heart Attack and Are Undergoing Surgery for Coronary Artery Bypass Grafting <b>Conditions</b>: Stem Cell Transplantation; Ventricular Dysfunction, Left<br/><b>Interventions</b>: Genetic: Lower dose mesenchymal stem cell (MSC) injection; Genetic: Placebo; Genetic: Higher dose MSC injection<br/><b>Sponsors</b>: National Heart, Lung, and Blood Institute (NHLBI); Johns Hopkins University Specialized Center for Cell Based Therapy<br/><b>Recruiting</b> - verified February 2008
Efficacy Study of Drug-Eluting and Bare Metal Stents in Bypass Graft Lesions <b>Condition</b>: Coronary Artery Bypass<br/><b>Interventions</b>: Device: Cypher drug-eluting stent; Device: Taxus drug-eluting stent; Device: ISAR drug-eluting stent; Device: bare metal stents<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Clopidogrel Use and Long-Term Safety After Drug-Eluting Stents Implantation <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: Other: Stopping clopidogrel<br/><b>Sponsor</b>: CardioVascular Research Foundation, Korea<br/><b>Recruiting</b> - verified October 2007
T-Wave Alternans in Acute Myocardial Infarction: An Evaluation of the Time of Testing on Its Prognostic Accuracy <b>Conditions</b>: Myocardial Infarction; Arrhythmias<br/><b>Intervention</b>: Procedure: T-wave Alternans<br/><b>Sponsor</b>: Creighton University<br/><b>Recruiting</b> - verified December 2007
Molecular Determinants of Coronaruy Artery Disease <b>Conditions</b>: Coronary Artery Disease; Arteriovenous Malformations; Myocardial Infarction<br/><b>Intervention</b>: <br/><b>Sponsors</b>: The Cleveland Clinic; National Heart, Lung, and Blood Institute (NHLBI)<br/><b>Active, not recruiting</b> - verified August 2006
Study to Test the Efficacy and Safety of Drug Eluting vs. Bare-Metal Stents for Saphenous Vein Graft Interventions <b>Condition</b>: Coronary Artery Disease<br/><b>Interventions</b>: Device: TAXUS Liberté (Drug eluting stent); Device: Liberté (Bare metal stent)<br/><b>Sponsors</b>: University Hospital, Basel, Switzerland; University of Leipzig<br/><b>Not yet recruiting</b> - verified January 2008
Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary Intervention <b>Condition</b>: Coronary Artery Disease<br/><b>Interventions</b>: Drug: clopidogrel treatment after bare metal stent implantation; Drug: clopidogrel treatment after bare metal stent implantation; Drug: clopidogrel after zotarolimus-eluting stent implantation; Drug: clopidogrel after paclitaxel-eluting stent implantation; Drug: clopidogrel after everolimus-eluting stent implantation; Drug: clopidogrel after zotarolimus-eluting stent implantation; Drug: clopidogrel after paclitaxel-eluting stent implantation; Drug: clopidogrel after everolimus-eluting stent implantation<br/><b>Sponsor</b>: Universitaria di Ferrara<br/><b>Recruiting</b> - verified November 2007
Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS) <b>Conditions</b>: Vertebrobasilar Insufficiency; Ischemic Attack, Transient; Cerebrovascular Disorder; Brain Ischemia; Stroke<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University of Illinois<br/><b>Not yet recruiting</b> - verified December 2007
Differences in Epicardial Plaque and Microvascular Function in Women With an Acute Myocardial Infarction <b>Condition</b>: Myocardial Infarction<br/><b>Intervention</b>: Procedure: IVUS<br/><b>Sponsor</b>: Mayo Clinic<br/><b>Recruiting</b> - verified March 2007
Clinical Management of Antiplatelet Drug Resistance in Patients With Drug Eluting Coronary Stents <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: Drug: Plavix (Clopidogrel)<br/><b>Sponsor</b>: Creighton University<br/><b>Recruiting</b> - verified January 2008
GeneBank at the Cleveland Clinic: Molecular Determinants of Coronary Artery Disease <b>Condition</b>: Cardiovascular Diseases<br/><b>Intervention</b>: <br/><b>Sponsors</b>: The Cleveland Clinic; National Institutes of Health (NIH); Millennium Pharmaceuticals<br/><b>Active, not recruiting</b> - verified December 2007
The Prevention of Myocardial Enlargement and Dilatation Post Myocardial Infarction Study <b>Condition</b>: Post Myocardial Infarction<br/><b>Intervention</b>: Device: Cardiac pacing using any Guidant/Boston Scientific Implantable ICD or CRT-D System and any Guidant/Boston Scientific Intracardiac Lead System<br/><b>Sponsor</b>: Boston Scientific Corporation<br/><b>Recruiting</b> - verified January 2008
Coronary CT Angiography as the Primary Initial Method of Evaluating Patients With Subacute Chest Pain (CT PRIME) <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: William Beaumont Hospitals<br/><b>Not yet recruiting</b> - verified December 2007
Levels of Inflammatory Markers in the Treatment of Stroke—An SPS3 Ancillary Study <b>Conditions</b>: Hypertension; Stroke<br/><b>Intervention</b>: <br/><b>Sponsors</b>: Columbia University; National Institute of Neurological Disorders and Stroke (NINDS)<br/><b>Recruiting</b> - verified December 2007

'); document.write('

'); document.write('

'); document.write('

ClinicalTrials.gov: Myocardial infarction AND Ischemia

'); document.write('

Trial to Assess the Ocular Safety of SCH 530348 in Patients With Atherosclerosis (Study P05183) <b>Conditions</b>: Atherosclerosis; Ischemia; Myocardial Infarction; Cerebrovascular Accident<br/><b>Interventions</b>: Drug: SCH 530348; Drug: Placebo<br/><b>Sponsors</b>: Schering-Plough; The TIMI Study Group; Duke University<br/><b>Not yet recruiting</b> - verified February 2008
The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: tirofiban<br/><b>Sponsor</b>: Samsung Medical Center<br/><b>Completed</b> - verified August 2007
Prophylactic Intra-Coronary Adenosine to Prevent Post Coronary Artery Stenting Myonecrosis <b>Conditions</b>: Coronary Artery Stenosis; Coronary Artery Disease<br/><b>Intervention</b>: Drug: Adenosine<br/><b>Sponsor</b>: University of Ottawa Heart Institute<br/><b>Recruiting</b> - verified January 2008
Italian Registry on Unprotected Left Main <b>Conditions</b>: Cardiovascular Disease; Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University of Turin, Italy<br/><b>Not yet recruiting</b> - verified January 2008
Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-Aortic Balloon Counterpulsation <b>Conditions</b>: Shock, Cardiogenic; Heart Failure; Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Pyruvate<br/><b>Sponsor</b>: Herzzentrum Goettingen<br/><b>Not yet recruiting</b> - verified January 2008
Bare Metal Bifurcation Stent Clinical Trial in Humans <b>Conditions</b>: Coronary Artery Disease; Myocardial Ischemia<br/><b>Intervention</b>: Device: Medtronic Bifurcation Stent System<br/><b>Sponsor</b>: Medtronic Vascular<br/><b>Not yet recruiting</b> - verified January 2008
Randomized Multi-Center Comparison of the Conor Sirolimus-Eluting Coronary Stent to the Taxus Liberte Paclitaxel-Eluting Coronary Stent in the Treatment of Coronary Artery Lesions <b>Condition</b>: Coronary Atherosclerosis<br/><b>Interventions</b>: Device: Drug-eluting stent (Conor Cobalt Chromium Sirolimus-eluting Coronary Stent System); Device: Drug-eluting stent (TAXUS Liberte Paclitaxel-eluting Coronary Stent System)<br/><b>Sponsor</b>: Conor Medsystems<br/><b>Not yet recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccination in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008
Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™ <b>Conditions</b>: Transient Ischemic Attack; Thromboembolic Stroke; Stroke Prevention<br/><b>Interventions</b>: Device: EndoTex™ NexStent™; Device: Filter Wire EZ™<br/><b>Sponsor</b>: Boston Scientific Corporation<br/><b>Completed</b> - verified January 2008
Examining Heart Attacks in Young Women (The Variation In Recovery: Role of Gender on Outcomes in Young AMI Patients [VIRGO] Study) <b>Condition</b>: Myocardial Infarction<br/><b>Intervention</b>: <br/><b>Sponsor</b>: National Heart, Lung, and Blood Institute (NHLBI)<br/><b>Active, not recruiting</b> - verified January 2008
A Safety/Efficacy Study of Intra-Coronary Tenecteplase During Balloon Angioplasty to Treat Heart Attacks <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Tenecteplase<br/><b>Sponsors</b>: Brigham and Women's Hospital; Genentech<br/><b>Not yet recruiting</b> - verified January 2008
Drug Eluting Stents for In-Stent Restenosis 2 <b>Condition</b>: Coronary Disease<br/><b>Interventions</b>: Device: Sirolimus eluting stent (Cypher); Device: Paclitaxel-eluting stent (Taxus)<br/><b>Sponsors</b>: Deutsches Herzzentrum Muenchen; Technische Universität München<br/><b>Recruiting</b> - verified January 2008
THE REOPEN-AMI STUDY - Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction <b>Condition</b>: Myocardial Infarction<br/><b>Interventions</b>: Drug: adenosine; Drug: nitroprusside; Drug: placebo<br/><b>Sponsor</b>: Catholic University of the Sacred Heart<br/><b>Not yet recruiting</b> - verified December 2007
Efficacy Study of Rapamycin- and Zotarolimus-Eluting Stents to Reduce Coronary Restenosis <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: rapamycin+probucol-eluting stent (ISAR stent); Device: polymer based Zotarolimus-eluting stent (Endeavor Resolute)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Not yet recruiting</b> - verified January 2008
3 Limus Agent Eluting Stents With Different Polymer Coating <b>Condition</b>: Coronary Heart Disease<br/><b>Interventions</b>: Device: biodegradable polymer Rapamycin-eluting stent (ISAR stent); Device: permanent polymer rapamycin-eluting stent (Cypher); Device: permanent polymer everolimus-eluting stent (Xience, Promus)<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Safety and Effectiveness of Human Mesenchymal Stem Cell Injections for Repairing Heart Damage in People Who Have Had a Heart Attack and Are Undergoing Surgery for Coronary Artery Bypass Grafting <b>Conditions</b>: Stem Cell Transplantation; Ventricular Dysfunction, Left<br/><b>Interventions</b>: Genetic: Lower dose mesenchymal stem cell (MSC) injection; Genetic: Placebo; Genetic: Higher dose MSC injection<br/><b>Sponsors</b>: National Heart, Lung, and Blood Institute (NHLBI); Johns Hopkins University Specialized Center for Cell Based Therapy<br/><b>Recruiting</b> - verified February 2008
Efficacy Study of Drug-Eluting and Bare Metal Stents in Bypass Graft Lesions <b>Condition</b>: Coronary Artery Bypass<br/><b>Interventions</b>: Device: Cypher drug-eluting stent; Device: Taxus drug-eluting stent; Device: ISAR drug-eluting stent; Device: bare metal stents<br/><b>Sponsor</b>: Deutsches Herzzentrum Muenchen<br/><b>Recruiting</b> - verified January 2008
Clopidogrel Use and Long-Term Safety After Drug-Eluting Stents Implantation <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: Other: Stopping clopidogrel<br/><b>Sponsor</b>: CardioVascular Research Foundation, Korea<br/><b>Recruiting</b> - verified October 2007
T-Wave Alternans in Acute Myocardial Infarction: An Evaluation of the Time of Testing on Its Prognostic Accuracy <b>Conditions</b>: Myocardial Infarction; Arrhythmias<br/><b>Intervention</b>: Procedure: T-wave Alternans<br/><b>Sponsor</b>: Creighton University<br/><b>Recruiting</b> - verified December 2007
Molecular Determinants of Coronaruy Artery Disease <b>Conditions</b>: Coronary Artery Disease; Arteriovenous Malformations; Myocardial Infarction<br/><b>Intervention</b>: <br/><b>Sponsors</b>: The Cleveland Clinic; National Heart, Lung, and Blood Institute (NHLBI)<br/><b>Active, not recruiting</b> - verified August 2006
Study to Test the Efficacy and Safety of Drug Eluting vs. Bare-Metal Stents for Saphenous Vein Graft Interventions <b>Condition</b>: Coronary Artery Disease<br/><b>Interventions</b>: Device: TAXUS Liberté (Drug eluting stent); Device: Liberté (Bare metal stent)<br/><b>Sponsors</b>: University Hospital, Basel, Switzerland; University of Leipzig<br/><b>Not yet recruiting</b> - verified January 2008
Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary Intervention <b>Condition</b>: Coronary Artery Disease<br/><b>Interventions</b>: Drug: clopidogrel treatment after bare metal stent implantation; Drug: clopidogrel treatment after bare metal stent implantation; Drug: clopidogrel after zotarolimus-eluting stent implantation; Drug: clopidogrel after paclitaxel-eluting stent implantation; Drug: clopidogrel after everolimus-eluting stent implantation; Drug: clopidogrel after zotarolimus-eluting stent implantation; Drug: clopidogrel after paclitaxel-eluting stent implantation; Drug: clopidogrel after everolimus-eluting stent implantation<br/><b>Sponsor</b>: Universitaria di Ferrara<br/><b>Recruiting</b> - verified November 2007
Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS) <b>Conditions</b>: Vertebrobasilar Insufficiency; Ischemic Attack, Transient; Cerebrovascular Disorder; Brain Ischemia; Stroke<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University of Illinois<br/><b>Not yet recruiting</b> - verified December 2007
Differences in Epicardial Plaque and Microvascular Function in Women With an Acute Myocardial Infarction <b>Condition</b>: Myocardial Infarction<br/><b>Intervention</b>: Procedure: IVUS<br/><b>Sponsor</b>: Mayo Clinic<br/><b>Recruiting</b> - verified March 2007
Clinical Management of Antiplatelet Drug Resistance in Patients With Drug Eluting Coronary Stents <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: Drug: Plavix (Clopidogrel)<br/><b>Sponsor</b>: Creighton University<br/><b>Recruiting</b> - verified January 2008
GeneBank at the Cleveland Clinic: Molecular Determinants of Coronary Artery Disease <b>Condition</b>: Cardiovascular Diseases<br/><b>Intervention</b>: <br/><b>Sponsors</b>: The Cleveland Clinic; National Institutes of Health (NIH); Millennium Pharmaceuticals<br/><b>Active, not recruiting</b> - verified December 2007
The Prevention of Myocardial Enlargement and Dilatation Post Myocardial Infarction Study <b>Condition</b>: Post Myocardial Infarction<br/><b>Intervention</b>: Device: Cardiac pacing using any Guidant/Boston Scientific Implantable ICD or CRT-D System and any Guidant/Boston Scientific Intracardiac Lead System<br/><b>Sponsor</b>: Boston Scientific Corporation<br/><b>Recruiting</b> - verified January 2008
Coronary CT Angiography as the Primary Initial Method of Evaluating Patients With Subacute Chest Pain (CT PRIME) <b>Condition</b>: Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: William Beaumont Hospitals<br/><b>Not yet recruiting</b> - verified December 2007
Levels of Inflammatory Markers in the Treatment of Stroke—An SPS3 Ancillary Study <b>Conditions</b>: Hypertension; Stroke<br/><b>Intervention</b>: <br/><b>Sponsors</b>: Columbia University; National Institute of Neurological Disorders and Stroke (NINDS)<br/><b>Recruiting</b> - verified December 2007

'); document.write('

'); document.write('

'); document.write('

ClinicalTrials.gov: Myocardial infarction AND Ischemia

'); document.write('

The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction <b>Condition</b>: Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: tirofiban<br/><b>Sponsor</b>: Samsung Medical Center<br/><b>Completed</b> - verified August 2007
Prophylactic Intra-Coronary Adenosine to Prevent Post Coronary Artery Stenting Myonecrosis <b>Conditions</b>: Coronary Artery Stenosis; Coronary Artery Disease<br/><b>Intervention</b>: Drug: Adenosine<br/><b>Sponsor</b>: University of Ottawa Heart Institute<br/><b>Recruiting</b> - verified January 2008
Italian Registry on Unprotected Left Main <b>Conditions</b>: Cardiovascular Disease; Coronary Artery Disease<br/><b>Intervention</b>: <br/><b>Sponsor</b>: University of Turin, Italy<br/><b>Not yet recruiting</b> - verified January 2008
Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-Aortic Balloon Counterpulsation <b>Conditions</b>: Shock, Cardiogenic; Heart Failure; Acute Myocardial Infarction<br/><b>Intervention</b>: Drug: Pyruvate<br/><b>Sponsor</b>: Herzzentrum Goettingen<br/><b>Not yet recruiting</b> - verified January 2008
Bare Metal Bifurcation Stent Clinical Trial in Humans <b>Conditions</b>: Coronary Artery Disease; Myocardial Ischemia<br/><b>Intervention</b>: Device: Medtronic Bifurcation Stent System<br/><b>Sponsor</b>: Medtronic Vascular<br/><b>Not yet recruiting</b> - verified January 2008
Randomized Multi-Center Comparison of the Conor Sirolimus-Eluting Coronary Stent to the Taxus Liberte Paclitaxel-Eluting Coronary Stent in the Treatment of Coronary Artery Lesions <b>Condition</b>: Coronary Atherosclerosis<br/><b>Interventions</b>: Device: Drug-eluting stent (Conor Cobalt Chromium Sirolimus-eluting Coronary Stent System); Device: Drug-eluting stent (TAXUS Liberte Paclitaxel-eluting Coronary Stent System)<br/><b>Sponsor</b>: Conor Medsystems<br/><b>Not yet recruiting</b> - verified January 2008
The Efficacy of Influenza Vaccination in Patients With Coronary Artery Diseases <b>Conditions</b>: Coronary Artery Diseases; Myocardial Infarction; Stable Angina<br/><b>Interventions</b>: Biological: influenza vaccine; Biological: placebo for influenza vaccine<br/><b>Sponsor</b>: Shaheed Beheshti Medical University<br/><b>Recruiting</b> - verified January 2008